Corporate & Foundation Relations

Health Sciences

Opportunities

**Added as of 9/24/2021

Pfizer Independent Medical Education Grant for Optimizing Patient Access to CDK 4/6 Inhibitors in the Armamentarium Against Metastatic Breast Cancer

Organization: Pfizer

Award amount: Up to $250,000

Deadline: 9/27/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. 

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP. 

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

The availability of CDK 4/6 inhibitors (CDK 4/6i) in combination with an aromatase inhibitor (AI) in HR+/HER2- Metastatic Breast Cancer (mBC) has led to additional months or years of progression free survival (PFS) for patients vs. an AI alone. 

The goal is to close gaps in care so that all HR+/HER2- mBC patients have equal access to this therapeutic option. All patients should have access to the same high quality of care as delivered by academic or NCI-designated cancer centers. 

The intent of this RFP is to increase healthcare professionals’ knowledge and understanding of the clinical trial and real world evidence for the CDK 4/6i class. 

Independent education proposals should include a plan for providing information on clinical trial design and results, real-world study design and results, real-world clinical experience, and best-practices in the treatment of HR+/HER2- mBC. 

The education should enable both clinical and access decision makers to better analyze, evaluate the quality of, and interpret relevant findings from randomized clinical trials and real world studies of CDK 4/6i, in terms of the validity, design, and source so that they can accurately interpret current evidentiary findings and incorporate this knowledge into their daily practice and decision making. 

The two audiences of interest for this RFP are as follows. Proposals may address one or both of these groups.

  1. Medical oncologists and the cancer care team in community settings including rural and underserved locations. 
  2. Institutional decision-makers such as managed-care professionals, pharmacy-managers, clinical pathway implementers, organized medicine leaders etc.

All activity formats will be considered under this RFP (live in-person, live virtual, enduring courses and materials, innovative technologies & platforms etc.)

Ongoing or continuous learning experiences are also in-scope such as the “telementoring” all-teach all-learn approach of Project ECHO from the University of New Mexico. 

This RFP is for medical education grants only. It is not our intent to support clinical research projects. Projects evaluating the efficacy / effectiveness of a therapeutic agent or diagnostic agents will not be considered. 

Eligibility: 

  • The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
  • If the project involves multiple departments within an institution and / or between different institutions / organizations / associations all institutions must have a relevant role, and the requesting organization must have a key role in the project.
  • For projects offering continuing education credit, the requesting organization must be accredited.

Link to complete RFP

Michael J. Fox Foundation for Parkinsons Research Therapeutic Pipeline Program

Organization: Michael J. Fox Foundation for Parkinson’s Research

Award amount: Up to $500,000

Deadline: pre-proposals due 9/28/2021

Description: This funding program — an Edmond J. Safra Core Program for PD Research — will support development of Parkinson’s disease (PD) therapeutics with potential for fundamentally altering disease course or significantly improving non-motor or motor symptoms.

Please note, this round, we are funding only pre-clinical studies. We will review applications for clinical studies in future rounds of this program.

The Therapeutic Pipeline Program funds novel approaches and interventions as well as repurposed or repositioned therapies approved or clinically safe from other disease indications. Pharmacological and non-pharmacological therapies are encouraged to apply.

Program Priorities:

  • Assay development, early screening campaigns, hit-to-lead and lead optimization
  • Proof-of-concept
  • Pharmacokinetics, pharmacodynamics and safety

Studies may request access to MJFF-sponsored biospecimen and cell line collections. 

Researchers from public and private institutions are encouraged to apply and to collaborate. 

Eligibility: Applications may be submitted by researchers or clinicians in:

  • U.S. and non-U.S. biotechnology/pharmaceutical companies, or other publicly or privately held for-profit entities; and
  • U.S. and non-U.S. public and private non-profit entities, such as universities, colleges, hospitals, laboratories, units of state and local governments and eligible agencies of the federal government.
  • Post-doctoral fellows are not eligible to apply as co-investigators in this call. 

As programs may require many kinds of expertise, MJFF encourages industry and academic collaborations when appropriate. 

Link to complete RFP

National Ataxia Foundation Young Investigator Award

Organization: National Ataxia Foundation

Award amount: Up to $50,000

Deadline: LOI due 9/28/2021

Description: The National Ataxia Foundation is committed to funding the best science relevant to hereditary and sporadic types of Ataxia in both basic and translational research.

The Young Investigator Award was created to encourage young clinical and scientific investigators to pursue a career in the field of Ataxia research. It is our hope that Ataxia research will be invigorated by the work of young, talented individuals supported by this award.

Eligibility: PIs:

  • Must have attained an MD or PhD degree
  • Must have an appointment as a junior faculty member, senior post-doc, or clinical fellow
  • Clinicians must have finished their residency no more than 5 years prior to applying
  • PhDs must be no more than 5 years from the end of completion of post-doc training
  • The sponsoring institution must agree in writing to the following provision: the Young Investigator must be able to allocate approximately half time (50%) for Ataxia related research.
  • Underrepresented minorities strongly encouraged to apply. 

NAF invites research applications from domestic and International nonprofit and for-profit institutions. Non-U.S. citizens are eligible to apply for a research grant from NAF.

Link to complete RFP

Pfizer Emerging Therapies in Alopecia Areata for Dermatologists Independent Medical Education Grant

Organization: Pfizer

Award amount: Up to $250,000

Deadline: 9/28/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. 

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP. 

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

The landscape of treatment for Alopecia Areata is advancing, with more evidence and potential breakthrough therapeutic options available to patients. Through this RFP it is our intent to support educational projects that focus on addressing knowledge and practice gaps specific to the recognition, diagnosis, treatment, and overall care management of Alopecia Areata (AA). 

Projects that will be considered for Pfizer support should focus on increasing the knowledge and understanding of: 

  • 1) Pathophysiology of AA with specific focus on JAK/TEC pathways
  • Epidemiology of the disease, including an understanding of the risk factors
  • Understanding the clinical manifestation of AA, including a holistic review of the burden of disease (e.g. psychosocial burden and associated autoimmune disorders)
  • Which patients require systemic therapies
  • Emerging therapies for AA, such as JAK/TEC inhibitors
  • Place in treatment of current treatment options and upcoming systemic therapies

Eligibility: 

  • The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
  • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project.
  • For projects offering continuing education credit, the requesting organization must be accredited.

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Link to complete RFP

Pfizer Pre-clinical & Translational Research in Multiple Myeloma

Organization: Pfizer

Award amount: Up to $150,000

Deadline: 9/28/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the research gaps as outlined in the specific RFP.

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program.

Only pre-clinical projects with a focus on these areas of interest will be considered for Pfizer support at this time:

  • Correlation between soluble B-cell Maturation Antigen (sBCMA) at baseline with FLC, M-spike, deepness of overall response, MRDnegativity, and response to prior therapy
  • Understanding the kinetics of sBCMA vs long-term responses (e.g., DoR, PFS, OS) in the context of bispecific treatment
  • Mechanisms of resistance (e.g., role of sBCMA in resistance/relapse; downregulation of membrane bound BCMA; T-cell exhaustion)
  • Correlation between Soluble BCMA and BCMA expression on myeloma cells (including assessment of gamma secretase activity)
  • Impact of prior treatment with BCMA-targeting agents on BCMA expression and sBCMA levels (including whether these prior treatments lead to BCMA mutations)
  • Mechanistic understanding of the impact of anti-myeloma agents (e.g., IMiDs, anti-CD38, proteasome inhibitors, dexamethasone) on elranatamab-mediated T-cell activation and anti-myeloma activity
  • Exploring in-vitro or in-vivo novel combinations with elranatamab (PF06863135) with a focus on drugs that are not currently SOC in myeloma
  • Immunosuppressive mechanisms in the bone marrow that negatively impact bispecific (elranatamab) activity
  • Comparative analysis of bone marrow aspirate transcriptomes between responders and non-responders to elranatamab

IMPORTANT NOTES:

  • Studies can be in-vitro or in-vivo or use existing patient samples (e.g. blood, bone marrow aspirates, etc.)
  • A limited amount of the Pfizer asset elranatamab (PF-06863135) is available and can be requested through this RFP for non-clinical studies

Eligibility: 

  • The institution and principal investigator (PI) must be based in one of the eligible countries noted above.
  • Only organizations are eligible to receive grants, not individuals or medical practice groups.
  • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy.
  • Applicant must be affiliated with a host institution

Link to complete RFP

American College of Surgeons Resident Research Scholarships

Organization: American College of Surgeons

Award amount: $30,000

Deadline: 9/30/2021

Description: The American College of Surgeons is offering two-year resident research scholarships. Eligibility for these scholarships is limited to the research projects of residents in surgery or a surgical specialty.

These scholarships are supported by the generosity of Fellows, Chapters, and friends of the College, to encourage residents to pursue careers in academic surgery.

Eligibility: 

  • The applicant must be a Resident Member of the College who has completed two postdoctoral years in an accredited surgical training program in the United States or Canada at the time the scholarship is awarded, July 1, 2022, and shall not complete formal residency training before June 2024. Scholarships do not support research after completion of the chief residency year.
  • The scholarship is awarded for two years, and acceptance of it requires commitment for the two-year period. The award is to support a research plan for the two years of the scholarship, July 2022 through June 2024. Priority will be given to the projects of residents involved in full-time laboratory investigation. Study outside the United States or Canada is permissible. Renewal of the scholarship for the second year is required and is contingent upon the acceptance of a progress report and research study protocol for the second year, as submitted to the Scholarships Section of the College by May 1, 2023.
  • Application for these scholarships may be submitted even if comparable application to other organizations has been made. If the recipient is offered a scholarship, fellowship, or research award from another organization, it is the responsibility of the recipient to contact the College’s Scholarships Administrator. The Scholarships Committee reserves the right to review potentially overlapping awards and adjust its award accordingly. Applicants who have previously won an award from another professional society are not eligible for this scholarship.
  • The scholarship is $30,000 per year; the total amount is to support the research of the recipient and may be used for salary or stipend, research materials, and travel related to the research. Indirect costs are not paid to the recipient or the recipient’s institution.
  • The scholar is expected to attend the Clinical Congress of the American College of Surgeons in 2024 to submit a report on the research as part of the Scientific Forum, and to receive a certificate at the annual meeting of the Scholarships Committee.
  • Approval of the application is required from the administration (dean or fiscal officer) of the institution. Supporting letters from the head of the department of surgery (or the surgical specialty) and from the mentor who will be supervising the applicant’s research must be submitted. The College encourages diversity of applicants and institutions; only in exceptional circumstances will more than one scholarship be granted in a single year to applicants from the same institution.

Link to complete RFP

American Heart Association and Enduring Hearts Research Awards in Pediatric Heart Transplantation

Organization: American Heart Association / Enduring Hearts

Award amount: $681,819 ($227,273 per year)

Deadline: 9/30/2021

Description: he American Heart Association (AHA) and Enduring Hearts (EH) share common priorities and interests in investing in biomedical research. Together, the AHA and EF have established this jointly funded request for applications (RFA) for the AHA/EH Research Awards in Pediatric Heart Transplantation.

EH was founded in 2013 with a mission to fund research to increase the longevity of, and improve the quality of life for,  pediatric heart transplant recipients.

The AHA was founded in 1924 and its mission is to be a relentless force for a world of longer, healthier lives. The AHA has invested more than $4.6 billion in research, making it the largest nonprofit funder of cardiovascular and cerebrovascular research outside the federal government.

These awards provide support for investigators who are committed to conducting research directly related to improving the life expectancy and quality of life of pediatric heart transplant recipients. This funding opportunity will further these areas of focus by offering competitive research grants in basic, clinical, population, and/or translational research via Collaborative Sciences Awards.

Proposals are encouraged from all basic science disciplines as well as epidemiological, behavioral, community and clinical investigations that bear on pediatric heart transplantation. Awards are open to the array of academic and health professionals. This includes but is not limited to all academic disciplines (biology, chemistry, engineering, mathematics, technology, immunology, physiology, etc.) and all health-related professions (physicians, nurses, advanced practice nurses, pharmacists, dentists, physical and occupational therapists, statisticians, nutritionists, behavioral scientists, health attorneys, biomedical engineers, psychologists, etc.). We strongly encourage applications from women, candidates from racial and ethnic groups underrepresented in the sciences, those who have experienced diverse and non-traditional career trajectories, and those whose research has previously been outside of cardiovascular science.

Clinical, translational, population, and basic scientists are encouraged to apply. AHA maintains dedicated Peer Review Committees by award type and subject. The extent to which the focus of the project is related to cardiovascular and/or cerebrovascular diseases is an important factor that will be considered. The applicant is not required to be a part of a cardiovascular/cerebrovascular-oriented laboratory, clinic or department.

Areas of Interest:

  • Improving longevity and quality of post-heart transplant life by reducing/eliminating rejection and Cardiac Allograft Vasculopathy (CAV) by: 
    • Integrating accurate non-invasive surveillance methods, technologies and biomarkers for care strategies, technologies, and methods towards EARLIER identification of the onset of acute cellular rejection (ACR), antibody-mediated rejection (AMR) and/or cardiac allograft vasculopathy (CAV)
    • Development of therapeutics and/or therapeutic strategies for acute cellular rejection (ACR), antibody-mediated rejection (AMR) and/or cardiac allograft vasculopathy (CAV)
    • Developing novel immunotherapies, identification of novel targets for immunosuppression, improving methods for monitoring and determining the optimal level of immunosuppression to prevent ACR, AMR, and/or CAV while reducing/eliminating secondary conditions that may arise due to immunosuppression (renal; infectious)
    • Development and validation of better experimental models to study the underlying mechanisms, therapies, and/or prevention of CAV
    • Developing more robust evidence for person-centered post-transplant care guidelines, including nutrition and exercise guidelines, and effective delivery of person-centered care.
    • Development of evidence-based strategies to improve the longevity of adolescent recipients
  • Additional consideration will be given to applications that: develop new technologies; include clinical research; include feasible clinical translations(s) to pediatric heart recipients.

Eligibility: 

  • At least one Co-PI must work in research directly related to pediatric heart transplantation.
  • At least one Co-PI must work in a different discipline (e.g. engineering, computer science, chemistry, mathematics, psychology, health law, genomics/genetics, etc.) and/or without prior focus in clinical pediatric heart transplantation.
  • At least one Co-PI must be an early-career (assistant professor or equivalent) or mid-career (associate professor or equivalent) investigator.
  • Co-PIs must each hold faculty/staff appointments.
  • Co-PIs must be independent researchers (i.e. must meet their institutions’ eligibility to apply for independent awards). This award is not intended for individuals in research training or fellowship positions.
  • Co-PIs may be from the same institution, or from different institutions.
  • Co-PIs must be from different disciplines and/or areas of expertise. For example: A collaboration between a clinician and a basic scientist or other collaboration that would not arise otherwise (organically).
  • Research awards are limited to U.S.-based non-profit institutions, including medical, osteopathic and dental schools, veterinary schools, schools of public health, pharmacy schools, nursing schools, universities and colleges, public and voluntary hospitals and others that can demonstrate the ability to conduct the proposed research. The primary Co-PI must be from an institution that fulfills this definition.

Link to complete RFP

American Psychiatric Association Kempf Fund Award for Research Development in Psychobiological Psychiatry

Organization: American Psychiatric Association

Award amount: $20,000

Deadline: 9/30/2021

Description: The Kempf Fund Award for Research Development in Psychobiological Psychiatry, established in 1988, recognizes a senior researcher who has made a significant contribution to research on the causes and treatment of schizophrenia as both a researcher and a mentor. An award is also made to support the career development of a young research psychiatrist working in a mentor-trainee relationship with the award winner. Funded by the estate of Dorothy C. Kempf.

Eligibility:

The senior researcher and young research psychiatrist must be:

  • Psychiatrists
  • Citizens or Permanent Residents of the U.S. or Canada

Link to complete RFP

Beckman Young Investigators (BYI) Program

Organization: Arnold and Mabel Beckman Foundation

Award amount: $600,000

Deadline: 9/30/2021

Description: The Beckman Young Investigator (BYI) Program provides research support to the most promising young faculty members in the early stages of their academic careers in the chemical and life sciences, particularly to foster the invention of methods, instruments and materials that will open up new avenues of research in science.

Projects proposed for the BYI program should be truly innovative, high-risk, and show promise for contributing to significant advances in chemistry and the life sciences. They should represent a departure from current research directions rather than an extension or expansion of existing programs. Proposed research that cuts across traditional boundaries of scientific disciplines is encouraged. Proposals that open new avenues of research in chemistry and life sciences by fostering the invention of methods, instruments and materials will be given additional consideration.

The BYI program funds promising young scientists early in their careers who have not yet received a major award from another organization. Proposals that already have substantial funding will not be considered for the BYI award (see eligibility for more information).

Projects are normally funded for a period of four years. Grants are in the range of $600,000 over the term of the project, contingent upon demonstrated progress after the second year of the award.

The Foundation does not provide for overhead or for indirect costs.

Eligibility:

  • The BYI program is open to those within the first three years of a tenure-track position, or an equivalent independent research appointment, at a United States academic or non-profit institution that conducts research in chemical and life sciences. Tenure-Track dates for the 2022 program must start after 1/1/2017 AND before 8/2/2021.
  • Candidates must be citizens or permanent residents of the United States at the time of application. Persons who have applied for permanent residency but have not received their government documentation by the time of application are not eligible.
  • No individual may apply for a Beckman Young Investigator award more than two times.
  • Investigators can have no more than $225,000 in direct, annualized external funding grants during any BYI Program Year (Aug-July) at time of application. Start-up funds, department-wide instrumentation grants, and “Transition” grants (such as NIH K99/R00) are not counted toward this total.
  • Institutions are not limited in the number of applicants who apply at the Letter of Intent stage.
  • Institutions with a currently funded BYI are eligible for award consideration.

Link to complete RFP

Benign Essential Blepharospasm Research Foundation Research Grants

Organization: Benign Essential Blepharospasm Research Foundation

Award amount: Up to $50,000

Deadline: 9/30/2021

Description: 

  • Funds of up to $50,000 for one year are available for support of research directly related to the cause of, treatment for, and complications derived from treatments for benign essential blepharospasm or Meige’s Syndrome, both forms of cranial dystonia.
  • Proposals for improvement of existing treatments and for new treatments (such as medical marijuana and neuroplasticity training for blepharospasm) are welcome.
  • Novel therapies for apraxia of eyelid opening, dry eye, and photophobia will also be considered for funding.

Eligibility: 

  • M.D. or Ph.D. is required for principal investigator.
  • Non-U.S. citizens working at institutions abroad are eligible to apply for a research grant.
  • The applicant seeking Foundation funding must be employed at a for-profit or non-profit organization or institution (each referred to as a “Grantee Institution”) within the United States, Canada, or those foreign countries where supervision of grant administration is possible. Such Grantee Institution must agree to be bound by these Terms and Conditions by signing this Application through its duly authorized representative. If the Grant Application is approved, the Grantee Institution will be the direct payee of the Foundation’s funding and receive such funding on behalf of the Recipient and will be solely responsible for the handling and disbursing of such funds in support of the Recipient’s research.

Link to complete RFP

Caplan Foundation for Early Childhood Grants

Organization: Caplan Foundation for Early Childhood

Award amount: Undisclosed. Previous awards up to $57,000.

Deadline: LOI due 9/30/2021

Description: The Caplan Foundation for Early Childhood is an incubator of promising research and development projects that appear likely to improve the welfare of young children, from infancy through 7 years, in the United States. Welfare is broadly defined to include physical and mental health, safety, nutrition, education, play, familial support, acculturation, societal integration and childcare.

Grants are only made if a successful project outcome will likely be of significant interest to other professionals, within the grantee’s field of endeavor, and would have a direct benefit and potential national application. The Foundation’s goal is to provide seed money to implement those imaginative proposals that exhibit the greatest chance of improving the lives of young children, on a national scale. Because of the Foundation’s limited funding capability, it seeks to maximize a grant’s potential impact.

The Foundation provides funding in the following areas:

  • Early Childhood Welfare
    • Children can only reach their full potential when all aspects of their intellectual, emotional and physical development are optimally supported.
    • Providing a safe and nurturing environment is essential as is imparting the skills of social living in a culturally diverse world. Therefore, the Foundation supports projects that seek to perfect child rearing practices and to identify models that can provide creative, caring environments in which all young children thrive.
  • Early Childhood Education and Play
    • Research shows that children need to be stimulated as well as nurtured, early in life, if they are to succeed in school, work and life. That preparation relates to every aspect of a child’s development, from birth to age seven, and everywhere a child learns – at home, in childcare settings and in preschool.
    • We seek to improve the quality of both early childhood teaching and learning, through the development of innovative curricula and research based pedagogical standards, as well as the design of imaginative play materials and learning environments.
  • Parenting Education
    • To help parents create nurturing environments for their children, we support programs that teach parents about developmental psychology, cultural child rearing differences, pedagogy, issues of health, prenatal care and diet, as well as programs which provide both cognitive and emotional support to parents.

Eligibility: ​The Foundation will not fund:

  • programs outside of the United States
  • the operation or expansion of existing programs
  • the purchase or renovation of capital equipment
  • the staging of single events (e.g. concerts, seminars, etc.)
  • the creation or acquisition of works of art or literature
  • the activities of single individuals or for-profit entities
  • political or religious organizations
  • programs with religious content
  • programs to benefit children residing in foreign countries
  • medical research applicable to both adults and children

Furthermore, the Foundation will only fund grant applications that define measurable outcomes, include credible methods for documenting and assessing results, provide for financial accountability in the application of funds, and include detailed, prudent implementation budgets.

Consistent with the Foundation’s mission, as an incubator of innovative research and development directed to improving the general welfare of young children, we will not fund more than the first year of multiple year projects. It is our belief that having multiple funders, of those worthy projects that demand more sustained efforts, increases the likelihood of their success by ensuring broader oversight and greater long term promotional possibilities.

Link to complete RFP

Memorial Sloan-Kettering Cancer Center Breast Pathology Fellowship

Organization: Memorial Sloan-Kettering Cancer Center

Award amount: Not disclosed

Deadline: 9/30/2021

Description: The Department of Pathology at Memorial Sloan Kettering Cancer Center offers one-year Breast Pathology Fellowship positions. All fellows should have completed residency training in anatomic pathology and be certified (or eligible for certification) by the American Board of Pathology.

The fellowship focuses on the characterization of mammary neoplasms and non-neoplastic diseases and emphasizes a multidisciplinary approach to patient management. Clinicopathologic and translational research is also an integral part of the training. The breast pathology fellows work closely with a cadre of breast pathology experts. The case material at MSK is especially complex and challenging and consists of both in-house specimens and submitted consultations. The breast pathology fellows actively participate in all clinical activities and present cases at the weekly multidisciplinary conference. The fellows are based at the state-of-the-art Evelyn H. Lauder Breast Center, and benefit from close interaction with a team of outstanding clinicians who specialize in the treatment of breast cancer patients. Selective rotations in the departments of surgery, radiology and radiation oncology enhance the understanding of the clinical aspects of breast diseases, and their implications for the practicing pathologist.

Eligibility: see the complete RFP for more information.

Link to complete RFP

Scleroderma Foundation New Investigator Grant Program

Organization: Scleroderma Foundation

Award amount: Up to $200,000

Deadline: 9/30/2021

Description: The Scleroderma Foundation is accepting applications for its New Investigator Grant Program, which supports new investigators who hold faculty or equivalent positions and who wish to pursue a career in research related to scleroderma. 

Grants of up to $50,000 per year for up to three years will support promising research that is likely to lead to individual research project grants. Appropriate research areas may include the following as they relate to scleroderma: scleroderma-related lung disease, pediatric scleroderma, vascular manifestations, studies of animal models, therapeutic modalities, mechanisms of end-organ damage, immunologic studies, endothelial cell biology, fibroblast biology, models and markers of gender and genetic factors, cell signaling, epidemiology studies, matrix biology, stem cell biology, and health services research (e.g., quality of life, healthcare delivery, and study of clinical manifestation). 

For the 2022 grant funding cycle, the foundation will award grants of up to $200,000 in the key areas of scleroderma-related lung disease research and pediatric scleroderma. An established investigator conducting scleroderma-related lung disease research will receive a specific, donor-funded grant of $200,000.

Eligibility: Applications may be submitted by U.S. nonprofit organizations, such as universities, colleges, hospitals, and laboratories. Foreign organizations and institutions are not eligible. Applicants must have a doctorate degree in medicine, osteopathy, veterinary medicine, or one of the sciences; and must have completed a postdoctoral fellowship by the grant award date.

For complete program guidelines and application instructions, see the Scleroderma Foundation website.

Link to complete RFP

Wiley Prize in Biomedical Sciences

Organization: Wiley Foundation

Award amount: $50,000

Deadline: 9/30/2021

Description: Since 2002, the annual Wiley Prize in Biomedical Sciences has recognized breakthrough research in pure or applied life science research.

The Wiley Prize in Biomedical Sciences, awarded by the Wiley Foundation, celebrates research that champions novel approaches and challenges accepted thinking in the biomedical sciences. It honors a specific contribution or series of contributions that demonstrate significant leadership or innovation in the development of research concepts or their clinical application.

Past prize winners have been chosen because of their breakthrough research in areas as diverse as genetics, cell motility, folded proteins and siRNA. The impressive list of past recipients includes winners of the Nobel Prize and the Lasker Prize in basic medical research.

The Wiley Foundation invites and encourages the nomination of exceptional scientists or research teams whose work has achieved an impressive level of excellence. Nominations for the prize are accepted up through the end of September each year. Each nomination should be submitted by someone other than the nominee. More than one nomination can be made from the same organization and international nominations are encouraged.

Link to complete RFP

Alzheimers Drug Discovery Foundation Drug Development Program

Organization: Alzheimer’s Drug Discovery Foundation

Award amount: $600,000

Deadline: LOI due 10/1/2021

Description: The Drug Development RFP seeks to support in vivo preclinical studies that advance lead molecules developed for Alzheimer’s disease and related dementias to IND-enabling studies. The proposed studies should be structured to deliver a compound with strong potential for clinical and commercial application.

This funding opportunity prioritizes novel drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP.

Stage of discovery:

  • Preclinical pharmacokinetics (PK) and pharmacodynamics (PD) (primarily in wild-type animals to inform dose selection for in vivo efficacy studies), as well as preliminary rodent tolerability studies
  • In vivo efficacy or proof-of-concept studies in animal models of disease or aging, with a focus on measures of direct and indirect markers of target engagement and downstream pharmacologic effects
  • Please note: Applications that focus on basic research (including target discovery), assay development, and screening to identify hit compounds are not a priority for this RFP and will be withdrawn
  • Please note: IND-enabling work and clinical trials are supported through the Program to Accelerate Clinical Trials.(PACT) RFP

Therapeutic modalities: Includes small molecules, biologics, gene therapies, antisense oligonucleotides, and stem cells. Development of novel devices or delivery systems will not be considered for this RFP.

Drug mechanisms or modes of action: Novel drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia are considered high priority. These include, but are not limited to:

  • Epigenetics
  • Inflammation
  • Mitochondrial & metabolic function
  • Neuroprotection
  • Proteostasis
  • Synaptic activity and neurotransmitters
  • Vascular function
  • Other mechanisms and modes of action related to the biology of aging (e.g. senescent cells)
  • Other novel mechanisms or modes of action that are supported by compelling evidence demonstrating a rational biological connection to the disease process
  • Please note: Anti-amyloid approaches (e.g., anti-amyloid aggregation, beta-amyloid vaccines, beta- or gamma-secretase inhibitors) and cholinesterase inhibitor proposals will not be considered

Eligibility: Funding is open to researchers and clinicians worldwide at:

  • Academic medical centers and universities or nonprofits. Industry partnerships are encouraged.
  • Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are both eligible.

Link to complete RFP

Alzheimers Drug Discovery Foundation Neuroimaging and CSF Biomarker Program

Organization: Alzheimer’s Drug Discovery Foundation

Award amount: Up to $600,000

Deadline: LOI due 10/1/2021

Description: The aim of this RFP is to further develop and validate established biomarkers for which there is a clear clinical need in Alzheimer’s disease and related dementias. This RFP prioritizes biomarkers with a defined context of use, a clear advantage over other relevant biomarkers, and a path to commercialization and/or clinical use.

Specifically, this RFP focuses on:

  • developing novel PET ligands for clinical trials
  • supporting novel CSF biomarkers
  • validating established MRI approaches in larger cohorts

Novel biomarkers of neuroinflammation, synaptic integrity, autophagy and TDP-43 are high priority. Other target areas of interest include:

  • Neuronal loss
  • Vascular injury and blood-brain barrier integrity
  • Mitochondria and metabolic function
  • Protein misfolding
  • Oxidative stress
  • White matter changes
  • Lewy body dementia
  • Other novel targets supported by compelling biological rationale and connection to disease

Eligibility: Funding is open to researchers and clinicians worldwide at:

  • Academic medical centers and universities or nonprofits. Industry partnerships are encouraged.
  • Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are both eligible.

Link to complete RFP

Alzheimers Drug Discovery Foundation Prevention Pipeline Program

Organization: Alzheimer’s Drug Discovery Foundation

Award amount: Up to $3,000,000

Deadline: LOI due 10/1/2021

Description: The Alzheimer’s Drug Discovery Foundation (ADDF) is inviting applications to its Prevention Pipeline program. Awards will be made in support of comparative effectiveness research, studies of cognitive symptoms due to health conditions, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.

The Prevention Pipeline RFP supports:

  • Studies of Cognitive Decline and Risk Reduction: Cognitive decline through aging and health conditions has been linked to an increased risk of dementia. ADDF will consider funding programs to prevent and treat these conditions, including menopause-related cognitive symptoms, postoperative delirium, and postoperative cognitive decline, mild and/or repetitive traumatic brain injury, and chemotherapy-induced decline. Methods may include epidemiology or clinical trials.
  • Comparative Effectiveness Research: For many health conditions, physicians have a choice of clinically equivalent drugs. Some of these drugs are being investigated for repurposing to treat Alzheimer’s or related dementias, due to potential disease-modifying properties that go beyond the treatment of their approved disease indication. ADDF will consider funding research to generate an evidence base on whether choices in the routine clinical care of pre-existing conditions could protect from dementia. Priority will be given to the comparison of drugs that are otherwise clinically equivalent for the pre-existing condition. Methods may include randomized trials or epidemiology.
  • Studies Leveraging the Consortium of Cohorts for Alzheimer’s Prevention Action: Epidemiological studies contribute unmatched information on whether the risk of dementia or cognitive decline may be influenced by long-term exposure to supplements or medications. However, high-powered studies are needed, ideally with dose, duration, and responder profiles, to translate epidemiological research into actionable interventions for testing. Through the CAPA Consortium, ADDF funds collaborative analyses on dementia prevention using a minimum of five longitudinal cohorts, either harmonized or analyzed through parallel analysis of cohorts using a shared analysis script.

Grants of up to $3,000,000 will be awarded for clinical trials based on stage and scope of research.

Eligibility: Eligible applicants include researchers and clinicians at academic medical centers, universities, nonprofits, and biotechnology companies worldwide. Existing companies and new spinouts also are eligible, and industry partnerships are strongly encouraged.

For complete program details, eligibility criteria, and a link to the application portal, see the Alzheimer’s Drug Discovery Foundation website.

Link to complete RFP

Alzheimers Drug Discovery Foundation Program to Accelerate Clinical Trials

Organization: Alzheimer’s Drug Discovery Foundation

Award amount: Up to $3,000,000

Deadline: LOI due 10/1/2021

Description: The PACT RFP supports IND-enabling studies and early-phase clinical trials that test promising pharmacological interventions and devices for Alzheimer’s disease (AD) and related dementias. Both disease-modifying and symptomatic agents will be considered.

This funding opportunity prioritizes diverse drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia. For this reason, amyloid targeted approaches and cholinesterase inhibitor proposals will not be considered for this RFP.

Stage of development:

  1. Early-stage human clinical trials including:
    • Phase 0 micro- or sub-therapeutic-dosing studies
    • Phase 1 trials in healthy subjects
    • Biomarker-based proof-of-concept studies (generally phase 1b or phase 2a trials) designed to assess target engagement and downstream pharmacologic effects
  2. Regulatory studies including:
    • Non-GLP and GLP pharmacology and toxicology studies, pre-formulation, and GMP manufacture required for investigational new drug (IND) and clinical trial authorization (CTA) preclinical packages. Funding is available for preparation of traditional and exploratory IND applications
    • Long-term toxicology studies to enable longer-term dosing in phase 2 trials
    • GMP manufacturing and testing of clinical grade drug required to move into phase 2 or phase 3 trials

For clinical trial applications, if IND-enabling work is in progress, funding for clinical studies would be contingent upon an IND (or equivalent) being granted and full review of the data package.

Type of therapy: Novel, repurposed and repositioned drugs, as well as natural products and devices will be considered. Therapeutic modalities of interest include small molecules, peptides, antibodies, gene therapies, antisense oligonucleotides, and stem cells. Other non-pharmacologic interventions, such as diet, meditation, and exercise, will not be considered.

Drug mechanisms or modes of action: Novel drug mechanisms and modes of action related to the biology of aging and other emerging therapeutic areas for dementia are considered high priority. These include, but are not limited to:

  • Epigenetics
  • Inflammation
  • Mitochondrial & metabolic function
  • Neuroprotection
  • Proteostasis
  • Synaptic activity and neurotransmitters
  • Vascular function
  • Other mechanisms and modes of action related to the biology of aging (e.g. senescent cells)
  • Other novel mechanisms or modes of action that are supported by compelling evidence demonstrating a rational biological connection to the disease process
  • Please note: Anti-amyloid approaches (e.g., anti-amyloid aggregation, beta-amyloid vaccines, beta- or gamma-secretase inhibitors) and cholinesterase inhibitor proposals will not be considered

Eligibility: Funding is open to researchers and clinicians worldwide at:

  • Academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged.
  • Biotechnology companies. Funding is provided through mission-related investments that require return on investment based upon scientific and/or business milestones. Existing companies and new startups are both eligible.

Link to complete RFP

American Academy of Neurology Career Development Award

Organization: American Academy of Neurology

Award amount: $450,000

Deadline: 10/1/2021

Description: Founded in 1948, the American Academy of Neurology represents more than thirty-six thousand members and is dedicated to promoting the highest quality patient-centered care and enhancing member career satisfaction.

To that end, AAN invites applications for its Career Development Award. Grants of $150,000 per year for three years will be awarded in support of junior investigators interested in an academic career in neurology. Investigators may also be interested in clinical, basic, or translational neurological research.

Eligibility: Recipients of individual K or R awards are not eligible to apply for the Career Development Award (CDA). Applicants are allowed to apply for the AAN CDA and other federally funded career development awards (including NIH K awards and VA CDAs) or other career development awards supported by foundations of a similar scope simultaneously. To be eligible to apply for this award, the applicant’s other grant source(s) cannot exceed $150,000 annually.

Applicants must be a neurologist and an AAN member who completed residency between five and ten years prior to the start date of the Career Development Award (July 1, 2022). For those who have completed both residency and a PhD, eligibility is based on when residency was completed.

For complete program guidelines and application instructions, see the American Academy of Neurology website.

Link to complete RFP

American Academy of Pediatric Dentistry Community-Based Initiatives

Organization: American Academy of Pediatric Dentistry

Award amount: Up to $20,000

Deadline: 10/1/2021

Description: The American Academy of Pediatric Dentistry (AAPD) Foundation is committed to supporting community-based initiatives that provide dental care and will ultimately serve as a “Dental Home” to underserved/limited-access children.

To that end, the foundation is inviting applications for its Access to Care Grants program, which will award up to $20,000 in support of U.S.-based community-based initiatives that provide dental care and will ultimately serve as a dental home to underserved/limited-access children. 

The AAPD defines a “Dental Home” as the ongoing relationship between the dentist and the patient, inclusive of all aspects of oral health care, delivered in a comprehensive, continuously accessible, coordinated, and family-centered way. The Dental Home should be established by no later than twelve months of age to help children and their families institute a lifetime of good oral health. A Dental Home addresses anticipatory guidance and preventive, acute, and comprehensive oral health care and includes referral to dental specialists when appropriate.

Eligibility: Eligible applicants include nonprofit organizations as defined under section 501(c)(3) or 501(c)(6) of the Internal Revenue Code; local health jurisdictions; county health departments; hospitals and clinics; state government agencies; colleges/schools of dentistry; colleges/schools of medicine (pediatric and family medicine departments only); and national, state, and local dental societies.

For complete program guidelines and application instructions, see the AAPD Foundation website.

Link to complete RFP

AAAS Michelson Philanthropies & Science Prize for Immunology

Organization: American Association for the Advancement of Science

Award amount: $10,000-$30,000

Deadline: 10/1/2021

Description: The Michelson Philanthropies & Science Prize for Immunology focuses on transformative research in human immunology, with trans-disease applications to accelerate vaccine and immunotherapeutic discovery. This international prize is intended to encourage and support young investigators from a wide range of disciplines, including computer science, artificial intelligence/machine learning, protein engineering, nanotechnology, genomics, parasitology and tropical medicine, neurodegenerative diseases, and gene editing, who apply their expertise to perform research that has a lasting impact on vaccine and immunotherapy. The prize will be awarded annually to one young scientist based on work done in the past 3 years.

Eligibility: 

  • Applicants must be no older than thirty-five (35) years of age and must hold an M.D., PhD., or M.D./Ph.D. at the time of entry.
  • The entrant’s essay must describe contributions to human immunology research based in their field of study.
  • The entrant must have performed or directed the work described in the essay.
  • The research must have been performed during the previous 3 years.
  • Employees of Michelson Philanthropies, its subsidiaries, Science and AAAS, and their relatives are not eligible for the prize.

Link to complete RFP

American Academy of Neurology Foundation Clinical Research Training Scholarships

Organization: American Academy of Neurology Foundation

Award amount: $65,000

Deadline: 10/1/2021

Description: The American Academy of Neurology is pleased to support clinical research training in the neurosciences. This award aims to recognize the importance of good clinical research and to encourage young investigators in clinical studies. The AAN Research Program demonstrates the AAN Board of Directors’ dedication to promoting neurology and neuroscience research and training.

Each award will consist of a commitment of $65,000 per year for two years, plus a $10,000 per year stipend to support education and research-related costs for a total of $150,000. Supplementation of the award with other grants is permissible, but to be eligible to apply for this award, the other grant source(s) cannot exceed $75,000 annually. 

Eligibility: 

  • For the purpose of this scholarship, research is defined as “patient-oriented research conducted with human participants, or translational research specifically designed to develop treatments or enhance diagnosis of neurologic disease. These areas of research include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.” Disease-related studies not directly involving humans or human tissue are also encouraged if the primary goal is the development of therapies, diagnostic tests, or other tools to prevent or mitigate neurological diseases.
  • Recipient must be an AAN member interested in an academic career in neurological research who has completed residency or a PhD no more than 5 years prior to the beginning of this award (July 1, 2022). If you have completed both residency and a PhD, your eligibility is based on when you completed residency. If you completed a fellowship of any kind after residency, your eligibility is still based on the date you finished residency.
  • Applicants at accredited US and international institutions are eligible

Link to complete RFP

American Roentgen Ray Society Annual Scholarships in Radiology

Organization: American Roentgen Ray Society

Award amount: $180,000 over two years

Deadline: 10/4/2021

Description: Founded in 1900, the American Roentgen Ray Society (ARRS) is the first radiology society in the United States, where it has served as a forum for progress in radiology since shortly after the discovery of the X-ray, and is dedicated to the advancement of medicine through the science of radiology and allied disciplines.

To advance its mission, ARRS welcomes nominations for the 2022 ARRS Scholarship, which supports early-career faculty members to study or research the radiologic sciences and explore ways to change the way radiology is practiced. Scholarship awards of $180,000 over two years are intended to provide salary support; cover the cost of scholarship-related travel (including travel to the ARRS annual meeting for selection and presentation years); and support scholars’ study related to the project plan, including study outside the parent institution (training/tuition expenses may not exceed 20 percent of total scholarship funding).

Up to two awards are given annually. Medical schools, affiliated hospitals, and clinical research institutions with interest in training and research related to diagnostic radiology, nuclear medicine, the basic sciences, or professions fundamental to imaging techniques are invited to submit one nomination per year.

Eligibility: To be eligible, candidates must be an ARRS member at the time the application is submitted and for the duration of the award; have earned an MD or DO (or equivalent) from an accredited institution and completed all required residency and fellowship training; and have held a full-time faculty appointment as a lecturer, instructor, assistant professor, or equivalent for no more than five years beyond their initial faculty appointment. The appointment must be in a department of radiology, nuclear medicine, or associated department in the radiologic sciences of a medical school teaching hospital in the United States or Canada.

For complete program guidelines and application instructions, see the American Roentgen Ray Society website.

Link to complete RFP

Association for Frontotemporal Degeneration Clinical Research Training Scholarship

Organization: Association for Frontotemporal Degeneration

Award amount: $150,000

Deadline: 10/1/2021

Description: The 2022 Clinical Research Training Scholarship, a new funding opportunity specifically for clinician scientists, continues AFTD’s long-standing commitment to supporting the next generation of FTD researchers. Funded by AFTD thanks to the generous support of the Holloway Family Fund, with additional support from the American Brain Foundation in collaboration with the American Academy of Neurology, the Clinical Research Training Scholarship supports (1) patient-oriented research or (2) translational research designed to advance the treatment or diagnosis of FTD. Eligible projects include epidemiologic or behavioral studies, clinical trials, studies of disease mechanisms, the development of new technologies, and health services and outcomes research.

Eligibility: This funding opportunity is open to U.S. and international applicants who:

  • Are AAN members
  • Are interested in an academic career in neurological research
  • Have completed their residency or a PhD no more than 5 years prior to the beginning of this award. Eligibility of applicants who have completed both residency and a PhD is based on when they completed residency.

Link to complete RFP

BrightFocus Foundation Macular Degeneration Research Grants

Organization: BrightFocus Foundation (formerly American Health Assistance Foundation)

Award amount: Not disclosed

Deadline: 10/1/2021; 6/1/2022

Description: BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of age-related macular degeneration.

Postdoctoral Fellowship Program

This fellowship program is intended to support young postdoctoral researchers during their final stages of mentored training. The award provides salary support for a young scientist to conduct postdoctoral studies in an established laboratory focused on research contributing to understanding the biological causes and/or new clinical treatment of macular degeneration and should also serve as the basis for the applicant’s own independent research career.

New Investigator Grant Program

This research grant is intended to support investigators during their early years as an independent investigator involved in studies that have an impact on the causes and/or treatment of macular degeneration.

Innovative Research Grants

This program is intended to provide support for high-risk/high-gain age-related macular degeneration research. We hope to attract established investigators to apply for this support, but the aims of the application must contain outside-the-box ideas that are novel in the field. Applicants who are experts in another field are encouraged to apply their talents to proposing innovative research in the macular degeneration field.

Eligibility:

Eligibility is limited to non-profit institutions, or government research facilities.

Link to complete RFP

Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS)

Organization: Burroughs Wellcome Fund

Award amount: $700,000

Deadline: 10/1/2021

Description: The Burroughs Wellcome Fund is committed to fostering the development of the next generation of biomedical scientists and is committed to supporting degree-granting institutions to achieve this goal. The career development of young scientists has been a major funding theme at BWF and various programs have provided major support to promising young scientists to help them make the transition from late postdoctoral training to early faculty service. 

The Career Awards for Medical Scientists (CAMS) was introduced in 2007 to specifically address the declining participation of physicians engaged in academic biomedical research. The CAMS award provides support to facilitate the transition from mentored position to independence for the early career physician scientist. The program is ideal for the physician scientist considering an academic career.

CAMS is a highly competitive program that provides $700,000 in support over five years for physician scientists (M.D., D.O., D.V.M., D.D.S.), who are committed to an academic career, to bridge postdoctoral/fellowship training and the early years of faculty service.

Proposals must be in the area of basic biomedical, disease-oriented, or translational research. Proposals in health services research or involving large-scale clinical trials are not eligible. BWF anticipates making up to 14 awards including up to two awards to clinically trained psychiatrists who focus their research at the interface between psychiatry and neuroscience

Eligibility: Competitive candidates for the CAMS award will have at least two years of research experience, be two years away from becoming an independent investigator, be a first author on at least one publication in a high impact top-tier journal, and have a significant publication record.

Applications must be approved and signed by an official responsible for sponsored programs (generally from the grants office, office of research, or office of sponsored programs) at the degree-granting institution. Candidates should contact one of these offices for an authorized signature before submitting the grant application. The following eligibility requirements must be adhered to and will be strictly enforced.

  • Candidates must hold an M.D., D.D.S., D.V.M., or D.O. degree.
  • Candidates must not be more than 13 years past their clinical doctorate degree. To meet this requirement, applicants must have received their clinical doctorate degree on or after January 1, 2005.
  • Candidates may hold a junior faculty appointment (Lecturer, Instructor, Assistant Professor-non-tenure track, etc.). However, candidates with tenure track appointments are not eligible.
  • Candidates that have non-tenure track faculty appointments with institutional start-up funds or hold an NIH R01 are not eligible.
  • Candidates must submit proposals through accredited, degree-granting institutions in the U.S. or Canada. Candidates must obtain approval and signature by an authorized official at the degree-granting university in the U.S. or Canada.
  • An authorized official at the degree-granting institution must verify candidate’s immigration status as part of the application.

BWF will make up to two additional awards to clinically trained psychiatrists who focus on research at the interface between neuroscience and psychiatry. These proposals must clearly demonstrate evidence of integration of neuroscience and psychiatry in project design.

Link to complete RFP

Gairdner Foundation Canada Gairdner Awards for Biomedical Scientists

Organization: Gairdner Foundation

Award amount: $100,000

Deadline: 10/1/2021

Description: The Canada Gairdner Awards recognize the world’s most creative and accomplished biomedical scientists who are advancing humanity and the world.

Annually, seven awards are given: five Canada Gairdner International Awards for biomedical research, the John Dirks Canada Gairdner Global Health Award, specifically for impact on global health issues, and the Canada Gairdner Wightman Award, reserved for a Canadian scientist showcasing scientific excellence and leadership.

Each laureate receives $100,000 CDN that they can put towards anything they wish. Laureates have put their winnings towards their labs, their research or even paid for their niece to attend medical school.

The Gairdner Foundation is committed to increasing the diversity and gender equity of our awards.

Eligibility: See the complete RFP for eligibility criteria

Link to complete RFP

Mike Slive Foundation for Prostate Cancer Research Research Grant

Organization: Mike Slive Foundation for Prostate Cancer

Award amount: $50,000

Deadline: 10/1/2021

Description: Guided by a commitment to find a cure for prostate cancer, the Mike Slive Foundation for Prostate Cancer Research funds pilot grants for innovative research in an effort to allow researchers to establish proof-of-concept when applying for larger, highly competitive federal grants.

Research projects may focus on any topic related to the scientific study of prostate cancer, including but not limited to the prevention, diagnosis, treatment, or etiology of prostate cancer. The investigation of these topics may be basic, translational, behavioral, or clinical in nature. Please visit our website for a list of previously funded projects. At this time, the application is open to faculty researchers only. 

Eligibility: Scientific investigators or health professionals who are currently funded for any project by the tobacco industry or have been funded in the previous five years, will not be eligible for research grants awarded by the Mike Slive Foundation for Prostate Cancer Research. Any grant awardees who accept tobacco industry funding during the term of a grant must immediately inform the Mike Slive Foundation.

The Mike Slive Foundation defines tobacco industry funding as monies and/or compensation provided or used for all or any of the costs of the research, including personnel, meetings and conferences, consumables, equipment, buildings, travel, and operating costs for laboratories and offices. Furthermore, the Mike Slive Foundation considers tobacco industry funding as monies and/or compensation provided by a company that is engaged, or whose affiliates are engaged, in the manufacture of tobacco products intended for human use; monies and/or compensation provided in the name of a tobacco brand, whether or not the brand name is used solely for marketing and production of tobacco goods; and monies and/or compensation from a body set up by the tobacco industry or by one or more companies in the industry. 

Link to complete RFP

Rally Foundation Collaborative Pediatric Cancer Research Awards

Organization: Rally Foundation

Award amount: Up to $100,000

Deadline: LOI due 10/1/2021

Description: Rally Foundation for Childhood Cancer Research (Rally) helps fund the most promising research initiatives, and we continue to invest in projects as they make progress. To streamline the grant application process for researchers, reviewers and other childhood cancer organizations, we founded A Collaborative Pediatric Cancer Research Awards Program utilizing ProposalCENTRAL for application submission.

Award Categories:

  • Fellowship Grants – Grants are for one or two years of support. At the end of the award you may apply for additional funding the next grant cycle. Each funded grant will be awarded up to $50,000 per year.
  • Young Investigator and Independent Investigator Grants – Grants are for one or two years of support. At the end of the award you may apply for additional funding the next grant cycle. Each funded grant will be awarded up to $50,000 per year.
  • Consortium Grants (three or more institutions collaborating on a grant-supported research project): Grants are for one or two years of support. At the end of the award you may apply for additional funding the next grant cycle. Each funded grant will be awarded up to $100,000 per year.

Eligibility: Fellows, Research Scientists, Instructors and Professors with MD or DO and/or PhD degrees.

Link to complete RFP

Society for Research in Child Development Victoria S. Levin Award For Early Career Success in Young Children’s Mental Health Research

Organization: Society for Research in Child Development

Award amount: Up to $25,000

Deadline: 10/1/2021

Description: In tribute to Vicki’s role as a guiding light in the early careers of many distinguished scientists, the Victoria S. Levin Award has been established. Its aim is to foster early career success in achieving funding for research that is informed by developmental science to address concerns affecting the early foundations of children’s mental health. The Award will add measurably to Vicki’s dream of a society in which all children are protected from disabling mental health problems by getting the healthiest start in life. Vicki believed strongly in the NIH’s critical role in creating a scientific basis for achieving this goal and in the need to attract the best and brightest new scientists. Therefore, the Victoria S. Levin Award is designed to increase the likelihood that promising early career scientists succeed in securing NIH funding. The Award of up to $25,000 USD serves the promising pre-tenured, early career investigator by:

  • Supporting release time from duties during which time the awardee writes and submits an application in the area of early childhood mental health to the NIH. This support compensates the awardee’s unit/department for the work from which the awardee is released. Having adequate time to develop and submit a grant application is essential for early career success. [Applicants must provide institutional and department assurance signifying acceptance of this guideline.]
  • Providing travel funds for a trip to NIH to meet program staff. This support helps the awardee develop meaningful contacts with NIH program staff who can guide the application preparation and revision (funding usually requires two application submissions).
  • Providing a pre-review of the application. The opportunity to hire a distinguished scientist to review the application in advance of submission to NIH heightens the chances of early success. In addition to providing a critique, the reviewer can also advise the new scientist, which NIH review panels cannot do.

Eligibility: 

  • Be employed at a nonprofit institution, either in the United States or abroad. In most instances, these organizations will have 501(c)(3) tax exempt status, set up to receive and process grants and awards. However, in rare cases, colleges or universities (such as Arizona State University) will not have 501(c)(3) tax exemption. If your institution fits into this category, we can instead accept an IRS determination letter which states that it is classified as a school under sections 509a1 and 170b1Aii of the IRS Code;
  • Be committed to submitting a major NIH application (e.g., R or K mechanism);
  • Show evidence of experience conducting research that addresses issues of compelling relevance for early childhood mental health theory, policies or practices. In keeping with Vicki’s passionate interest in the sensitive and formative nature of early childhood for the development of mental health, and the need for scientific research that informs early intervention both preventive and therapeutic, applications should clearly articulate their relevance to the development of mental health in early childhood. All applications and especially those involving research with individuals beyond the elementary school years must explain the pertinence of the planned research to the first years of life. Longitudinal research is of high interest to the Foundation, as is experimental work with typically developing or atrisk children. In all cases, the proposed research must have clear application to the promotion of mental health or the prevention of mental disorders in young children;
  • Have received a doctoral degree (or equivalent) within ten years of submitting the application. In many scholarly disciplines this translates to a maximum of ten years following the Award of the doctoral degree and includes time spent as a post-doctoral fellow. In medicine, the ten-year maximum is dated from the completion of the first residency;
  • Have a mentor who is an established investigator in NIH-funded early childhood mental health research. Applicants are advised to select as a mentor an individual other than their dissertation supervisor. The mentor will often not be at the same institution but may be. There must be clear evidence of the mentor’s role and commitment to supporting the awardee’s application; and
  • Be a current member in good standing of the Society for Research in Child Development.

Link to complete RFP

American Association of Anatomists Postdoctoral Fellowship Program

Organization: American Association of Anatomists

Award amount: $20,000

Deadline: 10/5/2021

Description: The Postdoctoral Fellowship is intended to provide salary support to an AAA member who is a postdoctoral trainee working in any aspect of biology relevant to the anatomical sciences. AAA will provide $20,000, plus travel support and registration fee (at early registration rate) to the next appropriate AAA Annual Meeting. The postdoc’s laboratory must supplement this stipend with funds that equal or exceed the NIH standard salary support for postdoctoral fellows. In addition, the laboratory must provide funds for health insurance for the postdoctoral fellow.

Eligibility: 

  • Applicants must be a current member and are expected to remain a member for the duration of the fellowship.
  • Candidates should be working on a research project encompassing any aspect of biology that is relevant to the anatomical sciences. Approaches can include (but are not limited to): cellular, molecular, genetic, or histological techniques, and/or emphasize development, evolution, morphology or human health.
  • Candidates should have all requirements of doctoral degree completed at the time of submission of fellowship application.
  • Women and underrepresented minority candidates are encouraged to apply

Link to complete RFP

National Ataxia Foundation Pioneer SCA3/MJD Translational Research Awards

Organization: National Ataxia Foundation

Award amount: Up to $100,000

Deadline: LOI due 10/5/2021

Description: The National Ataxia Foundation is committed to funding the best science relevant to hereditary and sporadic types of Ataxia in both basic and translational research.

The Pioneer SCA3/MJD Translational Research Award is for a research project that will facilitate the development of treatments for Spinocerebellar Ataxia Type 3/Machado Joseph Disease.

Eligibility: PIs must be an established Ataxia researcher.

NAF invites research applications from domestic and International nonprofit and for-profit institutions. Non-U.S. citizens are eligible to apply for a research grant from NAF.

Link to complete RFP

National Ataxia Foundation Post-doctoral Fellowship Award

Organization: National Ataxia Foundation

Award amount: Up to $35,000

Deadline: LOI due 10/5/2021

Description: The National Ataxia Foundation is committed to funding the best science relevant to hereditary and sporadic types of Ataxia in both basic and translational research.

Post-doctoral fellowship awards are to serve as a bridge from post-doctoral positions to junior faculty positions. Applicants should have shown a commitment to research in the field of Ataxia.

Eligibility:

  • Completed at least 1 year post-doctoral training but not more than 2 years at time of application
  • Award will permit individuals to spend an additional third year in a post-doctoral position and increase chances to establish an independent Ataxia research program
  • Underrepresented minorities strongly encouraged to apply. 

Link to complete RFP

Patient-Centered Outcomes Research Institute Comparative Effectiveness of Multimodal Interventions to Prevent Osteoporotic Fractures -- Cycle 3 2021

Organization: Patient-Centered Outcomes Research Institute

Award amount: Undisclosed. $40M total funds available.

Deadline: LOI due 10/5/2021

Description: The Patient-Centered Outcomes Research Institute (PCORI) intends to release a Targeted PCORI Funding Announcement on September 7, 2021, seeking to fund high-quality, comparative effectiveness research projects that focus on multimodal interventions to prevent fractures in people with osteoporosis and a history of a fracture. This preannouncement is provided to allow potential applicants additional time to identify collaborators; obtain stakeholder input on potential studies; and develop responsive, high-quality proposals.

Fracture is a significant consequence from osteoporosis with estimates of one in two women and up to one in four men experiencing a fracture in their lifetime due to osteoporosis, which translates to about 2 million people affected annually. Consequences of osteoporotic-related fractures include significant mortality and morbidity, with decreases in functional independence, quality of life, and ability to live in the community. Another consequence of fracture is a subsequent fracture, with about 10 percent refracturing within 1 year and 30 percent within 5 years.

Osteoporosis treatment is multimodal and includes drug therapies and nonpharmacological interventions. While evidence exists for single interventions, broad evidence gaps exist around multimodal interventions to prevent second fractures and stakeholders have identified more research as a priority. 

This Targeted PCORI Funding Announcement will solicit applications that respond to the following question: 

  • What is the comparative effectiveness of multimodal treatment interventions (i.e., combination of pharmacologic and/or non-pharmacologic) on patient-centered outcomes in people with osteoporosis and a history of fractures?

Proposed studies should compare the effectiveness of pharmacological and/or nonpharmacological combination interventions. PCORI is interested in comparing combinations and/or sequences of interventions that are either in common use, have suggested efficacy, or have strong theoretical underpinnings. Regardless, proposed combinations or sequences of interventions should address actual clinical choices or dilemmas faced by patients, caregivers, and clinicians in specific practice settings.

Studies should focus on postmenopausal women and on men with osteoporosis and a history of fracture. Underrepresented groups from previous studies (e.g., men and women in racial/ethnic groups other than Caucasian) are of particular interest. 

Eligibility: See complete funding opportunity and full funding announcement on 9/7/21.

Link to complete RFP

Patient-Centered Outcomes Research Institute Comparative Effectiveness of Novel Pharmacologic and Evidence-Based Nonpharmacologic Treatments for Migraine Prevention -- Cycle 3 2021

Organization: Patient-Centered Outcomes Research Institute

Award amount: Undisclosed. $40M total funds available.

Deadline: LOI due 10/5/2021

Description: The Patient-Centered Outcomes Research Institute (PCORI) intends to release a Targeted PCORI Funding Announcement (PFA) on September 7, 2021, seeking to fund rigorous, large-scale pragmatic trials that compare newly available pharmacologic and/or evidence-based nonpharmacologic treatments for the prevention of migraine. This preannouncement is provided to allow potential applicants additional time to identify collaborators; obtain stakeholder input on potential studies; and develop responsive, high-quality proposals.

Migraine is a highly prevalent chronic neurological disorder characterized by recurrent attacks and associated with symptoms that include nausea, pain, vomiting, and sensitivity to light and sound.   Approximately 40 million Americans experience migraines and in 2016, the Global Burden of Disease ranked migraine as the second leading cause of disability worldwide.

Preventive treatments include both pharmacological and nonpharmacological options, with the goal to reduce the frequency, severity, and duration of attacks. Although there are many pharmacological options used for migraine prevention, most options were originally developed for the treatment of other conditions. Newly approved treatments such as calcitonin gene-related peptide (CGRP) antagonists have been developed specifically for migraine prevention and have been shown to be efficacious. However, there are uncertainties regarding the long-term comparative effectiveness of CGRP inhibitors compared with commonly prescribed preventives. Further, there is growing interest in the use of nonpharmacological therapies and additional research is needed to understand the role of such options in the prevention of migraine.

Eligibility: See complete funding opportunity and full funding announcement on 9/7/21.

Link to complete RFP

Patient-Centered Outcomes Research Institute Healthy Aging: Optimizing Physical and Mental Functioning Across the Aging Continuum -- Cycle 3 2021

Organization: Patient-Centered Outcomes Research Institute

Award amount: Undisclosed. $50M total funds available.

Deadline: LOI due 10/5/2021

Description: The Patient-Centered Outcomes Research Institute (PCORI) intends to release a Targeted PCORI Funding Announcement (PFA) on September 7, 2021, seeking to fund high-quality, comparative effectiveness research (CER) projects that focus on optimizing physical and mental functioning for community-dwelling older adults and their caregivers. This preannouncement is provided to allow potential applicants additional time to identify collaborators; obtain stakeholder input on potential studies; and develop responsive, high-quality proposals.

By 2060, the number of Americans over 65 is projected to reach around 95 million, making up almost a quarter of the US population. The number of people of color among the older adult population is also projected to increase significantly. Many older adults live with multiple chronic conditions with a disproportionately greater burden experienced by people of color. Most older adults, including those with multiple chronic conditions, prefer to stay in their homes and communities for as long as they can, a concept referred to as “aging in place.” Family members or close friends often serve as the primary caregiver to older adults and play a critical role in helping them age in place by directly addressing their care needs and helping them navigate a fragmented healthcare system. As the needs of older adults become more complex, the caregiving role also intensifies, often resulting in a detrimental impact on caregiver well-being. Currently, the healthcare system is not well-equipped to address these complex care needs of the rapidly growing and diverse older adult population in the United States.

The Healthy Aging Targeted PFA will solicit applications for CER studies that focus on different phases of the aging continuum and aim to achieve one or more of the following four goals:

  • Maintaining function and independence
  • Facilitating chronic disease management
  • Supporting individuals with significant functional impairment  
  • Reducing caregiving burden and improving quality of life

Eligibility: See complete funding opportunity and full funding announcement on 9/7/21.

Link to complete RFP

Patient-Centered Outcomes Research Institute Improving Methods for Conducting Patient-Centered Outcomes Research -- Cycle 3 2021

Organization: Patient-Centered Outcomes Research Institute

Award amount: $750,000

Deadline: LOI due 10/5/2021

Description: With this PCORI Funding Announcement (PFA), PCORI aims to fund studies that address high-priority methodological gaps in patient-centered outcomes research (PCOR) and clinical comparative effectiveness research (CER).

PCORI seeks to fund projects that address important methodological gaps and lead to improvements in the strength and quality of evidence generated by PCOR/CER studies.

For the Cycle 1 2021 Methods PFA, PCORI has identified the following areas as programmatic priorities:

  • Methods to Improve the Use of Artificial Intelligence (AI) and Machine Learning (ML) in Clinical Research
  • Methods to Improve Study Design
  • Methods to Support Data Research Networks
  • Methods Related to Ethical and Human Subjects Protections Issues in PCOR/CER

The programmatic priority for artificial intelligence and machine learning replaced the priority for “Methods to Improve the Use of Natural Language Processing (NLP)” as of Cycle 3 2020. This change signals PCORI’s broader interest in funding methodological research that seeks to improve how massive amounts of data from a variety of sources can be: (1) appropriately analyzed and integrated into clinical care and health care delivery systems, and (2) facilitate population health models and social determinants of health analyses. Proposals should address mechanisms seeking to improve equitable, inclusive data collection and aggregation. NLP-related proposals will still be considered.

Eligibility: Applications may be submitted by any private sector research organization, including any nonprofit or for-profit organization, and any public sector research organization, including any university or college hospital or healthcare system, laboratory or manufacturer, or unit of local, state, or federal government. The Internal Revenue Service must recognize all US applicant organizations. Nondomestic components of organizations based in the US and foreign organizations may apply, as long as there is demonstrable benefit to the US healthcare system and US efforts in the area of patient-centered research can be clearly shown. Organizations may submit multiple applications for funding. Individuals are not permitted to apply. 

Link to complete RFP

Melanoma Research Alliance Team Sciences Award

Organization: Melanoma Research Alliance

Award amount: Up to $300,00 per year for three years (up to $900,000)

Deadline: LOI due 10/6/2021

Description: Team Science Awards are designed to foster a collaborative research process and promote transformational melanoma research advances with the potential for rapid clinical translation. Evidence of prior collaboration among team members is encouraged, but not required. 

Eligibility: 

  • Team must be multidisciplinary, and consist of two or more established Principal Investigators, one of whom is designated the Administrative PI, a Young Investigator with complementary expertise, and a Mentor for the Young Investigator;
  • Teams may consist of investigators from the same institution, or different institutions, and may be international;
  • The designated Administrative PI is responsible for administrative leadership. All other Principal Investigators on the team share authority for scientific leadership; 6
  • The Administrative PI and any other Principal Investigators on the team must be senior investigators, past the initial five years of their first academic faculty appointment and must hold a full-time faculty appointment at the level of Assistant Professor (or equivalent) or above. Co-PIs are not allowed. Other investigators on the team need to be designated as CoInvestigators, Collaborators, or Consultants. See Step #6 under the Application Instructions below for additional details and descriptions of these roles;
  • An investigator may serve as a PI, including Administrative PI or Principal Investigator on a Team, on only one proposal this cycle;
  • Each team must include at least one Young Investigator and a designated Mentor for the Young Investigator (the Mentor is not required to have any additional role within the team), whose work must be integral to one or more of the aims of the proposal (see and comply with all Young Investigator eligibility criteria above);
  • An investigator may only be the designated Young Investigator on one application in the Team Science Award category. However, a Young Investigator identified within a Team Science Award application may also apply in the same cycle for their own, individual Young Investigator Award provided that application has a unique research focus and hypothesis

Link to complete RFP

Organization: Foundation for Women’s Cancer

Award amount: $75,000

Deadline: Abstracts due 10/8/2021

Description: Research among diverse populations has demonstrated disparities in treatment outcomes, access to care, genetic testing rates, and disease survival across many diseases. This renewed Diversity and Health Equity Research Grant is a one-year project where the funding is available for two $75,000 Research grants.

The purpose of this award is to support research to understand and eliminate inequities in cancer care, specifically related to differential outcomes experienced by women from underserved or marginalized populations with gynecologic cancer, as well as to increase representation of underrepresented groups in gynecologic oncology as a strategy to achieve health equity for underserved women. 

This research would commence in April 2022, with a final report due on or before June 2023.

Eligibility: Those eligible for applying are those who propose a study focused on a marginalized group, or those who identify as being from an under-represented group within the field of research.

Link to complete RFP

Society of Toxicology Colgate-Palmolive Awards for Student Research Training in Alternative Methods

Organization: Society of Toxicology

Award amount: $3,750

Deadline: 10/9/2021

Description: The purpose of the Colgate-Palmolive Awards for Student Research Training in Alternative Methods is to enhance graduate student research training using in vitro methods or alternative techniques to reduce, replace or refine use of animals in toxicological research.

The training may include, but is not limited to, use of in vitro and ex vivo procedures, nonmammalian animal models, computer modeling, and structure-activity relationships. Graduate students may propose to develop expertise in relevant methodologies 1) at a laboratory away from their home institution, 2) at a laboratory at their home institution that would not be available to them otherwise, or 3) at approved workshops, symposia or continuing education programs where hands-on training will be received.

The training should help toxicology graduate students enhance their thesis or dissertation research. The overall goal is to support the replacement, reduction, or refinement of currently used animal models in toxicology research and testing. The proposal will include a budget of up to $3,750 to defray travel, per diem, training expenses, and research costs.

Eligibility:

  • Enrolled in PhD or MS study in the discipline of toxicology
  • Student member or pending student member of the Society at application deadline
  • Proposed training must involve in vitro alternative techniques to replace the use of animals in toxicological research
  • Application must clearly explain how this training relates to the goal of the award program
  • Willingness of host to assist with the training or acceptance to the program

Link to complete RFP

Society of Toxicology Colgate-Palmolive Postdoctoral Fellowship Award in In Vitro Toxicology

Organization: Society of Toxicology

Award amount: $44,000

Deadline: 10/9/2021

Description: The Colgate-Palmolive Company sponsors the Colgate-Palmolive Postdoctoral Fellowship Award in In Vitro Toxicology through the Society of Toxicology to advance the development of alternatives to animal testing in toxicological research. The award is given annually and includes stipend and research-related costs (up to $44,000) for one year. Postdoctoral trainees in their first year of study beyond the PhD, MD, or DVM degree who are at academic institutions, federal/national laboratories, or research institutes worldwide may apply. The award application deadline is October 9 of the year prior to the year in which the fellowship is awarded.

The award consists of a plaque and fellowship funds.

Eligibility:

  • Postdoctoral trainees employed by academic institutions, federal/national laboratories, or research institutes
  • Doctoral degree must have been conferred before this fellowship is awarded
  • Preference will be given to applicants in their first year of postdoctoral study
  • Applicant or postdoctoral advisor must be a member or pending member of the Society. If the recipient is not a member, he or she will be required to submit a membership application before the fellowship is conferred
  • Proposed research should involve in vitro or animal alternative methods
  • Potential of the proposed work to contribute to the advancement of the field of alternatives

Link to complete RFP

Society of Toxicology Syngenta Fellowship Award in Health Applications of New Technologies

Organization: Society of Toxicology

Award amount: $15,000

Deadline: 10/9/2021

Description: The Syngenta Fellowship Award in Human Health Applications of New Technologies is presented to either a third year (or later) graduate student or a postdoctoral trainee. Fellowship funding is to support mode-of-action research aimed at characterizing dose-dependent effects of xenobiotics on mammalian systems in such a way that the causal sequence of key events underlying toxicity is elucidated. The work should permit a quantitative basis for extrapolation of the results from animal bioassays or animal models (in silico, in vitro) to humans at relevant human doses. The awardee will receive travel support to travel to the SOT Annual Meeting to accept the award and for travel to a Syngenta facility to present the results. This is a one year, non-renewable award.

The award consists of a plaque, $15,000 in fellowship funds, travel support to the SOT Annual Meeting to accept the award, and travel support to a Syngenta site to present the results.

Eligibility:

  • Third year (or later) graduate student or postdoctoral trainee employed by academic institution, federal/national laboratory, or research institute
  • Applicant is member of the Society, or membership is pending at application deadline. Does not have to be a member (if not a member, awardee will apply before the fellowship is conferred).

Link to complete RFP

American Urological Association 2022 Gallagher Health Policy Scholar Program

Organization: American Urological Association

Award amount: $15,000 plus AUA will cover all travel, lodging, and legitimate expenses associated with program participation.

Deadline: 10/10/2021

Description: The American Urological Association is inviting applications for its Gallagher Health Policy Scholar program of the Public Policy Council.

The program will award one scholar a $15,000 stipend based on a commitment to, and strong interest in, health policy issues of importance to urology. In addition, AUA will cover all travel, lodging, and legitimate expenses associated with program participation. There will be no out-of-pocket expenses associated with the chosen candidate’s participation in this program.

The program requires the recipient to spend up to thirty days away from one’s practice or academic appointment during the yearlong program, as the awardee must agree to participate fully in all program activities, which include but are not limited to attendance at key meetings such as the RUC, CPT, and AMA House Delegate Meetings; participation in the Annual Urology Advocacy Summit in March 2022; and participation in the ACS summer course held at Brandeis University in June 2022.

Eligibility: For complete program guidelines and application instructions, see the American Urological Association website.

Link to complete RFP

American Sleep Medicine Foundation Strategic Research Awards

Organization: American Sleep Medicine Foundation

Award amount: Up to $250,000

Deadline: LOI due 10/11/2021

Description: The AASM Foundation is committed to improving patient-centered diagnosis and care for all patients with sleep disorders. To ensure that there is a continued advancement in effective diagnosis and care of patients with sleep disorders, the AASM Foundation provides research funding through the Strategic Research Grant. This grant is investigator-initiated and supports high-impact research projects aimed at addressing gaps in knowledge that impact the ability to provide optimal, patient-centered, cost-effective diagnosis and care for patients with sleep disorders.

This year, the AASM Foundation is issuing four different Strategic Research Grant request-for-applications focused on the following research domains that will advance the field of sleep medicine and population sleep health.

Eligibility: Individuals with the following education and training are eligible to apply:

  • Master’s level degree or higher.

Individuals may apply for multiple AASM Foundation grants, however, the same proposal (i.e., projects with budgetary and scientific overlap) may not be submitted for multiple requests for applications in a given cycle.

Individuals who are the Principal Investigator on an open or previous AASM Foundation research grant at the time of the application deadline are eligible to apply if they can demonstrate that there is no budgetary or scientific overlap between their open grant and the new project they are applying for funding. If there is budgetary and/or scientific overlap between projects, the applicant must indicate their plan to close their open grant in the event their new application is selected for funding (e.g., relinquish the current grant or complete the current grant to start the new grant).

International individuals who meet all the eligibility criteria are eligible to apply; however, payment of grant funds must be accepted by the institution in US dollars.

The following individuals are not eligible to apply:

  • Individuals who have a financial conflict of interest or have the potential to incur significant financial benefit from the proposed work and beyond the work itself are not eligible to apply.
  • Individuals who are seeking funding from AASM Foundation research grants to support ongoing projects that are currently funded by another granting body or supplement ongoing work (e.g., enrolling additional subjects into an ongoing trial) are not eligible to apply.

Link to complete RFP

Pfizer Independent Medical Education Grant for Acute Lymphoblastic Leukemia Peer-to-Peer Education & Support

Organization: Pfizer

Award amount: Up to $250,000

Deadline: 10/11/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. 

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP. 

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

The goal of this RFP is to improve and build confidence in the mitigation and management of Veno-Occlusive Disease (VOD) in order to optimize outcomes for Relapsed/Refractory (R/R) ALL patients who are hematopoietic stem cell transplant (HSCT)-eligible. Broader objectives and goals within R/R ALL are also encouraged such as optimizing treatment selection, sequencing, dosing, multidisciplinary communication and decision-making, and patient point-ofcare (in-patient versus out-patient.)

Projects that will be considered for Pfizer support will provide intensive and/or continuous learning opportunities where members of multi-disciplinary healthcare teams can interact with their peers in the management of relapsed/refractory (R/R) ALL patients. 

Academic institutions or professional societies interested in using peer-to-peer educational models are encouraged to apply.

Multi-disciplinary care team members should be able to receive expert tips and recommendations that will help them mitigate and manage VOD risk in R/R ALL patients proceeding to HSCT.

All education formats are in-scope of this RFP. Of particular interest are:

  • Tele-mentoring programs using models similar to Project ECHO from the University of New Mexico
  • Face-to-face expert roundtable sessions
  • Visiting Professorships or Academic Detailing programs
  • Ask-the-Expert or Decision-support programs
  • Coaching and mentoring programs
  • Interactive case-based workshops

Eligibility: 

  • The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
  • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project.
  • For projects offering continuing education credit, the requesting organization must be accredited.
  • It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Link to complete RFP

Sexual Medicine Society of North America Sexuality Research Grants Program

Organization: Sexual Medicine Society of North America 

Award amount: $5,000-$7,500

Deadline: 10/11/2021

Description: Established in 1994, the Sexual Medicine Society of North America (SMSNA) aims to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of human sexual function and dysfunction.

To that end, SMSNA invites applications for the SMSNA Scholars in Sexuality Research Grants Program, which offers early-career investigators interested in sexuality research the opportunity to obtain funding to support their research while engaged in qualifying study in sexuality. Grants of up to $5,000 for Undergraduate/Medical/Graduate School Students and $7,500 for Resident or Post-Doctoral/Fellows will be awarded.

Eligibility: Applications will be accepted from graduate or medical students, residents in graduate medical education training programs, and post-doctoral/post-residency fellows. Applications will be accepted from researchers representing diverse backgrounds including, but not limited to urology, psychology, psychiatry, gynecology, internal medicine, geriatrics, public health, physiology, genetics, molecular biology, social work, law, etc. 

To be eligible, research projects must be carried out within the United States or Canada, and the applicant’s mentor must be an SMSNA member.

For complete program guidelines and application instructions, see the Sexual Medicine Society of North America website.

Link to complete RFP

Cystinosis Research Foundation Research Grants

Organization: Cystinosis Research Foundation

Award amount: Undisclosed

Deadline: 10/13/2021

Description: The goal of the Cystinosis Research Foundation is to find better treatments and a cure for cystinosis. Research and fellowship applications must be consistent with the mission and goals of the foundation in order to be considered.

The Cystinosis Research Foundation is pleased to announce its Fall 2021 Call for Research Proposals and Fellowships. The Cystinosis Research Foundation is prepared to fund proposals to improve the immediate care of children and adults with cystinosis and to develop a new understanding and treatment of cystinosis in an effort to help these patients in the future.

Eligibility: See the complete RFP for eligibility criteria.

Link to complete RFP

Pfizer Independent Medical Education Grant for PARP-inhibitor Combination Treatments in Prostate Cancer

Organization: Pfizer

Award amount: Up to $250,000

Deadline: 10/13/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP. 

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Projects that will be considered for Pfizer support will focus on:

  • Increasing the understanding of the mechanism of action, biological and clinical rationale for PARP-inhibitor combinations as potential treatments for prostate cancer. Projects focusing on PARP-inhibitor combinations with androgen receptor targeted therapies are of high interest.  
  • The evolving paradigm of the potential treatment of mCRPC with future PARP inhibitor combinations.

Pfizer is especially interested in funding projects that spotlight educational content in meaningfully innovative ways using multimodal communications and message delivery platforms.

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered. 

Eligibility: 

  • The following may apply: medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
  • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project.
  • For projects offering continuing education credit, the requesting organization must be accredited.

Link to complete RFP

American Association for Cancer Research Anna D. Barker Basic Cancer Research Fellowship

Organization: American Association for Cancer Research

Award amount: $110,000

Deadline: LOI due 10/14/21

Description: The AACR Anna D. Barker Basic Cancer Research Fellowship encourages and supports postdoctoral or clinical research fellows to establish a successful career path in cancer research.

This fellowship provides $110,000 over a two-year period to support the salary and benefits of the fellow while working on a mentored basic cancer research project. A partial amount of funds may be designated for non-personnel expenses, such as research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, and other research expenses.

The research proposed for funding may be in any area of basic cancer research.

Eligibility: At the start of the grant term (July 1, 2022), applicants must:

  • hold a mentored research position with the title of postdoctoral fellow, clinical research fellow, or equivalent.
  • have completed their most recent doctoral degree within the past three years (i.e., degree cannot have been conferred before July 1, 2019; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on their diploma and/or transcript).
  • work under the auspices of a mentor at an academic, medical, or research institution anywhere in the world.

There are no citizenship or geographic requirements. However, by submitting a Letter of Intent for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Applicants must be AACR members in good standing by the Letter of Intent deadline. Annual dues are not required for early-career researchers eligible for in Associate membership. Nonmembers interested in this grant opportunity must submit an application for AACR Associate or Active membership by the Letter of Intent deadline. Nonmembers can apply for membership online. Members can renew their membership through myAACR to bring their membership current. You will need your logon (email address) and password to access the member portal. If you require assistance logging in, please submit a help form. Lapsed members must be members in good standing by the LOI deadline and should contact the Membership Department at membership@aacr.org for assistance.

Link to complete RFP

American Cancer Society Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families

Organization: American Cancer Society

Award amount: Up to $120,000

Deadline: 10/15/2021

Description: The American Cancer Society is welcoming applications for Pilot and Exploratory Projects in Palliative Care of Cancer Patients and Their Families.

According to ACS, the development of the specialty of palliative medicine is a critical step in addressing the unmet needs of patients with serious illness and their families. Pilot data are typically needed before funding agencies (e.g., NIH, VA, or the American Cancer Society) will consider funding a research project. In an effort to support clinician investigators conducting patient-oriented research in palliative care, the American Cancer Society (ACS), in parallel with the National Palliative Care Research Center (NPCRC), is soliciting applications for pilot/exploratory research grants in palliative care for cancer patients and their families. These grants will generate the pilot data necessary to maximize an investigator’s chances of successfully competing for larger grants.

To that end, through this RFA, awarded grants will provide funding for investigators to perform pilot and exploratory research studies with the purpose of testing interventions, developing research methodologies, or exploring novel areas of research in palliative care for cancer patients and their families. A condition of funding is a clearly defined plan as to how the investigator will use the results of the project to develop larger, extramurally funded research projects. This RFA is limited to applications that focus on palliative care research projects for seriously ill cancer patients and their families in three specific areas: exploring the relationship of pain and other distressing symptoms on quality and quantity of life, independence, function, and disability and developing interventions directed at their treatment in patients with advanced and chronic illnesses; studying methods of improving communication between cancer survivors living with serious illness with their families and health care providers; and evaluating models and systems of care for patients living with advanced illness and their families.

Grants of up to $60,000 per year (direct costs) plus 20 percent indirect costs for up to two years will be awarded. Salary support for the Principal Investigator may not exceed 20 percent of the direct costs.

Eligibility: Applications may be submitted by not-for-profit institutions located within the United States, its territories, and the Commonwealth of Puerto Rico. Applicants must hold a doctorate degree (MD, PhD, or equivalent) and have a full-time faculty position or equivalent at a college, university, medical school, or other fiscally responsible not-for-profit organization within the United States. Independent investigators at all stages of their career are eligible to apply.

For complete program guidelines and application instructions, see the American Cancer Society website.

Link to complete RFP

American Cancer Society Research Award for Role of Health Policy and Insurance in Improving Outcomes in Cancer Prevention

Organization: American Cancer Society

Award amount: up to $200,000 per year (direct costs) for up to five years

Deadline: 10/15/2021

Description: The American Cancer Society has issued a request for research that explores the Role of Health Policy and Health Insurance in Improving Access to and Performance of Cancer Prevention, Early Detection, and Treatment Services. Proposals will be accepted for research projects focused on the changes in national, state, and/or local policy and the response to these changes by healthcare systems, insurers, payers, communities, practices, and patients.

ACS is interested in evaluating the impact of the many changes now occurring in the healthcare system with a particular focus on cancer prevention, control, and treatment. Efforts that focus on improving access to care may also impact inequities that contribute to health disparities. Health public policy initiatives such as the new federal and state marketplaces that have expanded insurance coverage, as well as Medicaid expansion in some states, create natural experiments ripe for evaluation. ACS is keenly interested in supporting rapid learning research to study the effects of health policy changes on patients, providers, and health systems, including but not limited to facilitators and barriers to care; unintended consequences; differential experiences and outcomes of patients seeking or receiving care; best practice models for quality care; and economic impact.

Awards will not exceed $200,000 per year (direct costs) for up to five years.

Eligibility: Applicants must be affiliated with nonprofit institutions located within the United States, its territories, or the Commonwealth of Puerto Rico. Independent investigators at all stages of their career are encouraged to apply.

For complete program guidelines and application instructions, see the ACS website.

Link to complete RFP

American Hospital Association Quest for Quality Prize

Organization: American Hospital Association

Award amount: Undisclosed

Deadline: 10/15/2021

Description: The American Hospital Association (AHA) represents and serves nearly five thousand hospitals, healthcare systems, networks, and other providers of care and forty-three thousand individual members. 

AHA is inviting applications for its Quest for Quality Prize, which is presented annually to recognize hospitals and health systems that have demonstrated organization-wide commitment to and participation in improving quality and safety, innovating to improve care, addressing disparities, and working with other community organizations and agencies to improve health status.

Hospitals and health systems that are encouraged to apply include those committed to advancing health by providing access to exceptional quality, safe, and patient- and family-centered care that promotes individual and community well-being; partnering with other community organizations and agencies to improve the health status of their communities and address disparities; developing new models of care, services, and collaboration to provide seamless care; and partnering with patients and families to design the patient care experience and engage them fully in their health.

Eligibility: All health systems and hospitals in the United States are eligible to apply, though note the health system application is different from the hospital application. The AHA asks that applicants be sure they’re using the appropriate application. 

For complete program guidelines and application instructions, see the American Hospital Association website.

Link to complete RFP

**Biocodex Microbiota Foundation Microbiota Research Grants

Organization: Biocodex Microbiota Foundation

Award amount: $50,000

Deadline: 10/15/2021

Description: Biocodex Microbiota Foundation, a nonprofit organization founded by Biocodex, is inviting applications for its research program. The foundation’s annual call for grant applications is part of a multi-year research initiative to understand the interaction between microbiota and different pathologies.

A single grant of $50,000 will be awarded in support of the Biocodex Microbiota Foundation’s 2021 theme: gut microbiota and its impact beyond the digestive system.

Eligibility: The program is open to U.S.-based, early-career investigators; selected recipient can apply it toward a new or existing study. 

For complete program guidelines, application instructions, and information about previous grant recipients, see the Biocodex Microbiota Foundation website.

Link to complete RFP

Dermatology Foundation Research Awards Program

Organization: Dermatology Foundation

Award amount: Up to $55,000

Deadline: 10/15/2021

Description: The DF’s Research Award Program offers a variety of research awards intended to further the specialty and enable advancements in patient care. An emphasis is placed on supporting research that benefits the dermatology community at large and has significant potential to advance patient care. It is the expectation that the recipients of Foundation awards will be tomorrow’s expert teachers, innovative investigators and master clinicians in dermatology.

All DF-funded research must be conducted in the U.S. under the sponsorship of a department/division of dermatology that is ACGME-approved for training in dermatology. Applicants must meet the DF’s general eligibility requirements, in addition to award-specific requirements presented on or before the time of funding. Minority applicants are encouraged to apply.

The Dermatology Foundation encourages applications concerning health issues impacting minority groups, including, but not limited to, racial minorities, sexual­ gender/LGBTQ minorities, and underserved/disadvantaged populations.

Eligibility: All DF-funded research must be conducted in the U.S. under the sponsorship of a department/division of dermatology that is ACGME-approved for training in dermatology. A project to be performed as a part of the U.S. government research program (except Veterans Administration), or to be performed at a private foundation without an academic affiliation to dermatology, is not eligible for funding. A project involving human subjects must have IRB approval at the time funding commences, i.e., July 1, and throughout the term of the award.

An individual who is a prior or current principal investigator (PI) on a federal grant is not eligible to receive a DF career development award, fellowship or grant. The following two exceptions apply:

  1. CDA awardees may have effort on an NIH grant as long as he/she is not the senior PI who initiated the application and he/she does not have direct reporting responsibilities for this or prior federal awards. Total support from all federal grants must be less than 20% of their total effort during the term of the DF award.

OR

  1. The individual is the recipient of an NIH training grant or an equivalent grant from another granting agency.

Upon receipt as the PI of a federal grant, a DF CDA or grant will be withdrawn. Note, an individual who receives a federal grant that eliminates their status as a “new investigator” is not eligible to maintain/receive a DF CDA.

Fellowship recipients may receive NIH training grants or an equivalent grant from another granting agency.

Important Note: The Foundation utilizes the NIH definitions of “principal investigator” and “coinvestigator” to administer this policy, as found in the Glossary of NIH Terms.

Link to complete RFP

National Foundation for Cancer Research Szent-Györgyi Prize for Progress for Cancer Research

Organization: National Foundation for Cancer Research

Award amount: $30,000

Deadline: 10/15/2021

Description: The Szent-Györgyi Prize for Progress in Cancer Research was established in honor of NFCR’s co-founder, Albert Szent-Györgyi, M.D., Ph.D., who received the 1937 Nobel Prize for his study of vitamin C and cell respiration. The prize is a symbol of NFCR’s enduring commitment to uphold Dr. Szent-Györgyi’s vision of curing cancer through innovation and collaboration.

The annual prize honors scientists who have made an original discovery or breakthrough in scientific understanding that has had a lasting impact on the cancer field and a direct impact of saving people’s lives. In addition to winning the coveted award itself, prize recipients are given a $30,000 honorarium and attend a gala in their honor. The award serves to highlight the essential role basic research plays in understanding cancer.

Eligibility: Nominations for the Prize may be made by individuals from the research community, industry, government, or other organizations who are sufficiently familiar with the research accomplishments and contributions of the nominee. Self-nominations will not be accepted. Candidates must have made an original discovery or breakthrough in scientific understanding that has led to better prevention, earlier diagnosis, or new treatments for patients with cancer.

Link to complete RFP

Society of Pediatric Psychology Marion and Donald Routh Student Research Grant

Organization: Society of Pediatric Psychology

Award amount: Up to $5,000

Deadline: 10/15/2021

Description: This grant is designed to enable a student member of the Society of Pediatric Psychology to pursue research scholarship. Funding is available up to $5,000. Up to $500 of the award amount can be budgeted for convention and meeting travel. Funds may not be used for indirect costs of the University, stipends of principal investigators or costs associated with manuscript preparation.  Up to $1,000 will also be provided to the runner-up to support their proposed research.

Eligibility: This award is for current student members of SPP in full-time psychology graduate programs (i.e., graduate students or interns) conducting research under the supervision of a faculty advisor. Postdoctoral fellows are not eligible for this award. The research project for which funding is requested must be conducted under the supervision of a faculty advisor and may include work leading to a master’s or doctoral degree or may be an independent study. Research proposals should address areas consistent with the field of pediatric psychology. Topic examples might include relationships between psychological and physical well-being of children and adolescents, including behavioral and emotional components of disease and treatment, the role of pediatric psychology in pediatric medical settings or the promotion of health and the prevention of illness among children and youth. Please see our rating form for more information on the criteria on which the grant will be judged.

Link to complete RFP

University of Pittsburgh School of Medicine Dickson Prize in Medicine

Organization: University of Pittsburgh School of Medicine

Award amount: $50,000

Deadline: 10/15/2021

Description: The Dickson Prize in Medicine—the University of Pittsburgh School of Medicine’s highest honor—is awarded annually to an American biomedical researcher who has made significant, progressive contributions to medicine.

The Dickson Prize often presages other major accolades. Since 1970–71, the first year the prize was awarded, 15 Dickson winners have won Nobel Prizes, and 23 recipients of the Dickson prize have received the Lasker Award, the most prestigious American honor for medical research.

The Dickson Prize is for investigators who are at especially productive points in their careers and whose research is, or will be, so influential that it deserves major recognition.

Winners of the prize receive a medal, a $50,000 honorarium, and travel expenses to Pitt to accept the award and present the keynote lecture during the University’s annual campus-wide showcase of scientific research. During the prizewinner’s two-day visit to Pitt, he or she also participates in scientific activities and meets informally with students, postdoctoral fellows, and other investigators.

Eligibility: Nominees for the Dickson Prize in Medicine should be actively engaged in innovative, paradigm-shifting biomedical research that is worthy of significant and broad attention. This is a prize for someone whose career has been building, who is at an especially productive point currently, and whose research is—or will be—so influential that it deserves major recognition now. The recipient must be a U.S. citizen.

Link to complete RFP

**Adira Foundation Pervasive Needs in Neurodegenerative Disease Grants

Organization: Adira Foundation

Award amount: $60,000

Deadline: LOI due 10/18/2021

Description: Adira Foundation was created to counter the unforeseen consequences of siloed, disease-specific approaches that can lead to gaps in seeing and addressing shared systemic barriers, health inequities and day-to-day needs of patients and caregivers across complex health issues. 

To that end, the foundation is inviting Letters of Intent for its fall 2021 Pervasive Needs Grants program. Grants averaging $60,000 will be awarded in support of programs that aim to improve the lives of people impacted by neurodegenerative diseases such as ALS, Alzheimer’s disease and related dementias, Huntington’s disease, multiple sclerosis, or Parkinson’s disease and/or their caregivers. The foundation anticipates funding three to five projects. Priorities for this round of funding include: 

  • Simplifying Clinical Research: Programs that provide education, navigation, or direct support services to people living with neurodegenerative diseases and caregivers to facilitate the removal of participation barriers in clinical trials and research.
  • Preparing for Future Threats to Livelihood: Programs that support education, navigation, and skill-building activities that provide opportunity for people living with neurodegenerative diseases and caregivers to prepare and implement a planned, phased approach to their disease journey.
  • Thriving Again in Common Pursuits: Programs that support inclusive social and recreational activities, providing opportunity for people living with neurodegenerative diseases and caregivers to easily access and enjoy community-based spaces and resources.

Eligible applicants include qualified, tax-exempt nonprofits across the United States and its territories who serve people with Adira’s five focus neurodegenerative diseases and/or their caregivers.

Eligibility: Eligible applicants include qualified, tax-exempt nonprofits across the United States and its territories who serve people with Adira’s five focus neurodegenerative diseases and/or their caregivers.

For complete program guidelines and application instructions, see the Adira Foundation website.

Link to complete RFP

Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research by Female Scientists, in Honor of Ruth Bader Ginsburg

Organization: American Association for Cancer Research

Award amount: $300,000

Deadline: LOI due 10/18/2021

Description: The Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in Honor of Ruth Bader Ginsburg, has been established to honor the life and legacy of Justice Ginsburg, who worked tirelessly to advance gender equality, even while battling pancreatic cancer. The intent of this program is to support the development and diversity of talent working in pancreatic cancer research.

This Award represents a joint effort to support the career advancement of a female scientist engaged in pancreatic cancer research.

The grant provides $300,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient (grant recipient must devote at least 75% of their total effort to pancreatic cancer research), any collaborators, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses. Indirect costs are not allowable expenses.

Grantees supported through this Program will have the opportunity to interact and/or collaborate with other investigators from the network of Lustgarten Foundation-funded investigators and laboratories as well as leading investigators in the AACR’s grantee community.

The proposed project may be in basic, translational, clinical, or population sciences related research and must have direct applicability and relevance to the understanding, detection, diagnosis, or treatment of pancreatic cancer and be aligned with the goals and priorities of the Lustgarten Foundation.

Eligibility: Applicants must be female investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.

At the start of the grant term on July 1, 2022, applicants must:

  • Hold a faculty appointment at the rank of assistant professor. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are eligible. Applicants that have progressed to associate professor, or equivalent, appointments are not eligible.
  • Must devote at least 75% of their total effort to pancreatic cancer research.
  • Have independent laboratory space and be able to hold independent funding as confirmed by their institution.
  • Work at an academic, medical, or research institution anywhere in the world.

There are no citizenship or geographic requirements. However, by submitting an Letter of Intent for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Applicants must be AACR Active members. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the Competitive Letter of Intent (LOI) deadline. Nonmembers can apply for membership online. Members can renew their membership through myAACR to bring their membership current. You will need your logon (email address) and password to access the member portal. If you require assistance logging in, please submit a help form. Lapsed members must be members in good standing by the LOI deadline and should contact the Membership Department at membership@aacr.org for assistance.

Link to complete RFP

Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research by Underrepresented Racial and Ethnic Groups, in Honor of John Robert Lewis

Organization: American Association for Cancer Research

Award amount: $300,000

Deadline: LOI due 10/18/2021

Description: The Lustgarten Foundation-AACR Career Development Award for Pancreatic Cancer Research, in Honor of John Robert Lewis, has been established to honor the life and legacy of Representative Lewis, who worked tirelessly to advance the civil rights of all Americans, even while battling pancreatic cancer. The intent of this program is to support the development and diversity of talent working in pancreatic cancer research. Eligibility is limited to members of racial or ethnic groups that have been shown to be underrepresented in the cancer related sciences workforce.

This award represents a joint effort to encourage and support early career scientists engaged in pancreatic cancer research relevant to the goals and mission of the Lustgarten Foundation.

The grant provides $300,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient (grant recipient must devote at least 25% effort to the proposed project; and must devote at least 75% of their total effort to pancreatic cancer research), any collaborators, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses.

Grantees supported through this Program will have the opportunity to interact and/or collaborate with other investigators from the network of Lustgarten Foundation-funded investigators and laboratories as well as investigators of the AACR’s  grantee community.

Proposed projects may be in basic, translational, clinical, or population sciences related research and must have direct applicability and relevance to the understanding, detection, diagnosis, or treatment of pancreatic cancer and be aligned with the goals and priorities of the Lustgarten Foundation.

Eligibility: Applicants must belong to racial or ethnic group(s) that has(have) been shown to be underrepresented in the cancer related sciences workforce. For U.S. applicants, these groups include Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders. It is recognized that for both U.S. and international applicants, underrepresentation can vary from setting to setting and individuals from racial or ethnic groups not listed above may also be eligible to apply for this program. The AACR’s Scientific Review and Grants Administration Department (SRGA) must be contacted atgrants@aacr.org for information on additional verification materials/signatures that may be required prior to the Letter of Intent deadline.

Applicants must be investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.

At the start of the grant term on July 1, 2022, applicants must:

  • Hold a faculty appointment at the rank of assistant professor. Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor, or instructor are eligible. Applicants that have progressed to associate professor or equivalent appointments are not eligible
  • Must devote at least 75% of their total effort to pancreatic cancer research.
  • Have independent laboratory space and be able to hold independent funding as confirmed by their institution.
  • Work at an academic, medical, or research institution anywhere in the world.

There are no citizenship or geographic requirements. However, by submitting a Letter of Intent for this grant, an applicant applying from an institution located in a country in which they are not a citizen or permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Applicants must be AACR Active members. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the Competitive Letter of Intent (LOI) deadline. Nonmembers can apply for membership online. Members can renew their membership through myAACR to bring their membership current. You will need your logon (email address) and password to access the member portal. If you require assistance logging in, please submit a help form. Lapsed members must be members in good standing by the LOI deadline and should contact the Membership Department at membership@aacr.org for assistance.

Link to complete RFP

AACR-AstraZeneca Career Development Award for Physician-Scientists in Honor of José Baselga

Organization: American Association for Cancer Research

Award amount: $300,000

Deadline: LOI due 10/19/2021

Description: The AACR-AstraZeneca Career Development Award for Physician-Scientists, in Honor of José Baselga has been established to honor the life and legacy of Dr. José Baselga, who was a scientific leader and supportive mentor to an entire generation of physician-scientists. Dr. Baselga’s research focused on novel molecular targeted therapeutics and he played a leading role in the clinical development of multiple cancer drugs.

The grant provides $300,000 over a period of three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborator, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses. Indirect costs are not permitted.

Research projects may be in any area of translational or clinical cancer research.

Eligibility: Before the start of the grant term (July 01, 2022) applicants must:

  • have a medical degree (MD, MD/PhD, DO, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
  • hold a faculty position with the title of assistant professor, instructor, research assistant professor, or the equivalent. Applicants who have progressed to associate professor appointments are not eligible.
  • be able to commit at least 50% of full-time effort in research (applies to total research, not just the proposed project) during the grant term.
  • have completed their most recent doctoral degree or medical residency (or equivalent) – whichever date is later – within the past 11 years (i.e., degree cannot have been conferred before July 1, 2011; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on their diploma and/or transcript).
  • have independent laboratory space and be able to hold independent funding as confirmed by their institution.
  • have a valid, active medical license in the country where the research will be conducted
  • work at an academic, medical, or research institution anywhere in the world.

Investigators who are currently, or have been, a Principal Investigator on a substantial independent research award (e.g., an NIH R01 award, DP2 award, DP5 award, MIRA award, or the equivalent) are not eligible. Qualified investigators are invited to apply for AACR grants for independent investigators.

Current AACR Grantees may apply only if their current grant ends before the start of the grant term of this funding opportunity i.e., grant start date, and must be up to date with all reporting requirements to be considered eligible.

There are no citizenship or geographic requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Link to complete RFP

Pfizer 2021/2022 Global Nonalcoholic Steatohepatitis (NASH) Advancing Science and Patient Care through Innovative Research and Education (ASPIRE) Research Grant

Organization: Pfizer

Award amount: Up to $140,000

Deadline: LOI due 10/20/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP) to make final grant decisions. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. 

For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of the research program.

The ASPIRE NASH program will evaluate submitted research proposals that cover areas in basic, clinical and translational sciences. The research proposals with innovative and the potential of high impact in advancing the learning about NASH will be encouraged. 

The followings are the main areas of priority with high unmet needs:

  • Improving models of care in patients with NASH and evidence generation of optimal management of NASH in various populations.
  • Innovations in the use of non-invasive tools in the care of patients with NAFLD
  • Understanding biological drivers of heterogeneity in disease pathogenesis and/ or progression and regression in NASH

Out of scope research includes: 

  • Studies involving investigational products
  • Studies comparing a competitor drug vs. a Pfizer product
  • Highly invasive studies and studies that may have an ethical concern
  • Mere replication of existing studies (i.e., lack of innovation)

Eligibility: 

  • Only organizations are eligible to receive grants, not individuals or medical practice groups.
  • The applicant (PI) must have a medical or postdoctoral degree (MD, PhD, or equivalent), an advanced nursing degree (BSN with a MS/PhD), or a degree in Pharmacy, Physiotherapy, or Social Work.
  • Applicant must be affiliated with a host institution.
  • Both early career and experienced investigators are encouraged to apply and consideration will be given to all proposals meeting the selection criteria. 

Link to complete RFP

Pfizer Virtual Programs for Rheumatology Education Independent Medical Education Grant

Organization: Pfizer

Award amount: Up to $250,000

Deadline: 10/20/2021

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies. 

Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Projects that will be considered for Pfizer support will include a curriculum of virtual activities intended to improve the knowledge and competency of healthcare professionals (HCPs) that treat rheumatologic conditions regarding the mechanisms that drive the development of rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, and juvenile idiopathic arthritis. Treatment strategies for these conditions continue to advance rapidly in response to the changing needs of providers and patients. 

Programs that leverage engaging virtual technologies will be considered as Pfizer is committed to supporting HCPs and patients during this time of limited travel, limited in-person education opportunities, and increased number of telehealth interactions. 

It is our hope that by increasing the HCP community overall knowledge of the treatment landscape, including timely diagnosis, mechanism of action, and care management through virtual technology and patient engagement, there will be improved outcomes for patients. Focus may include the patient journey, i.e.: perspective from diagnosis to ongoing disease management. 

Please note that proposals can include projects that focus on one or more conditions listed in these areas of interest. 

Eligibility: 

  • The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
  • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project.
  • For projects offering continuing education credit, the requesting organization must be accredited.

Link to complete RFP

American Nurses Foundation Reimagining Nursing Initiative

Organization: American Nurses Foundation

Award amount: $500,000 to $1.5 million over three years

Deadline: 10/25/2021

Description: As the philanthropic arm of the American Nurses Association (ANA), the American Nurses Foundation works to achieve a healthy world through the power of nursing by elevating the profession of nursing globally, engaging all nurses to ensure professional success, and evolving the practice of nursing to transform health and health care.

The American Nurses Foundation’s Reimagining Nursing (RN) Initiative aims to elevate the nursing profession’s capability to match future health demands by investing in opportunities for transformative change that lie at the intersection of education, regulation, and practice. To that end, the foundation is seeking grantees to pilot and evaluate bold new ideas and undertake this work in ways that enable others to replicate the pilot’s success and accelerate widespread transformation in nursing.

Over the next three years, the RN Initiative will award up to $15 million in grants to as many as eleven innovative pilot programs that equip nurses with leading-edge knowledge, tools, environments, and systems to deliver exemplary care. Each pilot may request $500,000 to $1.5 million over three years. The foundation is seeking pilot programs that address one or more of the following priorities that capture the key dimensions of the nursing profession: capability, quality, and reach:

  • Practice-Ready Nurse Graduates: Efforts to support innovations in competency validation and clinical preceptorship that ensure newly graduated nurses can immediately contribute to and succeed in a continuously transforming health delivery system.
  • Technology-Enabled Nursing Practice: Efforts to support the design and implementation of technology-based tactics and tools designed by nurses and for nurses that meaningfully enhance the practice of nursing.
  • Direct-Reimbursement Nursing Models: Efforts to expand nursing practice opportunities and elevate the value of nursing through direct reimbursement for nursing care delivery, management, and coordination outcomes.

Eligibility: Eligible organizations include nonprofit organizations, government entities, and public agencies. For-profit entities are eligible to apply with the understanding that all grant funds must be used for a charitable, educational, or other tax-exempt purpose and must be segregated from the grantee’s general funds, and, the pilot will not result in more than incidental benefit or profit to any private persons or the business (other than any intended charitable beneficiaries). The requested grant amount cannot exceed the organization’s cost in carrying out the charitable or educational activity and that the pilot either will not result in any profit to the for-profit organization or its shareholders or that any gains will be returned to the American Nurses Foundation or otherwise dedicated exclusively for charitable or educational purposes.

For complete program guidelines and application instructions, see the American Nurses Foundation website.

Link to complete RFP

Foundation Fighting Blindness Free Family AMD Research Award

Organization: Foundation Fighting Blindness

Award amount: Up to $600,000

Deadline: LOI due 10/25/2021

Description: The Free Family Foundation, in collaboration with the Foundation Fighting Blindness, has committed funding over the next five years to advance potential treatments for dry age-related macular degeneration. The Foundation Fighting Blindness will make an award for a meritorious research proposal that proposes to understand pathophysiologic mechanisms that cause the transition from aging to early, dry AMD. If successful, the research will inform the design of targeted treatment for the greatest number of people afflicted with early AMD and prevent blindness from late AMD. Proposals must: 

  • Focus on early, dry AMD
  • Determine the most relevant pathophysiologic pathways and their interactions with other pathways that cause early AMD lesions
  • Include two PIs with distinct areas of scientific expertise who will implement a multidisciplinary project with a team science approach on a topic that is not optimally served by a single laboratory.
  • Use animal or cellular models that best address AMD pathobiology
  • Demonstrate that the outcome will have direct impact on AMD 

Eligibility: Applicants must hold a Ph.D., M.D., D.M.D., D.V.M., D.O., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory. 

Link to complete RFP

Pancreatic Cancer Action Network Career Development Award

Organization: Pancreatic Cancer Action Network

Award amount: $250,000

Deadline: 10/25/2021

Description: The Pancreatic Cancer Action Network’s (PanCAN) competitive Grants Program funds promising and meritorious research on pancreatic cancer. The organization’s grantmaking strategy recognizes the need to maintain a pipeline of researchers dedicated to studying pancreatic cancer and acknowledges an urgency to accelerate scientific and medical breakthroughs that benefit patients. Early career grants are awarded to attract researchers to the field of pancreatic cancer, and translational and clinical grants support research that is well positioned for next steps and has the potential to drive improvements in clinical practice and patient outcomes.

The Pancreatic Cancer Action Network Career Development Award represents an effort to encourage and support junior faculty to conduct pancreatic cancer research and establish successful career paths in this field. The grants provide $250,000 over two years for junior investigators that have yet to secure their first major research funding. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer. Special consideration will be given to understudied areas in pancreatic cancer research, minority researchers, and research focused on cancer health disparities.

Eligibility: Applicants must have a doctoral degree (including PhD, MD, DO, DC, ND, DDS, DVM, ScD, DNS, PharmD or equivalent) in the biomedical sciences or in a field applicable to health science research and may not currently be a candidate for a further doctoral degree.

At the start of the grant term on July 1, 2022, applicants must:

  • Hold a faculty position with the title of assistant professor, instructor, research assistant professor or the equivalent.
    • Applicants that have progressed to associate professor appointments are not eligible.
    • If eligibility is based on a future position, the position must be confirmed at the time of application and cannot be contingent upon receiving this grant.
    • If the future position is at a different institution than the applicant’s current institution, the applicant must contact PanCAN’s Research Grants Department at grants@pancan.org before submitting their application for information on additional verification materials/signatures that may be required.
  • Have completed their most recent doctoral degree within the past 11 years (i.e., degree cannot have been conferred before July 2, 2011; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on their diploma and/or transcript).
    • Applicants with a medical degree must have completed their most recent doctoral degree or medical residency – whichever date is later – within the past 11 years (time spent in medical specialty or subspecialty training is not considered part of medical residency and will be counted within the 11-year window).
    • An exception to the 11-year window may be granted for parental leave or other well justified leave from research for pressing personal or family situations of generally less than 12 months duration. Applicants whose experience exceeds the maximum of 11 years but who believe they are eligible (e.g., maternity/family leave) must contact PanCAN’s Research Grants Department at grants@pancan.org before submitting their application to verify their eligibility.
  • Have independent laboratory space as confirmed by their institution in the Letter of Institutional Support.
  • Work at an academic, medical or research institution within the United States; there are no citizenship requirements. However, by submitting an application, an applicant who is not a U.S. citizen or permanent resident assures that their visa status will provide sufficient time to complete the project and grant term within the United States.
  • Not have currently or previously served as a principal investigator on major research awards or grants (e.g., NIH R00, NIH R01 or equivalent). Applicants who are/were principal investigators on major grants are considered to have already received funding to catalyze their careers and are not eligible to apply. 
    • Training grants and other mentor-linked funding are not considered independent funding.  
  • Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.
  • For questions regarding eligibility, contact PanCAN’s Research Grants Department at grants@pancan.org before submitting an application. 

Link to complete RFP

BrightFocus Foundation National Glaucoma Research Grants

Organization: BrightFocus Foundation

Award amount: up to $200,000

Deadline: 10/26/2021

Description: BrightFocus provides research funds for U.S. and international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of glaucoma.

Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Please note that applicants to the NGR program are encouraged to apply for funding to create tools that would benefit all investigators in the field, including animal models of disease, or cell lines. While prior awardees are welcome to submit new proposals following the conclusion of the previously-sponsored project, the new proposals should not be extensions of the prior project.

Eligibility: 

Postdoctoral Fellowship

  • Postdoctoral Fellowships are available to junior and senior postdoctoral fellows. Applicants with pending appointments are eligible to apply, but the appointment must be finalized by the start of the award. The proposal should be initiated by the postdoctoral fellow and not the supervisor. In the event that a senior postdoctoral fellow becomes an independent investigator during the duration of the award, the balance of the award may be transferred to the new position at the discretion of the BrightFocus Foundation. In this case, an assurance that the original specific aims would be addressed in the new position would be required.
  • BrightFocus accepts the NIH/NSF definition of a Postdoctoral Research Fellow emphasizing the mentored training component of the position.

Standard

  • Traditionally, in order to be eligible for grant funding from the BrightFocus’ National Glaucoma Research (NGR) Standard Award Program, the Principal Investigator (P.I.) must have held an academic rank equivalent or higher than Assistant Professor.
  • In recent years, many outstanding junior faculty have taken non-tenure track positions that in earlier years might have been developed as tenure-track positions. Though BrightFocus continues to encourage innovative proposals from all career stages, BrightFocus’ guidelines have evolved with the field to extend eligibility to non-tenure-track applicants as well. Non-tenure-track positions are welcome to apply for funding if they are appropriately trained to lead an independent research study, and are permitted by their organizations to manage the grant and supervise any key personnel. Applicants should have completed their formal post-doctoral mentored research training, and must be the intellectual and creative leads for the proposed projects. Applicants with pending appointments are eligible to apply, but the appointment must be finalized by the start of the award.
  • The applicant should use the indicated space on the application forms to clarify any position that is not immediately recognizable as an independent research position.

Link to complete RFP

Retina Research Foundation Pilot Study Grants

Organization: Retina Research Foundation

Award amount: $25,000

Deadline: 10/26/2021

Description: RRF is currently welcoming applications for RRF pilot study grants for January 1, 2022 – December 31, 2022. The aim of the RRF pilot study grants is to allow investigators to perform retina research that will provide preliminary data that will allow successful submission for NIH or other major funding. The RRF pilot grants are awarded annually although if satisfactory progress on annual review is noted, grants may be renewed up to 3 times (for 3 years). RRF pilot grant awards are typically $25,000 – $50,000. The number and size of the grant awards varies depending on RRF’s income from donations and investments.

Eligibility: 

  • Applicants who hold a medical degree (M.D.) or a doctorate (Ph.D.);
  • Applicants who have a long term (at least 3 years) commitment to a project;
  • Applicants who will conduct research in the United States at a university, medical school or eye institute; applications from for-profit centers or industry-sponsored research centers will not be considered;
  • Applicants who are U. S. citizens or green card/permanent U. S. residents.

Link to complete RFP

American Academy of Neurology Foundation Sheila Essey Award (ALS Research)

Organization: American Academy of Neurology Foundation

Award amount: $50,000

Deadline: 10/28/2021

Description: This award recognizes an individual who has made significant research contributions in the search for the cause, prevention of, and cure for amyotrophic lateral sclerosis (ALS). The criteria being used to determine the recipient include recent major scientific impact, long-term scientific impact, and overall impact to ALS.

Eligibility: See the funding opportunity for eligibility criteria.

Link to complete RFP

American Association for Cancer Research Debbie’s Dream Foundation Career Development Award for Gastric Cancer Research

Organization: American Association for Cancer Research

Award amount: $200,000

Deadline: LOI due 10/28/21

Description: The AACR-Debbie’s Dream Foundation Career Development Award for Gastric Cancer Research represents a joint effort to encourage and support junior faculty to conduct gastric cancer research and to establish a successful career path in this field.

This award provides $200,000 over two years for expenses related to the research project, which may include salary and benefits of the grant recipient, collaborators, postdoctoral or clinical research fellows, graduate students (including tuition costs associated with graduate students’ education and training), or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses. Indirect costs are not an allowable expenses.

The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to gastric cancer. Projects may focus on any form of gastric cancer.

Eligibility: At the start of the grant term (July 1, 2022), applicants must:

  • hold a faculty position with the title of assistant professor, instructor, research assistant professor, or the equivalent.
  • have completed their most recent doctoral degree within the past 11 years (i.e., degree cannot have been conferred before July 1, 2011; the formal date of receipt of doctoral degree is the date the degree was conferred, as indicated on their diploma and/or transcript).
  • have independent laboratory space as confirmed by their institution.
  • work at an academic, medical, or research institution anywhere in the world.

There are no citizenship or geographic requirements. However, by submitting a Letter of Intent for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that their visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Applicants must be AACR Active members. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the Competitive Letter of Intent (LOI) deadline. Nonmembers can apply for membership online. Members can renew their membership through myAACR to bring their membership current. You will need your logon (email address) and password to access the member portal. If you require assistance logging in, please submit a help form. Lapsed members must be members in good standing by the LOI deadline and should contact the Membership Department at membership@aacr.org for assistance.

Link to complete RFP

National Multiple Sclerosis Society John Dystel Prize

Organization: National Multiple Sclerosis Society

Award amount: $15,000

Deadline: 10/28/2021

Description: The John Dystel Prize for Multiple Sclerosis Research is awarded jointly by the National Multiple Sclerosis Society and the American Academy of Neurology (AAN). The Prize, currently in the amount of $15,000, recognizes outstanding contributions to research in the understanding, treatment or prevention of multiple sclerosis. The prize recognizes significant and exciting work that has changed the way we think about multiple sclerosis. This Prize is not meant to be a lifetime achievement award.

The award is made possible through a special contribution from the John Dystel Multiple Sclerosis Research Fund at the National MS Society. The late Society National Board member Oscar Dystel and his late wife Marion established this fund in 1994 in honor of their son John Jay, an attorney whose promising career was cut short by progressive disability from MS. John died of complications of the disease in June 2003.

Eligibility: Must be actively engaged in basic or clinical research related to multiple sclerosis.

Link to complete RFP

Pfizer Local Level Educational Grants Program to Increase Awareness & Understanding of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Organization: Pfizer

Award amount: Up to $10,000 for small local/community programs. Up to $20,000 for large local/community programs.

Deadline: Rolling thru 10/28/21

Description: Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Projects that will be considered for Pfizer support will focus on improving the care of patients by:

  • Educating [HCPs] to increase awareness and enable appropriate patient identification by closing knowledge gaps in disease epidemiology, pathophysiology, diagnosis, and emerging treatment paradigms.
  • Addressing barriers to appropriate diagnosis and strategies that reduce burdens for patients and providers along the pathway to appropriate diagnosis
  • Exploring strategies that empower patients to play an active role in understanding TTR amyloidosis and decision making regarding available diagnostic and treatment options
  • Increasing awareness of the changing epidemiology of TTR amyloidosis with a focus on the prevalence of hereditary ATTR and wild-type ATTR subtypes as the science continues to evolve
  • Increasing awareness of at risk and undiagnosed populations with TTR amyloidosis with a focus on improving strategies that facilitate the appropriate diagnosis of patients early in the disease course before overt cardiomyopathy has ensued [e.g. populations with electrical disturbances, valvular disease, orthopedic manifestations, and cardio-oncology diseases (i.e. Light Chain Amyloidosis)]
  • Increasing awareness of bone radiotracer scintigraphy as a noninvasive alternative to invasive endomyocardial biopsy for the appropriate diagnosis of TTR cardiac amyloidosis in select patients
  • Supporting the dissemination of information related to the pharmacologic and non-pharmacologic management of ATTR-CM
  • Addressing geographic and racial healthcare disparities
  • Addressing challenges to appropriate diagnoses and caring for patients during an era of increased telehealth utilization
  • Supporting the development of cardiac amyloid centers that provide leadership, best practices, support and/or training of HCPs within a multidisciplinary team environment in order to improve the quality of care for cardiac amyloidosis patients.

Eligibility:

  • The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
  • If the project involves multiple departments within an institution and/or between different institutions / organizations / associations. all institutions must have a relevant role and the requesting organization must have a key role in the project.
  • For projects offering continuing education credit, the requesting organization must be accredited.

Link to complete RFP

American Association of Critical Care Nurses Impact Research Grant

Organization: American Association of Critical-Care Nurses

Award amount: $50,000

Deadline: 10/29/2021

Description: The AACN Impact Research Grants are funded and supported by AACN. We encourage experienced clinicians and researchers to propose projects that support inquiry and systematic research that generates new knowledge. The grants are designed to ensure a vital source of clinically relevant research for creating the evidence-based resources that influence high acuity critical care nursing practice. Research projects are two years in duration.

We designed the AACN Impact Research Grant to address gaps in high-acuity and critical care areas of clinical research. The grants will ensure the pipeline for research that is vital to AACN’s research translation resources, such as protocols and practice alerts.

These grants will also facilitate research to support other AACN priorities, such as describing the impact of family presence, influencing nurse certification and implementing standards for healthy work environments.

Eligibility: Principal investigators must be AACN members, and must hold an earned master’s degree or have completed candidacy requirements in a BSN-to-PhD or DNP program.

Link to complete RFP

**Leukemia & Lymphoma Society Translational Research Program

Organization: Leukemia & Lymphoma Society

Award amount: $200,000 annually

Deadline: LOI due 10/29/2021

Description: ince 1995, the TRP grants fund new and innovative research that shows high promise of moving from laboratory discoveries to clinical application.

The goal of this translational award is to reduce the time between laboratory findings and actual treatment, putting research on the bench-to-bedside fast track when it comes to finding better treatment and cures for blood cancers.

Eligibility: Applicants must hold an M.D., Ph.D., or equivalent degree, and work in domestic or foreign non-profit organizations, such as universities, colleges, hospitals or laboratories. Applications may involve multiple such institutions and the Applicant should have an independent research or academic position. Applicants need not be U.S. citizens, and there are no restrictions on Applicant age, race, gender or creed. 

Applications from non-academic facilities, post doctoral positions and the National Institutes of Health are not eligible

Link to complete RFP

**Optimal Management of Women and Girls with Blood Disorders: Annual Research Grant Award 2021

Organization: Foundation for Women and Girls with Blood Disorders

Award amount: $15,000

Deadline: 10/29/2021

Description: Menstruation, pregnancy, childbirth, and menopause present unique challenges in women and girls with blood disorders. Undiagnosed, untreated blood disorders in women have medical consequences at every life stage. Delay and/or failure in diagnosing and treating blood disorders in women and girls are major public health problems, resulting in significant morbidity, reduced quality of life, days lost from work and school, unnecessary invasive procedures and high healthcare costs.  

The overarching purpose of this award is twofold: to support a research project in the area of blood disorders—all blood disorders—affecting women and girls; and proposed by junior faculty or fellows who are pursuing careers in the following disciplines: Adult or Pediatric Hematology; Obstetrics/ Gynecology; a Women’s Reproductive Health speciality such as Adolescent Medicine or Pediatric/ Adolescent Gynecology; or another specialty that involves the care of  women and girls with bleeding disorders; and 2) to further sustain an interest in translating research into clinical care that will ultimately improve the lives of these women and girls.

The objectives of the 2021 FWGBD Promoting XXcellence in Women’s Health: Annual Research Grant Award are to:

  • Create and sustain interest/knowledge of the next-generation of healthcare providers, i.e., physician-researchers working in Blood Disorders Affecting Women/Girls
  • Foster collaboration between two core disciplines for WGBD—the Obstetrics/Gynecology (or Women’s Reproductive Health specialist) and the Hematologist
  • Provide an opportunity for junior faculty or fellows to conduct research in this important area

Eligibility: 

  • Be an MD or DO who is junior faculty who qualifies as an early-stage investigator (see application guide), or a current fellow, in Adult or Pediatric Hematology; Obstetrics/ Gynecology; a Women’s Reproductive Health speciality such as Adolescent Medicine or Pediatric/ Adolescent Gynecology; or another specialty that involves the care of women and girls with bleeding disorders
  • Have a research mentor who is senior faculty at the applicant’s home institution for the duration of the award
  • Demonstrate active, working collaboration with a peer in the related discipline—Obstetrics/Gynecology (or Women’s Reproductive Health specialty) for the Hematology applicant and Hematology for the Obstetrics/Gynecology, Women’s Reproductive Health specialty, or Related Career)
  • Have an apporived or a pending IRB approval at the submission of the grant application

Link to complete RFP

Motor Neurone Disease Association Biomedical Research Project Grants

Organization: Motor Neurone Disease Association

Award amount: Up to £255,000

Deadline: 10/29/2021

Description: The MND Association supports biomedical research on Amyotrophic Lateral Sclerosis and related conditions, in all relevant disciplines. The objectives of the MND Association research funding programme are to support research aimed at understanding the causes of MND, elucidating disease mechanisms and facilitating the translation of therapeutic strategies from the laboratory to the clinic. 

The essential purpose of the grant is to support a single project, ie a piece of work designed to answer a single question or a small group of related questions. Such support will usually be of limited duration and applications of up to three years will be considered. Applications for less than two years must include a named researcher with the relevant expertise, familiar with the laboratory. The continuation of a grant within this period will be subject to annual review after the submission of a progress report, which is required at the completion of each year of the project.

Eligibility: Applicants can be based outside the UK and Ireland, provided the project is unique in concept or design (ie no similar research is being performed in the UK) and involves a significant aspect of collaboration with a UK institute.

Link to complete RFP

American Medical Women's Association Medical Education Scholarships

Organization: American Medical Women’s Association

Award amount: $500

Deadline: Biannual. Next deadline 10/31/2021.

Description: We at national AMWA know that the cost of a medical education can be daunting, so we’d like to help. Supporting your medical education is important to us, and with this in mind, AMWA awards 4 (four) $500 scholarships to women currently enrolled in medical school. Awardees will be chosen based on the embodiment of the goals of AMWA. Financial need, though not a requirement, is also considered.

Eligibility: Medical Education Scholarship Requirements:

  • AMWA Medical Student Membership
  • Completed essay responses
  • Financial information
  • One letter of recommendation

Link to complete RFP

**National Association of School Nurses Research Grants

Organization: National Association of School Nurses

Award amount: Undisclosed

Deadline: 10/31/2021

Description: The National Association of School Nurses (NASN) aims to optimize student health and learning by advancing the practice of school nursing. 

To that end, NASN is inviting applications for its research grants program, which was established to encourage and support research regarding school nursing and health of school-age children and advance and fund quality school nursing practice and school-affiliated delivery of healthcare.

NASN encourages a broad range of research related to promoting student health. For 2021-2022, NASN is particularly interested in studies that address the infrastructure of school nursing and the impact of that infrastructure on outcomes. Examples of structural measures may include (but are not limited to) collaborative interdisciplinary approach, nurse staffing/delivery models, education level of school nurse, certification, supervision, onboarding, use of an electronic health record, and time management.

Priority topics to address when researching infrastructure and the unique contribution of a school nurse include COVID, diversity, mental health, vaccine hesitancy, chronic absenteeism, or substance use. Multisite projects are encouraged when appropriate.

Robust research on the following areas that align with NASN’s research trajectory are also welcome:

  • The impact of structure, culture, financing (including Medicaid), policy, or systems on school health care processes and outcomes (at both the individual and population level).
  • Efforts to standardize measures that define the quality of school nursing, particularly related to care coordination and reducing inequities.
  • Cost benefit analyses related to school nursing services.
  • Testing the impact of NASN guidelines on student health and well-being.
  • Analysis of effective implementation strategies to improve the number of school nurses using evidence-based practices.
  • Identification of key intermediate measures that are sensitive to school nurse interventions.
  • Analysis of existing data that examine the structural measures of school health services or school nursing interventions (process measures) on individual and population-based student outcomes (i.e. chronic absenteeism, chronic condition management, seat time, early dismissal, medication errors).

In addition to robust research projects, systematic literature reviews synthesizing the state of the science in priority areas would also be valued contributions to the literature.

Eligibility: To be eligible, the Principal Investigator or a member of the research team who participates in the entire process including proposal, design, and implementation of the research project must be a school nurse(s) engaged in the practice or leadership of school nursing as well as a current member of NASN.

For complete program guidelines and application instructions, see the National Association of School Nurses website.

Link to complete RFP

American Association of Neurological Surgeons Research Fellowship Grant and Young Clinician Investigator Award

Organization: American Association of Neurological Surgeons

Award amount: Up to $50,000

Deadline: 11/1/2021

Description: As the premier funder of neurosurgical studies, the Neurosurgery Research & Education Foundation (NREF) provides funding for studies in basic, translational and patient-oriented clinical research annually for North American investigators.

Research Fellowship Grant

  • As the premier funder of neurosurgical studies, the Neurosurgery Research & Education Foundation (NREF) provides funding for studies in basic, translational and patient-oriented clinical research annually for North American investigators.

Young Clinician Investigator Award

  • The NREF Young Clinician Investigator Award supports junior faculty pursuing careers as clinical investigators. Applicants must be neurosurgeons, no more than two years from completing neurosurgical residency training or clinical fellowship, who are full-time faculty in North American teaching institutions. Fifty percent of the young clinician investigator’s efforts during the funding period of this grant should be devoted to research, but exceptions can be considered.

The NREF does not pay for any indirect costs related to our grant awards. Grants may be awarded in lesser amounts depending on available support.

Eligibility: 

  • Research Fellowship Grant – Applicants must be physicians who have been accepted into, or who are currently in approved residency training programs in neurological surgery in North America.
  • Young Clinician Investigator Award – Applicants must be neurosurgeons, no more than two years from having completed their neurosurgical residency training, and/or clinical fellowship, who are full-time faculty in North American teaching institutions.

Link to complete RFP

American Association Of Plastic Surgeons Academic Scholarship Grants

Organization: American Association Of Plastic Surgeons

Award amount: $30,000

Deadline: 11/1/2021

Description: The American Association of Plastic Surgeons Academic Scholar Program is offering two-year faculty research scholarships to surgeons entering academic careers in Plastic and Reconstructive Surgery. The scholarship is to assist a surgeon in the establishment of a new and independent research program. Applicants should have demonstrated their potential to work as independent investigators. The fellowship award is $30,000 per year to provide salary and/or direct costs of the research. Funding of the award will begin July 1, 2022. The award may be renewed once.

Eligibility: 

  • The scholarship is open to Plastic and Reconstructive Surgeons who have: (1) completed the chief residency year or post-residency fellowship within the preceding five years; and (2) received a full-time faculty appointment in a department of surgery/plastic surgery at a medical school accredited by the Liaison Committee on Graduate Medical Education in the United States or by the Committee for Accreditation of Canadian Medical Schools in Canada.
  • This award is to be used by the recipient for salary support and/or direct costs of his/her research. The scholarship grant should not diminish or replace the usual, expected compensation or benefits. Indirect costs are not paid to the recipient or to the recipient’s institution. No overhead is to be taken by the institution.
  • Preference will be given to applicants who are not current recipients of major research grants. Application for this scholarship may be submitted even if comparable application to other organizations has been made.

Link to complete RFP

American Diabetes Association Leveraging Nutrition and Lifestyle for Diabetes Prevention Across the Life Span

Organization: American Diabetes Association

Award amount: Up to $600,000

Deadline:

  • Postdoctoral Fellowship Deadline: November 1, 2021
  • Junior Faculty LOI Deadline: November 22, 2021
  • Innovative Clinical or Translational Science LOI Deadline: November 22, 2021

Description: The American Diabetes Association is soliciting research to improve adoption of healthy diets and lifestyles at the individual and community level with interventions tailored to different racial and socioeconomic groups across the life span. Importantly, applicants should indicate how the proposed research will have a significant impact (“move the needle”) on outcomes in those individuals at risk of, or living with, diabetes. The goal of this RFA is to identify grants of the highest scientific merit, with greatest potential for successful outcomes and most innovative and transformative, for funding.

This RFA will prioritize:

  • Nutritional and/or physical activity interventions that more effectively incorporate cultural or personal preferences, psychological supports, comorbid conditions, socioeconomic status, food insecurity, and other factors that may impact consistency with an eating and/or exercise plan and its effectiveness.
  • Approaches that better tailor medical nutrition therapy (MNT) and diabetes self-management education and support (DSMES) to different racial and socioeconomic groups in sustainable real-world settings.
  • Behavioral interventions that help encourage and sustain health diet and increased physical activity.
  • Comparison and/or utilization of different delivery methods aided by wearable technology (e.g. accelerometers, continuous glucose monitors, etc.)
  • Cost-effectiveness studies to support third-party coverage and policy change.

The goal of this RFA is to identify person-centered, yet scalable, dietary and lifestyle interventions with the greatest potential for adoption and maintenance of diabetes-preventing or diabetes mitigating lifestyles by individuals at greatest risk. The breakdown of targeted grant types is: Innovative Clinical or Translational Science, Junior Faculty Development, and Postdoctoral Fellowship Awards.

Eligibility: See each opportunity for eligibility criteria.

Link to complete RFP

American Diabetes Association Leveraging Precision Medicine to Improve the Lives of People with Diabetes

Organization: American Diabetes Association

Award amount: Up to $600,000

Deadline:

  • Postdoctoral Fellowship Deadline: November 1, 2021
  • Junior Faculty LOI Deadline: November 22, 2021
  • Innovative Basic Science LOI Deadline: November 22, 2021
  • Innovative Clinical or Translational Science LOI Deadline: November 22, 2021

Description: The American Diabetes Association is soliciting research proposals that leverage precision medicine-based approaches at all stages in the course type 1 diabetes and type 2 diabetes. While this call is broad in scope and encompasses basic through clinical research, emphasis will be placed on clinical research and translation.

Importantly, submissions should indicate how the proposed research will have a significant impact (“move the needle”) on outcomes in those individuals living with diabetes.

Eligibility: See each opportunity for eligibility criteria.

Link to complete RFP

American Otological Society Research Grants

Organization: American Otological Society

Award amount: Undisclosed

Deadline: LOI due 11/1/2021

Description: The American Otological Society is committed to the non-promotional advancement of knowledge and science and to a free exchange of medical education in otology and neurotology. The American Otological Society, through its Research Foundation, is offering Research Grant Awards, an Award for a Clinical Trial, full-time Research Training Fellowships, and a Clinician-Scientist Award. All of the AOS grant awards may involve research on any topic related to ear disorders. The research need not be directly on an otological disease but may explore normal functions of the cochlea, labyrinth or central auditory or vestibular systems. However, the applicant must describe how the proposed research will benefit our understanding, diagnosis or treatment of otological disorders. Research supported by all of the grant mechanisms can relate to any aspects of the ear, hearing and balance disorders.

Eligibility: Grants are available to physician or doctoral-level investigators in the United States and Canada only.

Link to complete RFP

American Psychological Foundation Psychology and AIDS Leadership Award

Organization: American Psychological Foundation

Award amount: Undisclosed

Deadline: 11/1/2021; 11/1/2022

Description: The American Psychological Association (APA) Ad Hoc Committee on Psychology and AIDS (COPA) invites nominations for its Psychology and AIDS Leadership Award. Two awards will be granted each year, one in the category of “Emerging Leader” and one in the category of “Distinguished Leader.”

The following categories are used to examine each candidate’s work and qualifications for receiving an award. Successful candidates will have made significant contributions in one or more of the following areas:

  • Policy/Advocacy
    • Recognizes individuals who have demonstrated outstanding effort and leadership in policy/advocacy-related activities that improve the welfare of people living with or affected by HIV/AIDS, and/or improves the delivery of prevention services to individuals and communities affected by HIV/AIDS. Specific activities under this category may include, but are not limited to, leadership or outstanding effort with respect to: promoting legislation that improves the welfare of all people living with or affected by HIV/AIDS; improving the delivery of prevention services to individuals and communities affected by HIV/AIDS; advocating for the rights of people living with or affected by HIV/AIDS; advocating for the delivery of HIV prevention services to underserved populations; challenging the discrimination and harassment of people living with or affected by HIV/AIDS; increasing the representation of people living with or affected by HIV/AIDS in psychology and science; advocating for funding of HIV services and research at the local and/or federal levels; and/or increasing the recognition of the need for professional organizations to include HIV/AIDS-related issues in their policies and procedures.
  • Research
    • Recognizes individuals who have demonstrated outstanding effort and leadership in the conduct, dissemination, and translation of high-quality research in the areas of HIV/AIDS prevention, treatment/care and/or policy. Specific activities under this category may include, but are not limited to, leadership or outstanding effort in: conducting innovative research methodologies that increase our general knowledge and understanding of specific HIV/AIDS prevention, treatment/care or policy issues; developing innovative research approaches which enhance HIV/AIDS-related research; developing theory or conceptual models that are useful in guiding HIV/AIDS prevention, treatment/care or policy efforts; and advancing translation of knowledge related to HIV/AIDS prevention and treatment/care to those affected by HIV, community agencies, providers, and/or the media.
  • Service Provision
    • Recognizes individuals who have demonstrated outstanding effort and leadership in the delivery of psychological services to people living with or affected by HIV/AIDS, and/or the delivery of technical or support services to community agencies that provide a range of HIV/AIDS-related services to individuals and communities affected by HIV/AIDS. Psychological services to people living with HIV/AIDS may include both treatment and prevention, and technical and support services to community agencies may include a range of activities such as program evaluation and development, needs assessment and training. Specific activities under this category may include, but are not limited to, leadership or outstanding effort in: providing direct psychological/support services; developing, directing, and/or supervising psychological or support services; and creating or expanding venues/organizations that deliver psychological/support services. 
  • Teaching/Mentoring
    • Recognizes individuals who have demonstrated outstanding effort and leadership in educating psychologists or students in psychology about HIV/AIDS practice, research and/or policy. Specific activities under this category may include, but are not limited to, leadership or outstanding effort in: providing various forms of mentorship for psychologists and students of psychology working in the area of HIV/AIDS; developing and teaching innovative university/secondary school courses on HIV/AIDS related topics; developing and conducting training workshops on HIV/AIDS related topics; developing HIV/AIDS curriculum used in the training of psychologists or students of psychology; training and mentoring of students as part of a research lab; and publishing educational texts designed to advance the knowledge and involvement of psychologists in combating HIV/AIDS.

Eligibility: Nominees will be identified as “emerging” or “distinguished” leaders in one or more areas of influence: service provision, research, teaching/mentoring, and policy/advocacy. Emerging leaders are psychologists who have received their doctorate within the past 10 years, have made substantial contributions to the field of HIV/AIDS and show promise of an extensive, influential career. Distinguished leaders are psychologists who have worked for 10 years or more after receiving their doctorate. They should have a longstanding influence on HIV/AIDS issues, should be recognized leaders in the field and must be current members of APA.

Candidates must be APA members. Current COPA members, members of APA’s Board of Directors and individuals who have announced candidacy for APA president are not eligible. Current COPA members cannot make nominations.

Link to complete RFP

BrightFocus Foundation Alzheimers Disease Research Programs

Organization: BrightFocus Foundation

Award amount: $100,000-$300,000

Deadline: 11/1/2021

Description: BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer’s disease.

The goal of the program is to accelerate advances in fundamental and translational research on Alzheimer’s disease and related dementias to understand the mechanisms underlying the etiology and pathogenesis as well as innovative approaches to better diagnose, prevent or delay the progress of the disease. Preference is made for exciting pilot projects that would not, at their present stage, be competitive for large government or industry awards. Typically, these awards are made to early stage investigators, or to more established investigators who are proposing particularly innovative research.

Eligibility: All scientists working at non-profit and government laboratories are eligible to apply for a Standard Award. Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency).

Link to complete RFP

Foundation for Physical Medicine and Rehabilitation Mid-Career Research Grant

Organization: Foundation for Physical Medicine and Rehabilitation

Award amount: $20,000

Deadline: 11/1/2021

Description: The Foundation for Physical Medicine and Rehabilitation is requesting applications for its Mid-Career Investigator Research Grants program. One grant of $20,000 will be made; it is to be used as seed money for new research projects that extend an established investigator’s work in new directions.

Award is a short-term grant for research in topics related to the field of physical medicine and rehabilitation. Preference will be given to projects that address the topics in our Research Priorities, listed below.

Award will be presented during the AAP Annual Meeting.

Information about the grant recipient and their paper may be published in the Foundation UPDATE Newsletter and/or other publications. Additional items may be included in electronic and print materials produced by the Foundation for PM&R.

Eligibility: Eligible applicants for grant include any physiatrist or faculty member in a division or department of physical medicine and rehabilitation who is at least 5 and not more than 20 years post-completion of a terminal degree and subsequent training program. Applicants must be able to demonstrate a history of successful research experience.

Special consideration will be given to proposals that meet the Foundation’s goal of driving the evidence base for cost-effective, results-oriented rehabilitative care.

Link to complete RFP

GRAMMY Museum Grants Program for Scientific Research and Preservation Projects

Organization: GRAMMY Foundation

Award amount: Up to $20,000

Deadline: LOI due 11/1/2021

Description: With funding generously provided by The Recording Academy, the GRAMMY Museum Grants Program awards grants each year to organizations and individuals to support efforts that advance the archiving and preservation of the music and recorded sound heritage of North America, and research projects related to the impact of music on the human condition.

Grant funds have been utilized to preserve private collections as well as materials at the Library of Congress, the Smithsonian and numerous colleges and universities. Research projects have studied the links between music and early childhood education, treatments for illnesses and injuries common to musicians, and the impact of music therapy on populations from infants to the elderly. To date, over $7.7 million in grants have been awarded to nearly 450 grantees.

Scientific Research Projects:

  • Each year, the GRAMMY Museum Grant Program awards grants to organizations and individuals to support research on the impact of music on the human condition. Examples might include the study of the effects of music on mood, cognition and healing, as well as the medical and occupational well-being of music professionals, and the creative process underlying music. Priority is given to projects with strong methodological design and innovative research questions.

Preservation Projects:

  • The GRAMMY Museum Grant Program awards grants to organizations and individuals to support efforts that advance the archiving and preservation of the music and recorded sound heritage of the Americas. The Archiving and Preservation area has two funding categories.

Eligibility: See the guidelines in the complete RFP for eligibility criteria.

Link to complete RFP

**Leukemia & Lymphoma Society Career Development Program

Organization: Leukemia & Lymphoma Society

Award amount: Up to $625,000

Deadline: Determine eligibility by 11/1/2021

Description: Career Development Program (CDP) grants support researchers early and at different stages of their career: from those with less than two years of postdoctoral research to those who hold independent faculty-level positions.

The grants are designed to encourage these promising young investigators to embark on academic careers, offering researchers the opportunity to take part in basic, translational, or clinical research to help understand and treat blood cancers and relevant premalignant conditions.

  • Scholar: The Scholar award supports rising stars in the blood cancer research field. You must be a highly qualified investigator who has shown a capacity for independent, sustained, original investigation in the field of hematologic malignancies. You should hold an independent faculty-level position and should have obtained substantial support for your research from a national agency. Note that the application and selection process has changed from project-centric to research program-centric. This is a fundamental change in the Scholar award mechanism that is described in the Guidelines & Instructions. Award: $120,000 per year over five years
  • Scholar in Clinical Research: You must be a highly qualified investigator who holds an independent faculty-level appointment and is conducting original, independent clinical research, often involving early-stage clinical trials that will advance the prevention, diagnosis, or treatment of hematologic malignancies. The research should be related to your clinical activities, and must directly involve patients. You’re expected to have concomitant support for your research from another source or agency. Investigators who are primarily laboratory-based, and/or who are working on primarily blood cancer model systems rather than patients, are not eligible for the Scholar in Clinical Research Award, and should consider the Scholar Award. Award: $125,000 per year over five years
  • Special Fellow: You must be a highly qualified postdoctoral fellow or instructor who’s completed a minimum of 2.5 years of postdoctoral research training and is in a mentored research position, continuing a research program of direct relevance to hematologic malignancies and/or relevant pre-malignant conditions. In addition, your Sponsor must have the appropriate experience to mentor you as you engage in blood cancer-relevant research. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period. Award: $67,000 per year for two or three years
  • Fellow: You must be a promising investigator with less than 2.5 years of postdoctoral research training. This award encourages you to embark on an academic career involving basic or translational research in hematologic malignancies and/or relevant premalignant conditions under a research sponsor’s direction. The proposal must be directly relevant to hematologic malignancies and/or relevant pre-malignant conditions. In addition, your Sponsor must have the appropriate experience to mentor you as you engage in research of direct relevance to blood cancer. Award: $60,000 per year for three years

Eligibility: See the description and complete RFP for eligibility requirements.

Link to complete RFP

**Pelizaeus-Merzbacher Disease Foundation Research Grants

Organization: Pelizaeus-Merzbacher Disease Foundation

Award amount: $100,000 over two years

Deadline: 11/1/2021

Description: The Pelizaeus-Merzbacher Disease Foundation (PMD Foundation) has announced a new request for applications in support of the discovery and/or validation of biomarkers that are relevant to the development of therapies for patients with PMD. Proposals that are focused on biological (e.g., CSF), imaging (e.g., MRI, OCT), or functional (e.g., VEP) biomarkers are particularly encouraged. 

The grant will provide $100,000 total over two years ($50,000 per year), subject to available foundation funds and demonstration of progress on the proposed research. 

Eligibility: Investigators at established research institutions are eligible to apply. It is expected that the principal investigator indicated in the application is considered eligible to apply for a research grant by her or his institution. The principal investigator must be personally and actively responsible for the conduct of the research. International applicants and institutions are welcome to apply. 

For complete program guidelines and application instructions, see the PMD Foundation website.

Link to complete RFP

American Society of Hematology Bridge Grant Program

Organization: American Society of Hematology

Award amount: $150,000

Deadline: 11/2/2021

Description: Since 2013, ASH has helped hematologists continue their critical blood disease research amidst severe funding reductions for the National Institutes of Health (NIH). Each year, approximately 20-30 one-year awards of $150,000 are granted to ASH members who applied for an NIH R01 grant or equivalent but were denied funding due to budget cutbacks. The ASH Bridge Grant program is intended to help sustain recipients’ research and contribute to their retention in hematology investigation.

Eligibility: To be eligible for the ASH Bridge Grant Award  all applicants must:

  • Have submitted a hematology-related R01 or equivalent application to NIH in the past 18 months that was scored but not funded.
    • Please note: This can include a first time submission.
    • ASH uses the NIH definition of R01 equivalence: “R01-equivalent awards include R01, R23, R29, and R37 activity codes and, beginning in fiscal year 2008, DP2 awards to first-time NIH investigators. Not all of these activities are in use by NIH every year.”
    • The 18 month timeline is linked specifically to the date your R01 was reviewed by the NIH study section.
  • Be an ASH member or have a pending application for membership at the time of application. ASH membership details can be found in the membership section of the website.
  • If you have a pending application and are awarded a Bridge Grant Award, your award will be conditional based upon membership approval
  • Hold a faculty position in an academic institution or the equivalent position in a non-profit research organization. Employees of independent research institutions are eligible to apply if they have a faculty type appointment and the institution is allowed to independently apply for and receive NIH funding.

Link to complete RFP

DeGregorio Family Foundation Annual Award for Cancers of the Upper GI Tract

Organization: DeGregorio Family Foundation

Award amount: Up to $250,000 over two years

Deadline: 11/2/2021

Description: The DeGregorio Family Foundation for Gastric and Esophageal Cancer is pleased to announce our 12th annual funding opportunity for gastroesophageal malignancies. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies. We support high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment. Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported

Research projects are selected through a rigorous review process, and project goals must align with the DeGregorio Family Foundation’s mission. The Foundation’s application review process is guided by its Scientific Advisory Board. Criteria for successful grants are impact, the likelihood of completion, and making a significant contribution to understanding, diagnosing. or treating gastric or esophageal malignancies. The intention of this award is to provide seed funding for research in upper GI malignancies. Funded applicants are expected to apply for subsequent peer-reviewed support (i.e. NIH or similar agency).

We wish all the applicants luck and we hope to announce winners by mid-January.

Eligibility: The Foundation must be associated with an academic or medical institution possessing a tax-exempt status under section 501(c)(3) of the IRS code. We are not accepting applications from postdocs.  Research projects must not be funded currently under a separate mechanism.

Link to complete RFP

Warren Alpert Foundation Prize for Prevention, Cure or Treatment of Human Diseases and Disorders

Organization: Warren Alpert Foundation

Award amount: $500,000

Deadline: 11/2/2021

Description: The Warren Alpert Foundation Prize, in association with Harvard Medical School, recognizes and honors one or more scientists, physicians and researchers whose scientific achievements have led to the prevention, cure or treatment of human diseases or disorders, and/or whose research constitutes a seminal scientific finding that holds great promise of ultimately changing our understanding of or ability to treat disease.

The value of the prize has been increased to U.S. $500,000 (to be split equally if more than one recipient is selected), a citation and plaque.  

Eligibility:

  • Individuals and groups of scientific and medical professionals may be nominated.
  • Nominations are accepted from physicians and scientists from around the world. U.S. and non U.S. citizens are elgible to be nominated.
  • Self nominations are not accepted.
  • Nominees must be living.

Link to complete RFP

Melanoma Research Alliance Young Investigator Award

Organization: Melanoma Research Alliance

Award amount: Up to $255,000

Deadline: Applicant Eligibility Checklist due 11/3/2021

Description: Young Investigator Awards aim to attract early career faculty with original ideas into the field of melanoma, thereby recruiting and supporting the next generation of melanoma research leaders. Awardees will be provided funding to accomplish innovative and original, preclinical, translational, and/or early clinical research projects. Young Investigators are scientists within the first five years of their first academic faculty appointment. A mentorship commitment from a senior investigator is required.

Eligibility: 

  • Applicants must be within the first five years of their first independent, full time academic faculty appointment at the application deadline, at the level of Assistant Professor (or equivalent position);
  • Applicants must designate at least one Mentor who is an established investigator at the same institution who will ensure that adequate support and guidance are provided for successful completion of the proposed research project and provide career mentorship. At least one Mentor with expertise in melanoma research is strongly advised;
  • Applicants who have secured an independent full-time faculty position commencing by June 1, 2022 will be considered; in this case, a letter from an institutional official or department chairperson confirming the planned date of faculty appointment is required at the time of application;
  • Applicants do not have to be on a tenure-track; however, fellows or others who are in training positions are not eligible to apply;
  • Applicants who are in research support positions are not eligible to apply;
  • Applicants who have been awarded a prior MRA Young Investigator Award are not eligible to apply for an additional MRA Young Investigator Award;
  • Applicants may serve as PI on only one proposal submitted to MRA for any of the award mechanisms in this cycle;
  • All Young Investigator applicants must complete and return the Applicant Eligibility Checklist by November 3, 2021. Please email the completed checklist to Rachel Fischer Ph.D., MRA Senior Associate, Scientific Program and Grants Administration at rfischer@curemelanoma.org.

Link to complete RFP

Robert Wood Johnson Foundation People, Parks, and Power: A National Initiative for Green Space, Health Equity, and Racial Justice

**The UW does not qualify for this award, but we encourage you to share this opportunity with your partners at community-based organizations and base-building groups working in low-income communities of color.**

Organization: Robert Wood Johnson Foundation

Award amount: Up to $500,000 over two years

Deadline: 11/4/2021

Description: The People, Parks, and Power initiative comes at a critical moment. Imbalances in political and economic power and a legacy of racial discrimination in the conservation movement have excluded groups led by people of color from full participation in park and green space work or have tokenized their involvement. The P3 initiative is grounded in the premise that urban parks are essential community infrastructure that should serve every neighborhood in a fair, just, and safe manner, without displacing longtime residents or community-serving businesses. P3 will support community-based organizations and base-building groups working in urban, low-income communities of color across the United States to increase park equity through local policy and systems change. The geographic focus of the P3 initiative is urban areas—with a particular interest in small and mid-sized cities (under 500,000 population).

African Americans, Latinos, and people living in low-income urban areas across the United States have disproportionately been denied the health, social, and environmental benefits of vital public spaces—inequities born from historical and current day policies, systems, and norms. We strongly encourage community-based organizations to apply, especially those led by people of color working to build community power at the citywide, countywide, or district wide level. Until the policies, institutional practices, power dynamics, and problematic narratives that produced these inequities in the first place are transformed, park inequities will persist or worsen. Therefore, the “north star” of the P3 initiative is upstream policy and systems change, not planning, building, or operating individual, on-the-ground projects. We are interested in funding a spectrum of eligible organizations across the United States that either are in later or early stages of policy advocacy and systems change efforts to advance park equity.

Eligibility: 

  • Applicant organizations must be either public entities or nonprofit organizations that are tax-exempt under Section 501(c)(3) of the Internal Revenue Code and are not private foundations or non functionally integrated Type III supporting organizations. The Foundation may require additional documentation.
  • Awards will be made to organizations, not to individuals.
  • Organizations that are fiscally sponsored by a 501(c)(3) entity that meet all other eligibility criteria are eligible.
  • Coalitions are eligible if the lead applicant organization meets all other eligibility criteria. In the case of a coalition, one organization must be the lead applicant and will be responsible for administrative oversight of the grant. Universities or academic institutions are not eligible to be the lead applicant, but they may serve as a coalition partner to the lead applicant.
  • Applicant organizations must demonstrate the capacity to manage awards of this size, either directly or with the benefit of technical assistance.
  • Applicant organizations must be based in the United States or its territories.

Link to complete RFP

Foundation Fighting Blindness Individual Investigator Research/Clinical Innovation Awards (IIRA/CIA)

Organization: Foundation Fighting Blindness

Award amount: Up to $300,000

Deadline: LOI due 11/5/2021

Description: Individual Investigator Research Awards are designed to concentrate research in areas with the greatest potential to move toward treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration. This award provides approximately $100,000 per year up to three (3) years.

The Foundation Fighting Blindness will also award up to three Clinical Innovation Awards that address: (1) developing and applying new technology to measure structure and function in inherited retinal degenerations; (2) establish relationships between measures of retinal functional and retinal structure with the goal of understanding the relationship between genotype and clinical phenotype; (3) identifying outcome measures or biomarkers to demonstrate change over a time period spanning no more than 2 to 3 years.

Research Priority Areas

  • Novel Medical Therapies
  • Gene Therapy
  • Cell and Molecular Mechanisms of Retinal Disease
  • Genetics
  • Clinical-Structure and Function
  • Regenerative Medicine

Eligibility: These opportunities seek candidates that hold a Ph.D., M.D., M.D./Ph.D., D.M.D., D.V.M., D.O., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory.

Link to complete RFP

Foundation Fighting Blindness Program Project Award

Organization: Foundation Fighting Blindness

Award amount: Up to $2.5M

Deadline: LOI due 11/5/2021

Description: The PPA is designed to support collaborative, multi-disciplinary, research studies that engage investigators with different expertise and resources. The PPA is intended to enable studies that are too large or complex for a single investigator to undertake in a reasonable amount of time and to address gaps in our current knowledge or therapeutic options. The PPA must be unified around a single, well-articulated hypothesis and a clearly defined deliverable(s), relevant to the mission of FFB. The teams supported by a PPA must be tightly integrated and sharply focused, freely share data and creative ideas, and each be essential to the common goal. 

The PPA is not intended to support clinical research unless it is tightly integrated with the other projects and the PPA is not intended to support research cores.

Eligibility: Principal Investigators must hold an M.D., D.M.D., D.V.M., D.O., Ph.D. or recognized foreign equivalent and occupy a faculty position or equivalent position at a college, university, medical school, or other public or private research institution/facility. Application is not limited to the U.S. or U.S. citizens. Applicants who are not U.S. citizens and reside and work outside the U.S. may apply.

Link to complete RFP

Alpha Phi Foundation Heart to Heart Grant to Encourage Research and Education to Lessen the Impact of Heart Disease in Women

Organization: Alpha Phi Foundation

Award amount: $100,000

Deadline: 11/6/2021

Description: As a women’s organization, Alpha Phi Foundation places special emphasis on women’s heart health. In 1993, Alpha Phi Foundation designed an annual grant—the Heart to Heart Grant—to encourage research and education to lessen the impact of heart disease in women.

Since its inception, the Heart to Heart Grant has invested over $1.4 million into women’s heart health initiatives.

Alpha Phi Foundation announces a single recipient of the $100,000 Heart to Heart Grant every year

Eligibility: Who is Eligible?

  • Community Organizations
  • Hospitals
  • Universities/Schools
  • Research Programs

Additional Eligibility Requirements:

  • Institutions must have public charity status/nonprofit status under IRS Code Section 501(c)(3) or a Charitable Designation Number, if in Canada.
  • Programs must target education and/or care of women.

Link to complete RFP

American Gastroenterological Association Research Scholar Award for Early-Career Faculty

Organization: American Gastroenterological Association

Award amount: Up to $300,000 over three years

Deadline: 11/10/2021

Description: The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research (i.e., a minimum of 75 percent effort dedicated to the proposed project). The award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research.

This award provides $100,000 per year for three years (totaling $300,000) to early-career faculty (i.e., investigator, instructor, research associate or equivalent) working toward an independent career in digestive disease research.

Eligibility: 

  • Applicants for this award must hold an MD, PhD and/or equivalent degree (e.g., MBChB, MBBS, DO), and a full-time faculty or equivalent position at an institution in North America (U.S., Canada or Mexico) by the start date (i.e., July 2022) of this award.
  • Applicants must classify as “early career” according to the following criteria:
    • MD (or equivalent) applicants are considered “early career” if no more than seven years have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award (July 2022).
    • PhD (or equivalent) applicants are considered “early career” if no more than seven years have elapsed following the conferment of the PhD degree and the start date of this award (July 2022).
    • In response to the COVID-19 pandemic, applicants in August–November 2021 application period will automatically receive a one-year extension to the above early career classifications. You will qualify as early career if your clinical training was completed, or PhD degree was received, in or after July 2014.
    • An appropriately documented leave of absence, such as parental or medical leave, will not be counted toward the above seven-year eligibility criteria. Exceptional circumstances may also be considered. Exemption requests must be submitted to AGA via email (awards@gastro.org) at least three weeks prior to the application deadline and be clearly indicated in the submitted application documents.
  • Applicants performing any typ of research (basic, translational, clinical) relevant to digestive disorders are eligible to apply.
  • AGA membership is required at the time of application submission. Candidates whose AGA membership applications are pending approval may apply for the award. Please visit the AGA membership page or call 301-654-2055 for membership information.
  • Applicants who are physician-scientists, female or from racial/ethnic groups underrepresented in biomedical research are strongly encouraged to apply.

Link to complete RFP

American Association for Cancer Research-Bristol Myers Squibb Midcareer Female Investigator Grant

Organization: American Association for Cancer Research

Award amount: $225,000

Deadline: 11/11/2021

Description: The AACR-Bristol Myers Squibb Midcareer Female Investigator Grant represents a joint effort to encourage and support mid-career female physician-scientists and researchers to conduct immuno-oncology research and to foster their career advancement toward becoming a senior investigator. Research projects may be translational and/or clinical in nature with a focus on immuno-oncology.

The grant provides $225,000 over three years for expenses related to the research project, which may include salary and benefits of the grant recipient and any collaborators, postdoctoral or clinical research fellows, graduate students, and/or research assistants; research/laboratory supplies; equipment; publication charges for manuscripts that pertain directly to the funded project; and other research expenses (indirect costs are not permitted).

Research projects may be translational or clinical in nature with a focus on immuno-oncology.

Eligibility: At the start of the grant term on July 1, 2022, applicants must:

  • hold an appointment at the rank of associate professor
  • work at an academic, medical, or research institution anywhere in the world
  • have received their first NIH R01 (or equivalent) award within the past 10 years (i.e., grant cannot have been awarded before July 1, 2012

There are no citizenship or geographic requirements. However, by submitting an application for this grant, an applicant applying from an institution located in a country in which they are not a citizen or a permanent resident assures that the visa status will provide sufficient time to complete the project and grant term at the institution from which they applied.

Applicants must be AACR Active members. Nonmembers interested in this grant opportunity must submit a satisfactory application for AACR Active membership by the application deadline.

Link to complete RFP

**Doris Duke Charitable Trust Clinical Scientist Development Award

Organization: Doris Duke Charitable Trust

Award amount: $165,000

Deadline: pre-proposals due 11/12/2021

Description: The Doris Duke Clinical Scientist Development Award provides grants to junior physician scientists to facilitate their transition to independent clinical research careers.

The Clinical Scientist Development Award consists of $150,000 annual direct costs plus $15,000 (10%) annual indirect costs for three years. The priority of the CSDA program is to fund outstanding individuals with potential for clinical research careers, substantial institutional commitments to mentorship and career development, and whose projects will address highly significant research questions and lead to career advancement. DDCF does not have funding priorities based on disease area or research type.

Eligibility: In keeping with the wishes expressed in Doris Duke’s will, experiments that use animals or tissues derived from animals, including cell lines, will not be supported by this program. 

See the FAQs in the complete RFP for additional eligibility information.

Link to complete RFP

Alexs Lemonade Stand Foundation Innovation Grants for Pediatric Oncology

Organization: Alex’s Lemonade Stand Foundation

Award amount: up to $250,000

Deadline: LOI due 11/15/2021

Description: ALSF is committed to creating opportunities for new and innovative research into treatments and cures for childhood cancers. The Innovation Grant is designed to provide critical and significant seed funding for researchers with a novel approach to pediatric oncology scientific investigation. Proposals should have clinical translation in view. This may represent a change in research direction and/or an innovative new idea that moves away from an investigator’s prior research but for which a strong case is made for the potential impact on childhood cancers.

Eligibility: 

  • Applicants must have a faculty appointment at an academic institution.
  • Applicants may be M.D., D.O., Ph.D, or M.D./Ph.D.
  • Track record of publication and funding productivity in the last 5 years must demonstrate that the project can be accomplished by the investigator(s).  

Link to complete RFP

American Partnership for Eosinophilic Disorders 2022 Hope APFED/AAAAI Grant Award

Organization: American Partnership for Eosinophilic Disorders

Award amount: $140,000

Deadline: 11/12/2021

Description: Applications are now being accepted for the 2022 Hope APFED/AAAAI Grant Award. The award was established to allow investigators from a variety of disciplines to initiate new projects relevant to eosinophilic disorders. Successful applications will focus on the development of new ideas which are likely to lead to future external funding.

The 2022 Hope APFED/AAAAI Grant Award is a collaborative award program between the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American Partnership for Eosinophilic Disorders (APFED). The award program is administered by the AAAAI and equally funded by each Association.

Eligibility: See the complete RFP for eligibility criteria.

Link to complete RFP

American Foundation for Suicide Prevention Innovation Research Grants

Organization: American Foundation for Suicide Prevention

Award amount: Up to $125,000 over 2 years

Deadline: 11/15/2021

Description: Our research grants support studies that will increase our understanding of suicide or test treatments and other interventions that save lives.

Suicide research priority areas: 

  • Diversity: Suicide prevention research related to underrepresented communities, health and mental health disparities and inequities, as well as researchers from underrepresented backgrounds proposing research focused on understanding and preventing suicide.
  • Evaluation of technological tools for suicide prevention: The application of implementation science methodology to evaluate technological tools available in order to expand access and overcome barriers for suicide prevention.
  • Survivors of Suicide Loss: Research related to survivors of suicide loss, understanding the impact of suicide loss and it’s after-effects, and the process of healing.

Innovation Grants

  • Distinguished Investigator Innovation Grants
    • Up to $125,000 over 2 years
    • Grants awarded to investigators at the level of associate professor or higher with an established record of research and publications.
  • Standard Research Innovation Grants
    • Up to $100,000 over 2 years
    • Grants awarded to individual investigators at any level.
  • Young Investigator Innovation Grants
    • Up to $90,000 over 2 years
    • Grants awarded to investigators at or below the level of assistant professor. These grants must allocate $10,000 ($5,000 per year) of their award for an established researcher to mentor the Young Investigator. AFSP is available to assist you in identifying a suitable mentor.
  • Postdoctoral Research Fellowship Innovation Grants
    • Up to $132,900 over 2 years (Salary of $54,450 per year. Allowance of $12,000 per year.)
    • Grants awarded to investigators who have received a Ph.D., M.D., or other doctoral degree within the preceding six years and have had no more than three years of fellowship support. Fellows receive a stipend of $54,450 per year and an institutional allowance of $12,000 per year.
  • Pilot Innovation Grants
    • Up to $30,000 over 2 years
    • Awarded to investigators at any level, these grants provide seed funding for new projects that have the potential to lead to larger investigations. These grants typically entail feasibility studies rather than hypothesis-driven research. Examples include manual development and new biomarker development.

Eligibility: Investigators from all academic disciplines are eligible to apply, and both basic science and applied research projects will be considered, provided that the proposed study has an essential focus on suicide or suicide prevention.

A current grantee may submit a new application as their grant nears completion but it will not be funded until completion of the current grant and submission of a Final Report.

New grantees must begin their studies within 6 months of the approved start date. Failure to begin the study within this time frame may result in withdrawal of the grant award.

Grant applications are not accepted from for-profit organizations, or from federal or state government agencies. Applications from the Veterans Administration are eligible.

Link to complete RFP

American Society of Hematology Minority Medical Student Award Program

Organization: American Society of Hematology

Award amount: $7,000-$36,000

Deadline: 

  • Request a Mentor: Nov. 15, 2021
  • Full Applications: Jan. 15, 2022  

Description: The ASH Minority Medical Student Award Program (MMSAP) provides underrepresented minority medical students with an opportunity to conduct a research project under the supervision of an ASH member, receive guidance from a career-development mentor, gain valuable knowledge of hematology, and ultimately, advance their careers. As part of the ASH Minority Recruitment Initiative, the MMSAP aims to expand the program’s reach to the next generation of hematologists.

Applicants must have a research mentor who is an ASH member in good standing and may choose from one of three project options with varying program benefits. The summer project option requires an eight- to 12-week commitment; the flexible project requires a commitment of approximately 320 to 480 hours over the course of a year; and the yearlong project requires participants to take a year off from school to engage in research full-time.

The ASH Minority Medical Student Award Program (MMSAP) is designed to introduce minority medical students to hematology and hematology research through one of the following research options:

  • Summer project: for students in their first or second year of medical school, to be conducted during the summer break (over a span of eight to 12 weeks)
  • Flexible project: for students in their first, second, or third year of medical school, to be completed over the course of a year (must commit approximately 320 to 480 hours)
  • Yearlong project: students must take a year off from medical school during what would otherwise be their second, third, or fourth year of medical school

Eligibility: 

  • Identify as a minority; applicants are asked to self-identify, and participants for the MMSAP are drawn from this pool. For the purposes of this program, minority is defined as a group of people from racial and ethnic groups that have been shown to be underrepresented in health-related sciences in the United States and Canada. This includes American Indians or Alaska Natives, Blacks or African Americans, Hispanics or Latinos, Native Hawaiians or other Pacific Islanders, African Canadians, Inuit, and First Nation Peoples.
  • Be enrolled in a MD, DO, or MD-PhD medical school program.
  • If applying for a summer project, be within his/her first or second year of medical school; or, if applying for a flexible or yearlong project, be within his/her first, second, or third year of medical school.
  • To be eligible for consideration, an applicant must be planning and committed to conduct the relevant research project in the contiguous United States or Canada.
  • Have a research mentor who is an ASH member in good standing. To request assistance in identifying a research mentor, please submit a Request a Mentor form in the online awards system by the November 15 deadline.

Link to complete RFP

Cancer Research Institute Technology Impact Award

Organization: Cancer Research Institute

Award amount: Up to $100,000

Deadline: LOI due 11/15/2021

Description: The Cancer Research Institute Technology Impact Award provides seed funding of up to $200,000 to be used over 12-24 months to address the gap between technology development and clinical application of cancer immunotherapies. These grants aim to encourage collaboration between technology developers and clinical cancer immunologists and to generate the proof-of-principle of a novel platform technology in bioinformatics, ex vivo or in silico modeling systems, immunological or tumor profiling instrumentation, methods, reagents and assays, or other relevant technologies that can enable clinician scientists to generate deeper insights into the mechanisms of action of effective or ineffective cancer immunotherapies.

Award winners will be selected based on the novelty, creativity, technical sophistication, and transformative potential of the technology to impact cancer immunotherapy research around the world. The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time—developing immunotherapies that are effective for all cancer patients.

Areas of interest: 

  • The most competitive applicants will address areas where technological innovation stands to benefit the field and cancer patients most, and that will ultimately lead to effective next generation personalized cancer immunotherapies. These technologies may include but are not limited to:
  • New bioinformatics methods or technologies that speed collection and analysis of large sets of patient-derived biological data
  • Computer simulations for modeling biological systems and responses to immunotherapy
  • Tools and methods that improve profiling of tumors to inform therapeutic strategies
  • Real-time visualizations of molecular and cellular activity to improve tracking of responses to immunotherapy
  • In vitro tissue culture systems that recapitulate the interactions between primary tumor cells and the immune system

Eligibility: 

  • Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation.
  • The grant will be awarded to a scientist who describes an extraordinarily novel, yet practical research plan that is creative and technically sophisticated.
  • Joint submissions from collaborators will also be considered. (The collaborators will share the award.) Each collaborator must meet the eligibility criteria.
  • Selected projects that meet their 12 and 24 month milestones may be eligible for follow-on funding that will enable the established proof-of-concept technology to be developed into a methodology that improves cancer immunotherapy research worldwide.

Link to complete RFP

Brodeur Breast Cancer Foundation Research Grants

Organization: Brodeur Breast Cancer Foundation

Award amount: $100,000

Deadline: 11/19/2021

Description: The Terri Brodeur Breast Cancer Foundation is a nonprofit organization dedicated to providing critical funding to researchers investigating breast cancer cures and patient treatment options.

The Foundation is founded on the pledge of delivering 100 percent of gross fundraising dollars to breast cancer science and has held fast to this promise since its inception. The Foundation’s Grant Program seeks to fund clinical and pre-clinical fellowships in high impact, breast cancer therapeutic research areas.

The foundation seeks to fund broadly the very best proposals across all relevant disciplines and as such focus areas can include basic, preclinical, clinical research and clinical care. The award period is two years with a 1-year interim renewal to occur upon successful completion of the year one research goals. Stipends are $50,000 per year, with the intention that all funds are strictly used for direct support of the grantee or their research program.

Eligibility: This award is intended to support PhD, MD/Ph.D. and M.D. physician scientists at earlier formative stages of their careers to enable them to develop independent programs and compelling careers in breast cancer research.

See the complete funding opportunity for additional eligibility criteria.

Link to complete RFP

Society of American Gastrointestinal Endoscopic Surgeons Research Grants

Organization: Society of American Gastrointestinal Endoscopic Surgeons

Award amount: Up to $30,000

Deadline: 11/19/2021

Description: The purpose of these grants is to stimulate original research in gastrointestinal and endoscopic surgery. The study may be either “bench” research or clinical.

  • Grants are limited to no more than $30,000 each, for 1-year period
  • Made to the Institution

The SAGES Research Awards are open to any principal investigator who is a current SAGES member, including Candidate Members. Please read all the guidelines carefully. SAGES would like to especially encourage grant funding to young investigators/candidate members in the hopes that funding through SAGES will lead to additional extramural funding.

SAGES considers a Young Investigator as someone who has not practiced surgery independently for more than 5 years

Awards are conferred on a competitive basis by submission of a grant application, which is assessed by the SAGES Research and Career Development Committee, in a blinded fashion, free of conflict of interest. Ultimately the recommended grantees are approved by the governing board.

In the spirit of supporting the goals of our membership, applicants are encouraged to review: 2014 Surgical Endoscopy- SAGES Research Priorities for a recent review of key research questions. Part of the grant review process includes evaluation of the importance of the research question. The review committee will incorporate these published rankings to determine the importance of submitted topics.

Eligibility: The principal investigator must be a current SAGES member in good standing at the time of the application submission deadline.

Link to complete RFP

World Cultural Council Albert Einstein World Award of Science and José Vasconcelos World Award of Education

Organization: World Cultural Council

Award amount: $10,000

Deadline: 11/20/2021

Description: Nominees for the “Albert Einstein” World Award of Science should be eminent scientists whose achievements can serve as an inspiration for future generations. Considerations will be given to individuals or institutions in one of the Life Sciences, such as Neuroscience, Earth Science, Biology, Biochemistry, Medicine or Chemistry; or in one of the Natural Sciences such as Physics, Mathematics or Astronomy. The prize is awarded every year.

A candidate for the “José Vasconcelos” World Award of Education should be a renowned educator, an authority in the field of teaching, or an individual who has promoted education policies. Through his/her work, the individual or team should have had a significant influence on the advancement of culture for mankind. The prize is awarded every second year.

In addition to considering the candidate’s breakthrough achievements, the jury will also take into account the service which each has made to mankind and his/her qualities as a role model who inspires future generations to contribute to a better world.

Eligibility: See complete funding opportunity for eligibility criteria.

Link to complete RFP

Foundation for Women’s Cancer Research Prizes

Organization: Foundation for Women’s Cancer

Award amount: $1,000-$5,000

Deadline: 11/29/2021

Description: 

  • Foundation for Women’s Cancer/Norma Livingston Ovarian Cancer Foundation Excellence in Ovarian Cancer Research Prize – $5,000 one-year award
    • This annual prize will be given to an individual who can best demonstrate that he or she has been able to use their Foundation award to improve women’s health care by obtaining independent extramural funding, making important contributions to the literature, and/or developing programs that improved women’s health care, including early detection. This award is to the individual and not his or her institution. Only past Foundation award winners qualify for this prize and should apply by completing the application.
  • Perlman Family CCARE Lynch Syndrome Research Prize – $2,500 one-year award
    • Funding is available for a $2,500 stipend for a trainee to support a summer or short-term research project that advances knowledge about Lynch syndrome and its role in gynecologic cancers. The successful applicant must submit a short summary of the project’s goals and expected outcomes co-signed by the applicant’s mentor and supervisor.
  • Nina Donnelley and The Dickens Fund of the Donnelley Foundation Young Investigator Award in Honor of Laurel W. Rice, MD
    • Funding is available for a $1,000 prize to a fellow or resident who has promise to contribute to the field of gynecologic oncology in the future.

Eligibility: See each opportunity for eligibility criteria.

Link to complete RFP

Bayer Corporation Hemophilia Awards Program

Organization: Bayer Corporation

Award amount: Up to $80,000

Deadline: 11/30/2021

Description: The Bayer Hemophilia Awards Program demonstrates Bayer’s commitment to the bleeding disorders community and to advancing the state of the art of hemophilia care.

Clinical Research Award

  • This award will provide funds to undertake a clinical research project in the bleeding disorders field. Focus areas for such projects include, but are not limited to:
    • Developing evidence to support international and national management guidelines
    • Role of tailored, individualized FVIII treatment regimens, for example, for maximizing protection in order to achieve active lifestyles
    • Pain management, for example, joint or muscle pain, pain due to chronic hemophilic arthropathy, dental, postoperative pain
    • Patient-reported outcomes: Definition, documentation, and clinical implications
    • Subclinical / microbleeds: definition, documentation and clinical implications
    • Variability of outcomes in hemophilia A subpopulations, including but not limited to, elderly, co-morbid and adolescents
    • Joint health and interventions in patients with moderate/mild hemophilia A
    • Observational data (RWE) on factor utilization and cost-effectiveness
  • Clinical Research Project awards will provide funding of up to US$75,000 for one year. Up to 15% may be requested as salary support. Up to 20% may be requested as overhead. Up to three awards will be granted for the 2021/2022 cycle.

Basic Research Award

  • This award will provide funds to undertake a basic research project in the bleeding disorders field. Focus areas for such projects include, but are not limited to:
    • Investigating the role of FVIII in coagulation and outside of coagulation, for example, musculoskeletal, cancer, hypertension, angiogenesis and hematopoietic stem cells
    • Immunogenicity, inhibitor development and immune tolerance
    • Laboratory research, services, applications and genetic diagnosis of hemophilia
    • Cell and gene therapy, for example, basic science, tropism, transduction efficiency & tolerability
    • Alternative coagulation products
  • Basic Research Project awards will provide funding of up to US$75,000 for one year. Up to 15% may be requested as salary support. Up to 20% may be requested as overhead. Up to three awards will be granted for the 2021/2022 cycle.

Fellowship Project Award

  • This award is intended to facilitate the development of clinical and research expertise in the field of hemophilia for applicants who have completed medical training and have an interest in pursuing a career as a hemophilia clinician. The award will support a mentored physician for one year, who will be expected to undertake a research project as well as clinical training.
  • Fellowship Project awards will provide funding of up to US$80,000 for one year. Salary support is anticipated; there is no cap but the Committee will be looking for remuneration to be commensurate with institutional norms. Up to 20% may be requested as overhead. Two awards will be granted for the 2021/2022 cycle.

Patient Engagement Award

  • Bayer is proud to support a new Patient Engagement Award for the 2022 BHAP Awards Cycle.
  • This award will provide funds to support efforts in the field of patient engagement, education and advocacy within hemophilia. It recognizes the essential role of nurses, allied healthcare professionals and caregivers in the care of patients with hemophilia.
  • The Patient Engagement Award will provide funding of up to US$25,000 for one year. Up to 15% may be requested as salary support. Up to 20% may be requested as overhead.

Eligibility: 

  • Clinical and Basic Research Awards
    • Any individual affiliated with a facility that carries out research in inherited bleeding disorders, or provides care to patients with these disorders, may make a request for these awards. Such facilities may include medical universities, hospitals, treatment centers, blood centers and laboratories.
  • Fellowship Project Award
    • The applicant will be affiliated with a facility that carries out research in inherited bleeding disorders or provides care to patients with these disorders. Such facilities may include medical universities, hospitals, treatment centers, blood centers and laboratories. The applicant should have earned his/her medical degree within the previous eight years. The applicant may not have received previous funding from this award category.

Link to complete RFP

 

American Association of Neurological Surgeons Post-Residency Clinical Fellowship Program

Organization: American Association of Neurological Surgeons

Award amount: $75,000

Deadline: 12/1/2021

Description: As the premier funder of neurological studies and education, the NREF provides fellowship funding for basic and clinical neuroscience for neurosurgical programs in North America.

Collaborating with reviewers from the AANS/CNS Sections, the NREF awards the fellowships based on established program eligibility criteria and the needs of the requesting institution.

Fully-funded fellowship grants are awarded at $75,000, but may be awarded in lesser amounts, depending on available support.

Eligibility: Any academic institution or group practice with an established neurosurgery residency program in North America that qualifies as a non-profit, charitable entity may apply. 

Link to complete RFP

American Association of University Women Research Publication Grant in Engineering, Medicine and Science

Organization: American Association of University Women

Award amount: $10,000-$35,000

Deadline: 12/1/2021

Description: Having a strong publication record is a key to receiving promotions and tenure in engineering, medicine and science. Yet persistent gender stereotypes and bias in these fields can make it difficult for women to find the time and institutional support needed to publish their research. These grants help women overcome these barriers by funding research projects that will culminate in scholarly publications.

They are open to women scholars conducting basic research in engineering, medicine or the physical or biological sciences and who have a doctorate degree in one of those fields. The grantee must publish their research in a scholarly publication and be listed as a primary author.

Eligibility: 

  • Grants are not open to previous recipients of any AAUW national fellowship or grant (not including branch or local awards or Community Action Grants).
  • Members of the AAUW Board of Directors, committees, panels, task forces, and staff, including current interns, are not eligible to apply for AAUW’s fellowships and grants. A person holding a current award is eligible for election or appointment to boards, committees, panels, and task forces.
  • Grant candidates must be U.S. citizens or permanent residents.
  • Grants are open to scholars who identify as women and who are conducting basic research in engineering, medicine, or physical or biological sciences at an accredited institution of higher education or research. AAUW will make final decisions about what constitutes eligible institutions.
  • AAUW follows guidance from the National Science Foundation (NSF) and National Institute of Health (NIH) in determining what qualifies as basic research:
    • NSF: “Activity aimed at acquiring new knowledge or understanding without specific immediate commercial application or use.” The NSF Definitions of Research and Development provides additional guidance.
    • NIH: “The systematic study directed toward greater knowledge or understanding of the fundamental aspects of phenomena and of observable facts without specific applications towards processes or products in mind.” (32 CFR 272.3) The NIH Basic Research – Digital Media Kit and Basic Research: Building a First Foundation for Biomedicine provide additional guidance.
  • The grantee must plan to have this research accepted to a scholarly scientific publication within six months of the end of the grant year and be listed as the sole author, senior author, first author, or author of equivalent significance.
  • Applicants must hold a doctorate degree in engineering, medicine, or the physical or biological sciences.
  • Tenured professors are not eligible.
  • The grants are for tenure track, part-time and temporary faculty, as well as new and established researchers at universities.
  • Applicants may not apply for another AAUW national fellowship or grant in the same year.

Link to complete RFP

**American Federation for Aging Research Coins for Alzheimers Research Trust Grants

Organization: American Federation for Aging Research

Award amount: Up to $250,000

Deadline: 12/1/2021

Description: The goal of CART is to encourage exploratory and developmental AD research projects within the United States by providing support for the early and conceptual plans of those projects that may not yet be supported by extensive preliminary data, but have the potential to substantially advance biomedical research. This proposal should be distinct from those projects designed to increase knowledge in a well-established area unless it is intended to extend previous discoveries toward new directions or applications.

The CART Fund is inviting interested applicants from within the United States only to submit a LETTER-of-INTENT that includes sufficient detail to communicate the importance of your study as well as information on its feasibility.

Applications may encompass a project period of up to two years with a combined budget for direct costs up to $250,000. No indirect costs are allowed. Full-time faculty (or the equivalent status) at U.S.-based public and private institutions, such as universities, colleges, hospitals, and laboratories, are eligible. This is for NEW projects only. Applications will be deemed ineligible from for-profit and organizations outside of the United States, as well as those already supported by regular or program grants. At least one award of up to $250,000 will be made in 2022.

Eligibility: See the complete RFP for eligibility criteria.

Link to complete RFP

**American Society of Transplantation Fellowships and Grants

Organization: American Society of Transplantation

Award amount: $50,000 a year for one or two years

Deadline: 12/1/2021

Description: AST TIRN has provided research grants for fellows and junior faculty for more than 15 years. These one- or two-year grants are awarded to support the fellow or young independent investigator conducting a specific research project during the term of the grant.

The goal is to support research proposals by individuals who are early in their careers and who will contribute much to the field of transplantation in the future. Each summer, eligible applicants can apply for a Faculty Development Research Grant or a Fellowship Research Grant. Each year, AST TIRN identifies research priorities which are suggested focus areas for grant applicants. These priorities are intended to provide applicants with a set of emphasis areas that will receive special consideration by reviewers. However, it is important to note that we will still accept applications on any research topic, as we recognize the importance of innovation in areas outside of these priorities.

  • Faculty Development Research Grants
    • AST TIRN Faculty Development Research Grants are intended for young independent investigators within the first five (5) years of their first faculty appointment, encouraging them to expand on preliminary research findings that will become the basis for individual research or career development awards from the NIH, VA, or equivalent agencies.
  • Fellowship Research Grants
    • AST TIRN Fellowship Research Grants are intended for individuals who have spent two years or less (at the time of the application) performing research in the area of transplantation since obtaining their last doctoral degree (PhD, MD, or equivalent).

Eligibility: See the description and the complete RFP for eligibility requirements.

Link to complete RFP

Burroughs Wellcome Fund Next Gen Pregnancy Initiative Awards

Organization: Burroughs Wellcome Fund

Award amount: Up to $500,000 over four-years

Deadline: 12/1/2021

Description: Building upon the original goals of the BWF Preterm Birth Initiative, a recently convened Pregnancy Think Tank has helped shape the next generation of BWF preterm birth awards. Growing evidence suggests the interrelatedness of the duration of pregnancy, fetal growth, and adverse pregnancy outcomes such as preterm birth, preeclampsia, intrauterine growth restriction, stillbirth, and maternal medical complications including maternal mortality.

Other areas of interest are climate change and environmental impact on pregnancy, complications associated with ART, and epigenome-wide association studies.

We seek to expand the scope of this award mechanism to capture these and other pregnancy outcomes as we believe they will be mutually informative and accelerate discovery. Each award will continue to provide up to $500,000 over a four-year period ($125,000 per year).

The initiative is designed to stimulate both creative individual scientists and multi-investigator teams to approach healthy and adverse pregnancy outcomes using creative basic and translation science methods. The formation of new connections between reproductive scientists and investigators who are involved in other areas is particularly encouraged.

Proposals should address the biomedical causes and molecular mechanisms underlying adverse pregnancies and their outcomes including but not limited to peri-implantational events, placentation, fetal determinants, fetal-maternal immune responses, biological basis for racial-ethnic disparities, mechanisms relating preterm birth to other adverse pregnancy outcomes, biology of normal labor, genomics, evolutionary influences, maternal complications and other approaches. Proposals seeking to identify biomarkers predicting preterm birth are welcome.

Eligibility: Public or private non-profit organizations in the United States and Canada, including degree-granting academic institutions, research institutes and teaching hospitals, are eligible to receive Burroughs Wellcome Fund support.

Postdoctoral fellows nearing their transition to independent investigator status through senior established investigators are eligible to apply.

Citizens and non-citizen permanent and temporary residents of the U.S. and Canada who are legally qualified to work in the U.S. or Canada are eligible.

Candidates who are temporary U.S. residents must hold a valid U.S. visa (J-1, H1B, F-1 or O-1 visas).

Link to complete RFP

Cancer Research Institute Clinic and Laboratory Integration Program (CLIP)

Organization: Cancer Research Institute

Award amount: Up to $200,000 over two years

Deadline: LOI due 12/1/2021

Description: The Cancer Research Institute Clinic and Laboratory Integration Program (CLIP) supports pre-clinical and translational research that can be directly applied to optimizing cancer immunotherapy in the clinic. CLIP grants are awarded to qualified scientists exploring clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. 

The Cancer Research Institute mission is save more lives by fueling the discovery and development of powerful immunotherapies for all types of cancer. It funds research aimed at furthering the development of immunological approaches to the diagnosis, treatment, and prevention of cancer.

The development of new and effective cancer treatment requires the translation of basic laboratory discoveries into novel therapies that can be tested in patients. This area of translational research—where laboratory findings move into clinical testing, and where questions from clinical studies are brought back into the lab—is critical to bringing new and better immunotherapies to patients.

The Cancer Research Institute established CLIP to support investigators who are studying critical topics at the intersection of laboratory and clinical research. CLIP grants provide up to $200,000 over a two-year period.

Eligibility: CLIP Grants provide funding for qualified scientists who are working to explore clinically relevant questions aimed at improving the effectiveness of cancer immunotherapies. The grant will support pre-clinical and translational research, which will provide information that can be directly applied to optimizing cancer immunotherapy in the clinic.

Candidates for a CLIP Grant must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation. If not, documentation from their institution must accompany the Letter of Intent indicating they will hold the position of assistant professor (or higher rank) by the time of award activation. CRI has no citizenship restrictions, and research supported by the award may be conducted at medical schools and research centers in the United States or abroad. Please note that CLIP Grants do not support research at for-profit institutions.

Link to complete RFP

Damon Runyon Cancer Research Foundation Physician-Scientist Training Award

Organization: Damon Runyon Cancer Research Foundation

Award amount: $460,000 over four years (not including debt repayment and dependent child allowance)

Deadline: 12/1/2021

Description: In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon wishes to encourage more physicians to pursue research careers. To do so, the Foundation established a program designed to recruit outstanding U.S. Specialty Board eligible physicians into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training. The goals are a) to transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer and b) to eliminate the financial disincentive to entering this career path.

This award will provide a funding source that will enable these individuals to pursue research intensively (at least 80% effort) for up to four years, while, if they wish to maintain their clinical skills, continuing to be clinically active (no more than 20% effort). With the recognition that very few other funding sources (if any) exist to support these developing physician-scientists, this award is structured to provide recipients with significant salary support and necessary research expenses, with the expectation that their institutions will provide an environment and additional support (such as benefits and institutional overhead) to ensure their success. In addition, the Foundation will retire up to $100,000 of any medical school debt still owed by an award recipient.

The Damon Runyon Cancer Research Foundation will retire up to $100,000 of any qualifying medical school debt still owed by the awardee. The Foundation also provides a Dependent Child Allowance of $1,000 per child per year.

Eligibility: Physician-scientist applicants (MDs and DOs only) must have completed their residencies and clinical training, be U.S. Specialty Board eligible prior to the award start date, and be able to devote at least 80% of their time and effort to research. MD/PhDs are not eligible to apply. Applicants cannot be pursuing a PhD.

The candidate may not have had more than three years of postdoctoral laboratory research experience.

Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent). Postdoctoral fellows, clinical fellows, and clinical instructors are eligible to apply. If the awardee transitions to a fully independent assistant professorship appointment (or equivalent) during the award term, they must terminate the award (see Terms of the Award below).

Candidates holding or awarded NIH K awards at the time of application are not eligible to apply. (Candidates holding institutional K12 awards may apply, but must return their K12 funding to the U.S. Government/NIH if they are awarded a Damon Runyon Physician-Scientist Training Award.)

Candidates must apply with a Mentor. The Mentor’s role is to foster the development of the applicant’s knowledge, technical and analytical skills, and capacity for scientific inquiry in the field of basic or translational research chosen by the candidate and in which the Mentor is an outstanding figure. The Mentor will also serve as an advocate for the applicant at departmental, institutional, and other relevant professional levels.

  • Only one application will be accepted from a Mentor per review session (including Co-Mentors); there is no limit, however, to the number of applications from an institution.
  • No more than two Damon Runyon Physician-Scientists will be funded to work with the same Mentor at any given time (including Co-Mentors).
  • Eligible candidates may apply up to two times.

Link to complete RFP

**Harvard University Commonwealth Fund Fellowship in Minority Health Policy

Organization: Harvard Medical School

Award amount: $60,000 stipend, full tuition, individual health insurance, books, travel, and related program expenses, including financial assistance for a practicum project.

Deadline: 12/1/2021

Description: The Commonwealth Fund Fellowship in Minority Health Policy at Harvard University is a one-year, full-time, academic degree-granting program designed to prepare physicians, particularly physicians from groups underrepresented in medicine, to become leaders who improve the health of disadvantaged and vulnerable populations through transforming health care delivery systems and promoting innovation in policies, practices and programs that address health equity and the social determinants of health. Fellows complete academic work leading to a Master of Public Health degree at the Harvard T.H. Chan School of Public Health, or a Master of Public Administration degree at the Harvard Kennedy School with prior MPH. Fellows also participate in leadership forums and seminars with nationally recognized leaders in health care delivery systems, minority health, and health policy; site visits, shadowing, and practicum projects.

Each fellowship provides: $60,000 stipend, full tuition, individual health insurance, books, travel, and related program expenses, including financial assistance for a practicum project.

The Fellowship is designed to prepare physician-leaders who will, over time, improve the capacity of the health care system to promote policies and practices that improve minority, disadvantaged and vulnerable populations’ access to high quality care. 

Eligibility: 

  • Physicians who have completed residency in the U.S., either BE/BC. Additional experience beyond residency, such as chief residency, is preferred.
  • Experience or interest in addressing and improving the health needs of minority, disadvantaged and vulnerable populations as well as in advancing system change in ways that improve the health for all populations, but with particular emphasis on vulnerable populations.
  • Strong evidence of leadership experience or potential, especially as related to community efforts, quality improvement, transformation of health care delivery systems, and/or health policy.
  • Intention to pursue a career in policy, public service, and/or academia.
  • U.S. citizenship or U.S. permanent residency.

Link to complete RFP

Howard Hughes Medical Institute Hanna H. Gray Fellows Program to Increase Diversity in the Biomedical Research Community

Organization: Howard Hughes Medical Institute

Award amount: $90,000 in postdoctoral phase. $270,000 in the faculty phase.

Deadline: 12/1/2021

Description: HHMI seeks to increase diversity in the biomedical research community. We know that the biggest challenges in science call for diverse perspectives and original thinking. The goal of the Hanna H. Gray Fellows Program is to recruit and retain individuals from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those individuals from disadvantaged backgrounds. Through their successful careers, HHMI Hanna Gray Fellows will become leaders in academic research and inspire future generations of scientists from America’s diverse talent pool.

Following the “people, not projects” philosophy of HHMI, the competition is open to those dedicated to basic research from both doctoral and/or medical training paths in the biomedical and life science disciplines, including plant biology, evolutionary biology, biophysics, chemical biology, biomedical engineering, and computational biology. Fellows have freedom to change their research focus and follow their own curiosity for the duration of the award.

Fellows will receive funding through their academic institution for postdoctoral training and may continue to receive funding during their early career years as independent faculty. The program provides opportunities for career development, including mentoring and networking with others in the HHMI scientific community.

Eligibility: The program application is open to individuals who:

  • are from gender, racial, ethnic, and other groups underrepresented in the life sciences, including those individuals from disadvantaged backgrounds. This includes, but is not limited to, women of any ethnic or racial group as well as any individual identifying as Hispanic, Black, Native Hawaiian / Pacific Islander, or American Indian / Alaska Native.
  • are basic science researchers and physician-scientists in the biomedical and life science disciplines.
  • hold a PhD and/or MD (or equivalent), which must be conferred by the start of the grant term.
    • U.S. citizens must have a degree from a research institution in the U.S. (including Puerto Rico) or an international research institution.
    • Non-U.S. citizens and applicants with other nationalities must have a degree from a research institution in the U.S. (including Puerto Rico).
  • have been accepted to join a laboratory as a postdoctoral researcher at a research institution located in the U.S. (including Puerto Rico) at the time of the application due date.

PhD applicants can have no more than 27 months of postdoctoral research experience at the time of the application due date.

  • The date or anticipated date of conferral of the doctoral degree must be on or after September 1, 2019, and before January 17, 2023.

MD or MD/PhD applicants in residency, clinical fellowship, or postdoctoral training can have no more than 27 months of postdoctoral training by December 1, 2021.

  • For the purposes of this award, research activities during residency or clinical fellowship are not considered postdoctoral training.

The postdoctoral training mentor must hold a tenured or tenure-track position (or equivalent) at an institution in the U.S. (including Puerto Rico).

Link to complete RFP

**Myocarditis Foundation Research Grants

Organization: Myocarditis Foundation

Award amount: $40,000

Deadline: 12/1/2021

Description: Myocarditis is a rare disease, and many medical professionals lack the resources needed to care for affected patients. That’s why the Myocarditis Foundation is proud to sponsor myocarditis research grants dedicated to diagnosis, treatment and an eventual cure. If you’re interested in conducting research related to myocarditis, our grants could help you take the next step on the journey to eradicating this disease.

One of the most critical aspects of myocarditis research is encouraging promising physician-scientists to devote their talents to this important work. To do so, the Myocarditis Foundation Research Grant supports the training and career development of those who are dedicated to the study of myocarditis. Research Grants are intended to offer seed funding to support the early stages of long-term research, from the investigation of an initial hypothesis to the collection of preliminary data.

Grant recipients will receive a $40,000 stipend payable over the course of one year. This amount does not include additional funding for benefits, travel and/or other costs associated with research. At the end of the grant period, recipients should be well-prepared to seek long-term funding from the National Institute of Health (NIH) or other major granting institution.

Eligibility: Candidates may apply up to 10 years following receipt of an MD, PhD, or an equivalent degree and plan to perform the funded work in the United States or Canada, in order to apply for the Fellowship. All applicants must select a preceptor with a proven track record of research in myocarditis. In addition to providing a letter of recommendation, the preceptor is expected to assist in preparing the application. For applicants wishing advice in the selection of a preceptor, a list of potential preceptors is available from the MF.

Link to complete RFP

National Blood Foundation Early-Career Scientific Research Grants Program

Organization: National Blood Foundation

Award amount: Undisclosed

Deadline: 12/1/2021

Description: NBF awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.

Grants applications are evaluated on the basis of their scientific merit, relevance to and impact on transfusion medicine, focus and appropriateness to the scope of funding, and likelihood of yielding meaningful data.

Research content areas:

  • Immunology
    • Alloimmunization, immune modulation, and tolerance
    • Animal models for the study of graft-vs-host disease
    • Biology of autoimmune hemolytic anemia
  • Hematology
    • Autologous and allogeneic stem cell transplants
    • Detection of residual disease following stem cell transplants
    • Effects of growth factors in vitro and in vivo
    • Biochemistry of coagulation factors
  • Immunohematology
    • Blood group serology
    • Biochemistry of red cell antigens
    • Molecular genetics of the blood groups
  • Infectious diseases
    • Studies on Lyme disease, West Nile Virus, SARS and babesiosis and other emerging diseases
    • Effect of allogeneic transfusion in HIV-infected and immunocompromised patients
    • Improved detection of transfusion – transmitted diseases
  • Cellular therapies
    • Cell separation, cell culture or expansion studies for cell therapy applications
    • Development of novel cell therapies or assays to measure cell viability or function
    • Pilot studies in regenerative medicine
    • Studies on mechanisms or roles of cells in stem cell transplantation
    • Studies on cytokines or growth factors involved in stem cell differentiation
  • Patient blood management
    • Treatment of pre-admission anemia and bleeding tendencies; Intraoperative/postoperative blood recovery; Surgical hemostasis; Appropriate indications for transfusion; Changing physician behaviors; Blood utilization review.

Eligibility: 

  • An applicant must be a doctor (MD or PhD), medical technologist, transfusion medicine or cellular therapies professional. All applicants will be considered regardless of age, race, gender, national origin or religion.
  • The NBF accepts national and international early-career applicants. How does NBF describe early-career?
    • An early-stage investigator is a new investigator who has completed a terminal research degree or medical residency – whichever date is later – within the past 10 years of the grant application deadline and has not yet been awarded a substantial research grant (i.e. NIH R01). Of note, there is a 13-month period during which an investigator can resubmit a revised application and retain early-stage investigator status.
    • Clinical fellowship training in a medical specialty or subspecialty training in the years that follow the internship/residency period is not considered a part of the residency. Often the clinical fellowship period will consist of a mixture of clinical and research training. The time spent in research training will be considered as applicable toward the 10 years of research and research training.
    • If you have competed successfully for a substantial research grant (i.e. NIH R01) at any time in your career, you are NOT considered early-career and therefore you are not eligible for an NBF early-career Scientific Research Grant.
  • The NBF intends to fund researchers on a path towards independence.
  • No candidate is eligible to receive more than one NBF grant over the course of their career.

Link to complete RFP

**Plastic Surgery Foundation/MTF Allograft Tissue Research Grant

Organization: Plastic Surgery Foundation

Award amount: Up to $100,000

Deadline: 12/1/2021

Description: The PSF and MTF Biologics offer research grants to investigators studying allograft tissue transplantation in plastic and reconstructive surgery. These grants are intended to provide support for research projects focused on biologic repair and reconstruction with a strong clinical translation component that utilize dermal, adipose, placental or other allograft transplant technologies. Proposed studies should focus on novel translational and clinical research in the fields of tissue allograft transplantation and science, novel uses of allografts, combination with other biomaterials to enhance properties, and transformative regenerative medicine technologies relying on allograft tissues and matrices. However, proposals focusing solely on autologous grafts and synthetic applications that do not incorporate investigation of allograft use and/or grant proposals where the allograft is solely a scaffold for autograft materials (including cells) are beyond the scope of this award.

The PSF and MTF Biologics offer research grants for projects with a high likelihood of impact on scientific discipline and/or on patient care. Both clinical and basic science research projects will be considered for submission. Examples of clinical technologies of interest include but are not limited to the use of allograft biologics in breast reconstruction, wound healing, nose reshaping, soft tissue defect filling, allograft in fat transplantation and injection, use of allograft in tissue engineering or bioprinting, and other applications of allograft tissue in plastic and reconstructive surgery. Clinical evaluation of allograft tissues will also be considered for funding, following the same scientific topics and technologies previously described.

Eligibility: See the funding opportunity for eligibility criteria.

Link to complete RFP

**Plastic Surgery Foundation Translational and Innovation Research Grant

Organization: Plastic Surgery Foundation

Award amount: Up to $50,000

Deadline: 12/1/2021

Description: The PSF translational research grant provides funding to support novel translational innovative research (e.g. devices, diagnostics, technology, etc.) that accelerates discovery through FDA approval into clinical testing. The research must lead to improvements in commercial development, and the objectives of the project should include an outcome that will benefit patients and address unmet clinical needs.

Projects should be milestone-driven and not discovery, hypothesis-based research. The grant is intended to support a viable commercial product, with plan for commercialization within three years. Projects with a clear path to market and go/no-go milestones will be favorably reviewed.

Eligibility: See the complete funding opportunity for eligibility criteria.

Link to complete RFP

McKnight Endowment Fund for Neuroscience Technological Innovations in Neuroscience Awards

Organization: McKnight Endowment Fund for Neuroscience

Award amount: Up to $200,000

Deadline: LOI due 12/6/2021

Description: Technological Innovations in Neuroscience Awards support scientists who work on novel and creative approaches to understanding brain function.

The program seeks to advance and enlarge the range of technologies available to the neurosciences. It does not support research based primarily on existing techniques.

The Endowment Fund is especially interested in how technology may be used or adapted to monitor, manipulate, analyze, or model brain function at any level, from the molecular to the entire organism. Technology may take any form, from biochemical tools to instruments to software and mathematical approaches. Because the program seeks to advance and enlarge the range of technologies available to the neurosciences, research based primarily on existing techniques will not be considered.

A goal of the Technological Innovations awards is to foster collaboration between the neurosciences and other disciplines; therefore, collaborative and cross-disciplinary applications are explicitly invited.

Established in 1999, the Technological Innovations in Neuroscience Awards provide up to $100,000 per year for two years. Each year, up to three awards are given. Funds may be used toward a variety of research activities but not the recipient’s salary.

Eligibility: A candidate for a McKnight Technological Innovation in Neuroscience Award must work as an independent investigator at a not-for-profit research institution in the United States, and must hold a faculty position at the rank of Assistant Professor or higher. Those holding other titles such as Research Professor, Adjunct Professor, Professor Research Track, Visiting Professor or Instructor are not eligible. If the host institution does not use professorial titles, a letter from a senior institutional official (e.g. Dean or Director of Research) must confirm that the applicant has his/her own dedicated institutional resources, laboratory space, and/or facilities.

A candidate may not hold another award from the McKnight Endowment Fund for Neuroscience that would overlap in time with the Technological Innovation in Neuroscience Awards award.

Link to complete RFP

Autism Science Foundation 2022 Pre- and Postdoctoral Training Awards & Medical Student Gap Year Research Training Awards

Organization: Autism Science Foundation

Award amount: Up to $50,000

Deadline: 12/7/2021

Description: The Autism Science Foundation invites applications for its Pre- and Postdoctoral Training Awards from graduate students, medical students and postdoctoral fellows interested in pursuing careers in basic and clinical research relevant to autism spectrum disorders.

The proposed training should be scientifically linked to autism but may be broadened to include training in a closely related area of scientific research. Autism Science Foundation will consider all areas of related basic and clinical research including but not limited to: human behavior across the lifespan (language, learning, behavior, communication, social function, motor skills & planning, epilepsy, sleep, repetitive disorders), neurobiology (anatomy, development, neuroimaging), pharmacology, behavioral intervention, neuropathology, genetics and gene/environment interactions, epigenetics, genomics, epigenomics, immunology, molecular and cellular mechanisms, studies employing model organisms and systems, and studies of treatment and service delivery, and dissemination of research findings.

Eligibility: 

  • Applicants for Predoctoral Awards must be enrolled students in good standing in a program leading to a research doctorate, such as a Ph.D. or Sc.D., or a dual degree, such as an M.D./Ph.D., in an academic department at an accredited university or health/medical institution.
  • Applicants for Medical School Gap Year Research Training Awards should be enrolled at an accredited university medical school. Medical school applicants must apply prior to graduation from medical school, but the gap year may be taken immediately after graduation.
  • Applicants for Postdoctoral Awards must have completed their doctoral or medical degree and have been accepted as a postdoctoral fellow in good standing in a program as of the award start date (July – September 2022).
  • Applicants may apply at any point during their training. The fellow may work on a project that extends past the funding period; however, there must be specific goals and accomplishments stated as part of the fellowship. The selected awardee also must spend 80% of his/her professional time engaged exclusively in the autism research activities stipulated in the application for the duration of the award, and cannot simultaneously hold another fellowship award during the support period.
  • U.S. citizens enrolled in universities inside or outside of the United States are eligible to apply. Non-U.S. citizens enrolled in universities based inside or outside of the U.S. are also eligible to apply.

Link to complete RFP

Cystic Fibrosis Foundation Postdoctoral Research Fellowship Award

Organization: Cystic Fibrosis Foundation

Award amount: Up to $129,050 (details in description)

Deadline: 12/7/2021

Description: Postdoctoral research fellowship awards are offered for support of postdoctoral research training related to cystic fibrosis. Preference will be given to recent graduates and those just beginning their research careers.

Salary support of up to $50,000 (plus $8,850 fringe) is available for the first year of the award and $52,000 (plus $9,200 fringe) for the second year of the award. Research and travel expenses of $4,500 per year are available. Indirect costs are not allowed.

Applicants seeking to submit proposals focused on topics such as the restoration of CFTR protein function or approaches to fix/replace the defective CFTR gene should apply through the Path to a Cure (PTAC) Postdoctoral Research Fellowship Award Program. Topics for the PTAC program include, but are not limited to, characterization of rare CFTR mutations, nonsense modulation, gene editing/replacement strategies, and characterizing cellular targets for CFTR correction. 

Eligibility: Open to U.S. citizens, permanent residents, and non-residents working in U.S.-based laboratories.

Please note that applications will be accepted during the Spring and Fall submission cycles in 2021. However, applicants may submit only one postdoctoral fellowship application in 2021 (either Spring or Fall cycle).

Link to complete RFP

Cystic Fibrosis Foundation Research Grants

Organization: Cystic Fibrosis Foundation

Award amount: $125,000 annually for up to two years

Deadline: Biannually on 5/13/2021 and 12/7/2021

Description: Research grants are intended to support basic science research. Studies may be carried out at the subcellular, cellular, animal, or patient levels. To be considered, proposals must be hypothesis-driven and provide sufficient preliminary data to justify Cystic Fibrosis Foundation support.

Priority will be placed on those projects that propose to better understand the mechanisms behind disease pathophysiology and to develop strategies to prevent or treat CF. Projects proposing interventional clinical studies must not be submitted through this funding mechanism and should instead be submitted as a Clinical Research Award or Clinical Pilot and Feasibility Award.

Applicants seeking to submit proposals focused on topics such as the restoration of CFTR protein function or approaches to fix/replace the defective CFTR gene should apply through the Path to a Cure (PTAC) Research Grant Program. Topics for the PTAC program include, but are not limited to, characterization of rare CFTR mutations, nonsense modulation, gene editing/replacement strategies, and characterizing cellular targets for CFTR correction.

Eligibility: Applicants may submit only one Research Grant application in 2021 (either Spring or Fall cycle). United States residents and applicants from outside the United States are welcome to apply. Applicants must be independent investigators (an individual who is out of fellowship training and whose institution allows them to submit applications for research funding as a Principle Investigator).

Candidates who are clinical fellows should apply to the CFF Clinical Fellowship program for the appropriate year. Candidates who are postdoctoral fellows should apply to the CFF Postdoctoral Research Fellowship program

Link to complete RFP

Michael J. Fox Foundation for Parkinsons Research Edmond J. Safra Fellowship in Movement Disorders

Organization: Michael J. Fox Foundation for Parkinson’s Research

Award amount: $180,000

Deadline: 12/9/2021

Description: The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global base of movement disorder specialists — neurologists with additional training in Parkinson’s disease and other movement disorders — by training movement disorder clinician-researchers who can provide expert care and lead scientific advances.

As the demand for movement disorder specialists increases, not enough neurologists are receiving vital training in Parkinson’s and related conditions. To address this need, The Michael J. Fox Foundation (MJFF), in collaboration with longtime partner the Edmond J. Safra Foundation, launched The Edmond J. Safra Fellowship in Movement Disorders. The program annually funds academic centers to train a new movement disorder clinician-researcher over a two-year period and is growing an international, collaborative network of next-generation leaders in Parkinson’s research and care.

Eligibility: The program grants funding directly to academic centers, which then must identify and train a new movement disorder clinician-researcher over a two-year period. Grant support cannot be used for a fellow already enrolled or selected. The Edmond J. Safra Fellowship in Movement Disorders is open to academic centers worldwide. Previously awarded centers — except those that received an Edmond J. Safra Fellowship grant in the most recent funding cycle — are eligible to apply.

Link to complete RFP

American Society for Gastrointestinal Endoscopy Research Award

Organization: American Society for Gastrointestinal Endoscopy

Award amount: Up to $75,000

Deadline: 12/10/2021

Description: ASGE Research Awards are offered to investigators (MD, DO, PhD, or equivalent) for projects in basic, translational and clinical research with a relationship to gastrointestinal endoscopy. The ASGE is particularly interested in research pertaining to (in no particular order): colorectal cancer screening, Barrett’s esophagus, endoscopy training, health disparities, quality measurement and improvement, endoscope reprocessing and infection control, endoscopic sedation/anesthesia, bowel preparation, novel endoscopic treatments for obesity, endoscopic ultrasound (EUS), endoscopic retrograde cholangiopancreatography (ERCP), and other endoscopically-guided imaging/interventions. The research committee will consider funding pilot projects if there is an explicit outline for subsequent projects, and their funding plan (e.g. NIH, VA Merit), based on the preliminary data generated by the proposed pilot.

Eligibility: Candidate is required to be an ASGE member at the time of application, be an MD (or have equivalent degree), and be currently practicing in North America (international applications will be considered as described below). Candidates who are delinquent on prior ASGE research grants (e.g., progress reports) are not eligible for future ASGE funding. If the candidate is a trainee, there must be a letter from the trainee’s Division Chief confirming the trainee’s ongoing appointment and position at the institution for the duration of the grant. If the trainee applicant is not guaranteed an appointment for the duration of the grant, a contingency plan is required. Also, trainees must include a letter of support from a research mentor.

Link to complete RFP

Tourette Association of America Young Investigator Award

Organization: Tourette Association of America

Award amount: Up to $160,000

Deadline: Pre-proposals due 12/11/2021

Description: The Tourette Association of America (TAA) aims to encourage early career researchers to invest their efforts and expertise in increasing our biological understanding of Tourette Syndrome (TS), pursuing clinical research aimed at improving patient care, and developing and testing new therapies.

Eligibility: 

  • The award is open to post-doctoral fellows, and independent clinical/research faculty members within 5 years of their first independent faculty appointment at the time of pre-proposal application submission.
  • Investigators are required to have an advanced degree such as a Ph.D., M.D., or equivalent.
  • Investigators outside the U.S. are welcome to apply.
  • Investigators cannot have received previous early career funding support from the Tourette Association.
  • Applications must include a career development component as well as an independent research project.

Link to complete RFP

Gruber Foundation International Prize Program in Cosmology, Genetics, and Neuroscience

Organization: Gruber Foundation

Award amount: $500,000

Deadline: 12/15/2021

Description: The International Prize Program honors individuals in the fields of Cosmology, Genetics, and Neuroscience, whose groundbreaking work provides new models that inspire and enable fundamental shifts in knowledge and culture.

In the spring of 2011, Yale University and The Peter and Patricia Gruber Foundation signed an agreement that established The Gruber Foundation, which will carry on its philanthropic mission from Yale. The Foundation’s Science Prizes and its Young Scientist Awards will remain the same; the missions of the Justice and Women’s Rights Prizes have merged and transitioned into the Gruber Program for Global Justice and Women’s Rights.

Eligibility: Only candidates who have been officially nominated on a fully completed nomination form will be considered for a  Gruber International Prize. All nominations materials must be submitted in English, and self-nominations are not accepted. The Chair of each Selection Advisory Board ensures that nominations are of sufficient caliber to merit consideration prior to the meeting of the Board. If a nomination passes the Chair’s review, it remains active for three years unless the nominee is selected to receive the prize or is voted off by the Board. After the third year of eligibility, further consideration of a nomination requires that it be resubmitted.

Link to complete RFP

**McGovern Institute for Brain Research Scolnick Prize in Neuroscience

Organization: McGovern Institute for Brain Research, Massachusetts Institute of Technology

Award amount: $150,000

Deadline: 12/15/2021

Description: The Scolnick Prize is awarded annually by the McGovern Institute to recognize outstanding advances in the field of neuroscience. The prize is named in honor of Edward M. Scolnick, who stepped down as president of Merck Research Laboratories in December 2002 after holding Merck’s top research post for 17 years. Scolnick is now at the Broad Institute, where he established the Stanley Center for Psychiatric Research. He also served as a member of the McGovern Institute’s scientific advisory board. The prize, which is endowed through a gift from Merck to the McGovern Institute, consists of a $150,000 award, plus an inscribed gift.

Eligibility: Candidates for the award must be nominated by individuals affiliated with universities, hospitals, medicals schools, or research institutes, with a background in neuroscience. Self-nomination is not permitted. 

Link to complete RFP

Research to Prevent Blindness Grants Program

Organization: Research to Prevent Blindness

Award amount: Varies

Deadline: 12/15/2021

Description: Research to Prevent Blindness (RPB) provides grants to high-performing U.S.-based departments of ophthalmology and their faculty and, through some of our awards, to high-potential vision researchers in any institution of higher education in the U.S.  There is an RPB grant category available to a scientist at any stage in his or her career — from a medical student considering academic eye research to a seasoned investigator extending the frontiers of vision science. The unrestricted nature of RPB grants allows for the greatest flexibility in the pursuit of breakthrough discoveries.

RPB accepts grant applications twice a year, January and July. Application forms must be requested by the chair of the department of ophthalmology or the department’s grant coordinator. Departments of ophthalmology must have an RPB Unrestricted/Challenge (U/C) Grant in order to apply for individual grants, and only permanent, full-time department chairs are eligible to apply for any RPB grants. Chairs may nominate only one candidate per grant category per cycle.

Chairs may nominate only one candidate per grant category per cycle.  Nomination forms are required for all individual awards.  For the January 10 and January 20 deadlines, nomination forms are due no later than December 15; for the July 1 deadline, nomination forms are due no later than June 15.

Grants are available 1-2 times a year in the following categories:

  • Career Advancement
  • Career Development
  • Disney/Amblyopia
  • Int’l Research Collaborators
  • Low Vision Research
  • Med Student Fellowships
  • Physician Scientists
  • Stein Innovation
  • Unrestricted/Challenge

Eligibility: See specific funding opportunity categories for eligibility criteria.

Link to complete RFP

American Lung Association Dalsemer Research Grant for Interstitial Lung Disease Research

Organization: American Lung Association

Award amount: Up to $100,000

Deadline: 12/16/2021

Description: The American Lung Association Dalsemer Research Grant is a mentored award meant to provide seed monies to junior investigators on the path to independence for researching the mechanisms and biology of interstitial lung disease. 

The Dalsemer Research Grant is for $50,000 per year, for up to two years. Grants are subjected to annual review and may be granted for two years. The second year of support is based on demonstrating satisfactory progress, as well as, the availability of funding from the Lung Association. Applicants should be on-track to pursue a career in lung heath research with a mentor who has a demonstrated history of lung disease research and mentorship. 

No more than 75% of the requested budget may be used for an awardee’s salary and/or fringe benefits and no more than 30% of the total award budget may be used to fund the purchase of permanent equipment. Grant funds may be used for the salary and fringe benefit costs of personnel other than the Applicant. 

Eligibility: At the time of application, candidates must be United States citizens or foreign nationals holding one of the following visa immigration statuses: permanent resident (Green Card), exchange visitor (J-1), temporary worker in a specialty occupation (H-1B), Canadian or Mexican citizen engaging in professional activities (TN), Australians in Specialty Occupation (E-3) or temporary worker with extraordinary abilities in the sciences (O1). At the time of application and throughout the award, an applicant must be employed by a U.S. institution.

Applicants should be on-track to pursue a career in lung disease research with a mentor who has a demonstrated history of research experience and mentorship.

At the time of application, the applicant must hold a doctoral degree and have a faculty appointment or equivalent with demonstrated institutional commitment (salary support, research space) in a recognized academic or other not-for-profit institution. Fellows and PhD post-docs are eligible to apply only if their Department Chair can assure a promotion to faculty status by the start of the award. MD applicants must have completed two years of post-doctoral research training by the start of the award. 

Medical residents, those presently enrolled in a degree program (e.g., graduate students), and established investigators are not eligible to apply. Factors that are considered indicative of an established investigator include, but are not limited to, academic rank of professor or associate professor; awards of established investigatorship (e.g., NIH-R01 Awards, Veterans Administration Merit Review Awards), an extensive bibliography, or a national reputation as an investigator in their field.

Link to complete RFP

American Academy of Otolaryngology CORE Grants

Organization: American Academy of Otolaryngology

Award amount: $5,000-$150,000

Deadline: LOI due 12/17/2021

Description: The Centralized Otolaryngology Research Efforts (CORE) grants program is a collaboration of several societies, foundations, and industry supporters focused on providing support for research in the field of otolaryngology-head and neck surgery.

Since 1985, CORE has played a vital role by awarding more than 600 grants and more than $13 million for research projects, research training, and career development to further the specialty of otolaryngology. These grants, ranging in award size from $5,000 to $150,000, have been essential for increasing the research base for otolaryngology.

The CORE program brings greater scale and less fragmentation and overlap to otolaryngology-head and neck surgery research opportunities, reduces the aggregate costs of the individual grant programs, and enables a comprehensive overview of the spectrum of promising otolaryngology and head and neck surgery research/researchers to promote to NIH and other agencies.

Eligibility: See 2021 CORE funding opportunities for eligibility requirements.

Link to complete RFP

**Society for Progressive Supranuclear Palsy CurePSP Venture Grants

Organization: Society for Progressive Supranuclear Palsy

Award amount: Up to $100,000

Deadline: 12/17/2021

Description: CurePSP has always believed that truly effective clinical interventions will follow good, solid basic scientific research. For this reason, CurePSP promotes research that helps generate an integrated picture of PSP and CBD at pre-clinical and clinical levels. CurePSP believes that in the long term, research of this nature will prove indispensable in developing a prevention or cure for PSP, CBD, and other prime of life diseases.

CurePSP will fund studies on PSP and CBD with a particular interest in (i) molecular and cellular (pathological) mechanisms that may operate also in related diseases and (ii) translational clinical research involving PSP and CBD patients.

CurePSP has carefully structured its research program and has identified the programs that have been the most successful and those that need strengthening. With an increased research budget made possible through improved donor support, CurePSP will be able to markedly intensify the efforts to cure the disease in a way that promises relief for those afflicted today as well as hope for those who may be afflicted tomorrow.

Eligibility: CurePSP accepts proposals for research projects from academic and non-academic institutions. CurePSP does not accept applications from any country which is subject to trade sanctions or embargos by the U.S. government or who is a “blocked person” within the meaning of U.S Department of Treasury regulations. All PIs must have an academic degree in science, social work, engineering, or medicine such as a ScD, PhD, MD, MD/PhD, DO, DSW, and DVM degree.

Link to complete RFP

AWS Diagnostic Development Initiative

Organization: Amazon Web Services

Award amount:  Total program is committing $20 million over two years for all projects.

Deadline: We will accept applications through December 31, 2021, with priority consideration given to applications received before July 31, 2021.

Description: Through the initiative, AWS will award $20 million over two years in support of research and innovation that accelerates the understanding and detection of COVID-19 and helps mitigate current and future infectious disease outbreaks.

To that end, AWS is offering AWS Promotional Credits and technical expertise to support the use of AWS services for projects by selected institutions and companies in four program areas: early disease detection, diagnostics, prognosis, and public health genomics. Given the need, the emphasis initially will be on COVID-19, but AWS will also consider applications for other infectious diseases. AWS will not support administrative workloads associated with routine IT operations through this program.

Eligibility: Eligible applicants include accredited research institutions, research consortia, nonprofits, and private entities that are AWS customers. Individuals who apply must apply on behalf of their organization and not in a personal capacity.

Link to complete RFP

**Hastings Center Cunniff-Dixon Physician Awards

Organization: Hastings Center

Award amount: $25,000

Deadline: 12/31/2021

Description: Nominations for the 2022 awards will be open from September 1-December 31st 2021.  We look forward to your nominations and please stay tuned for more information!      

The Hastings Center Cunniff-Dixon Physician Awards will be presented to physicians in recognition of clinical contributions and commitment to the cause of end-of-life medical care.

Prizes in the amount of $25,000 will be awarded to one senior physician (20+ years in practice) and one in mid-career (8-19 years in practice) who have demonstrated an exemplary commitment to patients near the end of life through their doctoring, their research, and/or their service to their community. Three additional awards in the amount of $15,000 will go to early-career physicians (0-7 years) who have already demonstrated exemplary efforts with patients near the end of life. (Note: the amount of time in total practice will be counted, not the amount of time in this particular field.)

Eligibility: Nominees must be licensed physicians practicing in the United States. Any individual or group — including professional associates, patients, and their families – may submit nominations. Nominations submitted in prior years may be resubmitted.

Link to complete RFP

Union Internationale Contre le Cancer - International Union Against Cancer UICC Yamagiwa-Yoshida Memorial International Cancer Study Grants (YY Grants)

Organization: Union Internationale Contre le Cancer – International Union Against Cancer

Award amount: $10,000

Deadline: 12/31/2021

Description: The YY Study Grants provide an important opportunity to advance cancer research through international collaboration. Their purpose is to enable individuals from any country to carry out cancer research projects abroad and including the opportunity to receive further training in research methods or techniques.

Since its inception in 1972, the YY Study Grant programme has contributed to the professional capacity development of over 330 Fellows from over 40 countries.

Eligibility: 

  • Possess appropriate scientific or medical qualifications and a minimum of two years postdoctoral experience
  • Actively engaged in cancer research
  • Have recent publications in the international peer-reviewed literature

Link to complete RFP

**McKnight Endowment Fund for Neuroscience Scholar Awards

Organization: McKnight Endowment Fund for Neuroscience

Award amount: $225,000

Deadline: 1/10/2022

Description: The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Endowment Fund for Neuroscience invites applications for the 2022 McKnight Scholar Awards.

These awards were established to give promising young investigators in the early stages of an independent research career the opportunity to develop their work on critical problems in brain science. Applicants for the McKnight Scholar Awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience. Awards are given to exceptional young scientists who hold the M.D. and/or Ph.D. degree and who are in the early stages of establishing an independent laboratory and research career. Traditionally, successful candidates have held faculty positions for at least one year. 

Eligibility: Applicants for the McKnight Scholar Award must be independent investigators at not-for-profit research institutions in the United States, and must hold a Full-time appointment at the rank of Assistant Professor, and must have served at that rank for less than four years at the application deadline. Scientists holding other titles such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility. If the host institution does not use professorial titles, a letter from a senior institutional official (e.g. Dean or Director of Research) must confirm that the applicant has his/her own dedicated institutional resources, laboratory space, and/or facilities. We are interested in geographic, gender, and racial diversity, and we encourage women and communities of color to apply. Additionally, applicants must have:

  • A record of meritorious research
  • Evidence of a commitment to a career in neuroscience
  • Documentation that the sponsoring institution has government approval for the applicant to work in the U.S.

Applicants may not:

  • Apply in more than two rounds of competition
  • Have already been granted tenure
  • Hold another award from the McKnight Endowment Fund

Link to complete RFP

Foundation for Anesthesia Education & Research Research Fellowship Grants

Organization: Foundation for Anesthesia Education & Research

Award amount: Up to $250,000

Opens: 12/1/2021

Deadline: 2/15/2022

Description: The Foundation for Anesthesia Education and Research (FAER) provides research grant funding for anesthesiologists and anesthesiology trainees to gain additional experience in basic science, clinical or translational, health services, and education research. Current grant funding opportunities include:

  • Mentored Research Training Grants (MRTG)
  • Research Fellowship Grant (RFG)
  • Research in Education Grant (REG)
  • Transition to Independence Grant (TIG) 
    • Note: TIG grants are accepted on a rolling basis and follow a separate application process. Eligibility requirements and application information can be found at TIG.
  • FAER GEMSSTAR Grant (GEMSSTAR) 
    • Note: FAER GEMSSTAR grants are accepted on a rolling basis and follow a separate application process. Eligibility requirements and application information can be found at GEMSSTAR.

For early career anesthesiologists interested in pursuing careers as physician-scientists, an RFG or MRTG can be an important starting point. These grants aim to help anesthesiologists develop the skills and preliminary data they need to become independent investigators. The REG aims to advance the careers and knowledge of anesthesiologists interested in researching the concepts, methods and techniques of education in anesthesiology. The goal is to improve the quality and productivity of education and research in anesthesiology.

Eligibility: At the time of the award, applicants must meet all of the following eligibility requirements:

  • Be a U.S. citizen, permanent U.S. resident, or holder of H-1 visa that will be valid through the period of FAER funding. A J-1 visa holder would not qualify.
  • Be an anesthesiologist who is within 10 years of graduating from residency and who has a license to practice medicine or osteopathy in at least one state or jurisdiction of the U.S.
  • Be an active member of the American Society of Anesthesiologists (ASA) throughout the duration of the award.

Recipients of a FAER MRTG grant may not simultaneously be receiving support from an NIH T32 grant. MRTG applicants may at the time of the MRTG application be on a T32, but if awarded an MRTG, they are allowed up to a 12-month delay in the start date of the MRTG due to the T32. Start date delays of longer that 12 months will not be accepted.

The MRTG is not intended for investigators who have received significant extramural funding, such as NIH R-awards, K23, K08, K12, KL2 or AHA Young Investigator Awards. FAER does not allow for concurrent funding of an MRTG with these or similar awards.

The MRTG is not intended for established investigators who are changing areas of interest.

Link to complete RFP

Desmoid Tumor Research Foundation Research Grants

Organization: Desmoid Tumor Research Foundation

Award amount: Up to $65,000

Deadline: 3/1/2022

Description: The Desmoid Tumor Research Foundation, Inc. (“DTRF”) funds research that will advance the current scientific knowledge about desmoid tumors, moving toward the development of new treatment options and bringing us closer to our ultimate goal of a cure.

DTRF is the only foundation in the country dedicated to facilitating and funding research for a cure for desmoid tumors.  We fund research that uses cutting-edge science and creative clinical applications, in addition to novel approaches addressing potential leads based on prior research.  Research proposals with additional sources of funding support are particularly desirable. Researchers must be willing to collaborate with other scientists and institutions with similar interests.  Grantees must agree to participate as reviewers in DTRF’s future grant review cycle, as well as to present the results of their research at the annual September International DTRF Desmoid Tumor Research Workshop, and to make best efforts to attend the Workshop thereafter.

Eligibility: MD, PhD, or equivalent degree, and sponsorship by an Exempt Organization as defined by Section 501(c)(3) of the Internal Revenue Code (the “Sponsoring Institution”).

Link to complete RFP

Damon Runyon Fellowship Award (Postdoctoral Research Fellowships for Basic and Physician Scientists)

Organization: Damon Runyon Cancer Research Foundation

Award amount: up to $60,000 a year + $2,000 expenses for four years

Deadline: 3/15/2022

Description: The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.

Candidates must apply for the fellowship under the guidance of a Sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the Fellow.  In addition to aiding in the planning, execution and supervision of the proposed research, the Sponsor’s role is to foster the development of the Fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry.  The Sponsor is also expected to assist the Fellow in attaining his/her career goals.

Awards are made to institutions for the support of the Fellow under direct supervision of the Sponsor.  Candidates who have already accepted a postdoctoral research fellowship award are not eligible.

Eligibility: see the complete RFP for the complete eligibility requirements.

Link to complete RFP

Sigma Global Nursing Research Grant

Organization: Sigma Theta Tau International

Award amount: Up to $10,000

Deadline: 5/1/2022

Description: The Sigma Global Nursing Research Grant encourages nurses to focus on responding to health disparities globally.

Allocation of funds is based on the quality of the proposed research, cross-country (at least two countries) collaboration between research teams, and the applicant’s research budget. Annual funding for this grant is provided by the Sigma Foundation for Nursing’s Patricia E. Thompson Global Research Fund donors. Funds for this grant do not cover expenses incurred prior to the funding date.

Eligibility: The proposed nursing research should meet the following criteria:

  • The project should be conducted by a cross-country (at least two countries) research team and focus on responding to health disparities globally. 
  • The principal investigator(s) should be registered nurses (or country equivalent) with current license and have at least a master’s in nursing (or country equivalent).
  • Submit a completed research application package and signed research agreement with appropriate additional documentation and letters of support by deadline (no extensions).
  • Ready to implement a research project when funding is received (including proof of Institutional Review Board approval or country equivalent).
  • Complete project within eighteen (18) months of funding.
  • Submit a final report and completed abstract to the Sigma Repository to receive final grant disbursement, if owed.

Link to complete RFP

Alkermes Investigator Sponsored Studies for Research in Substance Use Disorders (SUDs) and Schizophrenia

Organization: Alkermes

Award amount: Undisclosed

Deadline: Ongoing

Description: Alkermes seeks to support research designed and conducted by independent clinicians and scientists through our Investigator Sponsored Studies (ISS) program.

The ISS program reviews study concept submissions related to the ISS Areas of Interest below on a rolling basis. Alkermes may occasionally announce a Request for Proposals (RFP) for research in clinical areas where gaps in data have been identified. Submission deadlines for any RFP topics will be announced on this site.

The ISS research Alkermes supports must be based in the United States and is typically conducted by experienced researchers who have an established history of successfully completing research with independent funding.

Alkermes can provide its marketed products to the ISS programs it supports. In addition, there may be financial support available.

If you intend to request only study drugs from Alkermes and will be seeking funding from a different source, we strongly recommend you submit your request to Alkermes for review before submitting a funding request to any third party.

Areas of Interest:

  • Substance Use Disorders
    • Improving treatment initiation and adherence in Alcohol Use Disorder (AUD)/Opioid Use Disorder (OUD)
    • Long-term treatment outcomes, including real-world data in AUD/OUD
    • Neurologic profile of early recovery in OUD, including but not limited to sleep, cognition and craving
    • Digital technologies for assessment of physiological parameters (e.g., wearables) and/or treatment access and outcomes (e.g., telehealth) in AUD/OUD
    • Implementing medication for AUD in healthcare systems
  • Schizophrenia
    • Reduction in social burden (e.g., family, treatment team) through use of long-acting injectables (LAIs)
    • Demonstration of LAI benefits in specific comorbidities of schizophrenia (e.g., persistent substance problems) or subpopulations (e.g., persons with schizophrenia over the age of 60)
    • Short-term and long-term economic and clinical outcomes of LAI treatment in schizophrenia using real-world data
    • Outcomes research on whether LAI use supports continuity of care in schizophrenia, utilizing telehealth or other innovative technology-based approaches     

Eligibility: See the complete RFP for more information. 

Link to complete RFP

Alkermes Pathways Research Awards for Early-Career Investigators in Substance Use Disorders (SUDs), Schizophrenia and Bipolar Disorder

Organization: Alkermes

Award amount: Up to $100,000

Deadline: Annual

Description: With millions of people impacted by neurological disorders, more research is urgently needed to advance science in this area. The Alkermes Pathways Research Awards® program is designed to support the next generation of researchers who are working on the front lines to advance our understanding of diseases in the field of neuroscience.

The Alkermes Pathways Research Awards® program provides opportunities for individual grants of up to $100,000 per research project for early-career investigators focused on research relating to substance use disorders (SUDs), schizophrenia and bipolar disorder.

Areas of Interest:

  • Preclinical, clinical, translational and epidemiological research
  • Research on treatment and patient- centered outcomes
  • Clinical and health economic outcomes using real-world data
  • Outcomes research supporting continuity of care utilizing telehealth or other technology-based approaches

Eligibility: 

  • Has an M.D., Ph.D., or equivalent
  • Is affiliated with a medical or research center within the United States at the time of application
  • Is within 5 years of initial academic appointment (e.g., assistant professor) or is a current postdoctoral fellow
  • Has a research mentor with extensive experience in the field of SUD, schizophrenia or bipolar disorder
  • Has not received an NIH R01 grant at the time of award, but may be the recipient of a career development (K) award or other mentored research grant
  • Is willing and able to accept funding from a for-profit, biopharmaceutical company
  • Is able to complete the proposed research within 2 years
  • Is a citizen or permanent resident of the United States or holds a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

Link to complete RFP

Alzheimers Drug Discovery Foundation Funding Program

Organization: Alzheimer’s Drug Discovery Foundation

Award amount: Varies

Deadline: Rolling. 2021 LOIs due 5/28/2021 and 10/1/2021.

Description: The ADDF provides funding to academic centers and biotechs from around the world that are advancing therapeutic and biomarker development for Alzheimer’s and related dementias. We have dedicated our funding to several key areas:

  • Translational research to develop new drugs and build preclinical evidence
  • IND-enabling studies and early-stage clinical trials for novel and repurposed drugs
  • Development and validation of plasma, CSF, neuroimaging and digital biomarkers
  • Epidemiological studies and comparative effectiveness research

Applications are reviewed throughout the year through our core programs. Check back regularly for additional joint funding opportunities with our partners in non-profits, government, and industry.

Eligibility: Varies by opportunity.

Link to complete RFP

Alzheimers Drug Discovery Foundation Diagnostics Accelerator: Digital Biomarkers

Organization: Alzheimer’s Drug Discovery Foundation

Award amount: $250,000-$500,000

Deadline: Rolling

Description: The Diagnostics Accelerator is a partnership of funders dedicated to accelerating the development of affordable and accessible biomarkers for Alzheimer’s disease, frontotemporal degeneration, and other related dementias. The Diagnostics Accelerator supports research and development through translational research awards and access to consulting support from industry experts. The current RFP is soliciting projects to develop and validate digital biomarkers for Alzheimer’s disease and related dementias. Digital biomarkers are defined as objective, quantifiable physiological and behavioral data that are collected, measured and analyzed by means of digital devices such as portables, wearables, or ambient sensors. Digital biomarkers range from computerized or app-based versions of traditional neurocognitive tests to novel technology platforms that combine multiple complex data sources into a phenotypic signature.

Proposals addressing a range of potential clinical uses are of interest, especially technologies for early assessment and those aiding in diagnosis and monitoring treatment response or rate of disease progression. Creative approaches to leverage new and existing software and hardware are encouraged. Importantly, the use of the digital technology should be driven by 1) an unmet patient or scientific need for a better assessment and/or 2) providing a more cost-effective, efficient, and less burdensome approach to diagnosis and monitoring in clinical practice and clinical trials.

Eligibility: Funding is open to researchers and clinicians worldwide at: Academic medical centers and universities or nonprofits. Industry partnerships are strongly encouraged. See the Alzheimer’s Drug Discovery Foundation website for complete program guidelines and application instructions.

Link to complete RFP

American Cancer Society Clinician Scientist Development Grant

Organization: American Cancer Society 

Award amount: $135,000

Deadline: Ongoing. Next deadline Oct 15, 2021.

Description: The Clinician Scientist Development Grant (CSDG) fosters the development of clinicians to clinician scientists.

Clinician scientists are investigators licensed to provide patient care and trained to conduct research. They pursue research questions across the cancer research continuum of relevance to improving health.

The CSDG provides support for protected time to allow junior faculty who see patients to be mentored and participate in research training to aid their development as independent clinician scientists.

All applications must fit into at least 1 of 6 research priority areas:

  • Etiology
  • Obesity/Healthy Eating and Active Living (HEAL) 
  • Screening and Diagnosis
  • Treatment 
  • Survivorship
  • Health Equity Across the Cancer Control Continuum  

Eligibility: Licensed clinicians who are US citizens and are within the first 6 years of their initial faculty appointment, who have an active role in patient care 

Link to complete RFP

American Cancer Society Research Scholar Grants for Early Careers

Organization: American Cancer Society 

Award amount: Up to 4 years, for up to $165,000 a year for direct costs, plus 20% allowable indirect costs

Deadline: Ongoing. Next deadline Oct 15, 2021.

Description: The Research Scholar Grant (RSG) supports investigator-initiated projects across the cancer research continuum. 

All applications must fit into at least 1 of 6 research priority areas:

  • Etiology
  • Obesity/Healthy Eating and Active Living (HEAL) 
  • Screening and Diagnosis
  • Treatment 
  • Survivorship
  • Health Equity Across the Cancer Control Continuum  

Priority Area on Cancer Health Equity: For the RSG award in the Cancer Control and Prevention Research Program with a focus on health equity, the maximum award is for 4 years at up to $165,000 per year (direct costs), plus 20% allowable indirect costs. Additionally, large multilevel studies that address cancer health equity may propose up to a maximum of 5 years and $200,000 per year (direct costs), plus 20% allowable indirect costs. 

Eligibility: Independent investigators in the first 8 years (previously 6 years) of an independent research career or faculty appointment are eligible to apply. Eligibility is extended for 10 years (previously 8 years) for clinician scientists who remain active in clinical care. Applicants typically must be within 14 years of receiving a terminal (doctorate) degree and cannot have more than one R01/R01-like grant (>$100,000/year direct costs for more than 3 years) as principal investigator at the time of application.  

Areas of expanded eligibility: In the Cancer Control and Prevention Research Program, RSG applicants may be at any stage in their career if they focus their project on either: 1) Health Policy/Health Services research or 2) Cancer Health Equity. 

Link to complete RFP

American Psychological Foundation Grants Program

OrganizationAmerican Psychological Foundation

Award amount: Varies

Deadline: Rolling

Description: APF is seeking to seed innovation through supporting projects and programs that use psychology to solve social problems. APF grants align with our mission of enhancing psychology to elevate the human condition and advance human potential. We offer grants for early career funding and seed grants for research and for targeted programs.

Eligibility: See specific grant opportunities for eligibility criteria.

Link to complete RFP

American Society of Colon and Rectal Surgeons (ASCRS) Research Foundation Grants and Awards

Organization: American Society of Colon and Rectal Surgeons (ASCRS)

Award amount: See description

Deadline:

  • March 15
    • Career Development Award
    • Limited Project Grant
    • Medical Student Research Initiation Grant
    • Training in Research Methodology Grant
  • August 15
    • Research in Robotic Technology Grant
    • International Fellowship Grant
    • General Surgery Resident Research Initiation Grant

Description: The Society offers a range of grant opportunities distributing funds made available by the Research Foundation Board of Trustees to members of the Society. There are two cycles of funding opportunities, spring and fall, but only Limited Project Grants are funded twice a year. Other grant categories are funded as and when resources permit. Potential applicants are advised to contact the Research Foundation office well in advance of any proposed application date to seek clarification and advice about the forthcoming funding cycle. The Chair of the Research Committee encourages members to request points of clarification from him directly.

  • Career Development Award
    • Purpose:  To provide young surgeons with the support necessary for the initiation and development of an academic career in colorectal surgery. The CDA focuses on career development and mentorship of the individual rather than solely on the research proposal. The award is intended for the academic investigator demonstrating significant creativity in research relevant to the pathophysiology or management of diseases of the small bowel, colon, rectum, or anus.
    • Amount:  $75,000/year for two years
  • General Surgery Resident Research Initiation Grant
    • Purpose: To attract General Surgery Residents or recent graduates of such programs into the field of colon and rectal surgery by providing opportunities to engage in clinical or laboratory-based research focused on diseases of the colon, rectum and anus.
    • Amount:  $20,000
  • International Fellowship Grant
    • Purpose:  To provide support to research programs that are focused on diseases of the colon, rectum and anus that will ultimately impact how we treat these patients. This grant will focus on providing support to clinical investigators in the United States or Canada who would like to participate in research outside the United States or Canada, including US investigator engagement in global health research projects focused in colorectal surgery. Additionally, funding will be considered to support clinical investigators from outside the United States and Canada who would like to participate in research in the United States or Canada.
    • Amount: $12,500/year
  • Limited Project Grant (LPG)
    • Purpose:  To provide investigator the opportunity to pursue research interest, specifically germane to the field of colon and rectal surgery. It is anticipated that successful research projects, initially funded through the Research Foundation’s LPG mechanism, will ultimately secure funding from other national funding agencies.
    • Amount:  Up to $25,000/year
  • Medical Student Research Initiation Grant
    • Purpose:  To provide opportunities for Medical Students to participate in clinical or laboratory-based research focused on diseases of the colon, rectum and anus.
    • Amount:  $4,000
  • Research in Robotic Surgical Technology
    • Purpose:  The purpose of the Research Foundation of the American Society of Colon and Rectal Surgeons is to promote research that relates to the practice of colon, rectal and anal surgery. The Research in Robotic Surgical Technology Grant provides an investigator the opportunity to pursue research interest, specifically germane to robotic surgical technology in the field of colon and rectal surgery. Innovative projects are encouraged. The Research Committee is particularly interested in fostering collaborative research.  Proposals which include two or more institutions may be eligible for additional funding.
    • Amount:  dependent on industry funding
  • Training in Research Methodology Grant
    • Purpose:  This award aims to provide an opportunity for a graduating CRS resident to attend training that will enhance their career. They may attend one of the following courses: the Career Development Course, Fundamentals of Surgical Research Course from the Association for Academic Surgery (AAS) or the American College of Surgeons (ACS) Health Services Research Methods Course.
    • Amount:  Up to $3,000

Link to complete RFP

Amgen Independent Medical Education Funding

OrganizationAmgen

Award amount: Undisclosed 

Deadline: Varies

Description: As part of Amgen’s mission to further the advancement of medicine and healthcare, Amgen supports Independent Medical Education (“IME”). IME is professional education given by accredited medical education providers who design and implement programs totally independent of any Amgen influence, as defined by standards such as the Accreditation Council for Continuing Medical Education (“ACCME”) guidelines, the FDA’s Guidance: Industry Supported Scientific and Educational Activities, and the PhRMA Code.

Amgen supports IME that address:

  • Education of health care providers including trainees, allied health professionals and payers
  • Advancing the understanding of the disease state
  • Improving health care providers’ understanding of the diagnosis, treatment, outcomes, and co-morbidities
  • Quality, reimbursement, access to care
  • Innovative and biosimilar drug development

See the complete funding opportunity to review Amgen’s disease states and areas of interest.

Eligibility: Must be provided by a United States based accredited provider (e.g. ACCME, ACPE, ANCC) or other organizations authorized by state law to award continuing medical education credits.

Amgen will not provide IME funding for individuals, requests for payments to individuals, fellowships, overhead expenses, general operating expenses, entertainment expenses, awards and travel awards, cost of travel or other personal expenses on non-faculty individuals attending IME, or meals.

See the funding opportunity for complete eligibility criteria.

Link to complete RFP

Angelman Syndrome Foundation General Research Grants

OrganizationAngelman Syndrome Foundation

Award amount: One- or two-year grants are awarded for various amounts up to $100,000 per year.

Deadline: Rolling. Submission deadlines occur biannually on Apr 15 and Oct 15.

Description: The mission of the Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research, and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.

The ASF Scientific Advisory Committee identified the following areas of unmet need in AS research. Priority will be given to the following topics:

  • Projects studying or correcting the heterozygous effect of non-UBE3A genes in deletion.
  • Projects studying the potential results of increasing UBE3A after therapies or for some subtypes of AS.
  • Projects studying delivery of therapies and potential for improvement.
  • Symptomatic therapies that impact the daily life of people with Angelman syndrome and their families.

Proposals that do not address these topics are still welcome and will be given full consideration.

Eligibility: Undisclosed

Link to complete RFP

Arnold Ventures Complex Care Research Agenda

OrganizationArnold Ventures

Award amount: Not disclosed

Deadline: Rolling

Description: Arnold Ventures seeks to address some of the most pressing policy challenges facing our country. Our work within the health care sector is driven by a belief that our current system costs too much and struggles to adequately care for people with one condition, let alone a complex array of conditions. There is no population for whom this is truer than those who are dually eligible for Medicare and Medicaid. Dual-eligible individuals account for a disproportionate share of Medicare and Medicaid spending, yet the outcomes we get for these dollars are poor. They are more likely to have inpatient stays, visit emergency rooms, and use nursing homes than their Medicare-only counterparts. That is why in July 2019, we launched a new effort centered around funding research, technical assistance, and policy solutions aimed at improving the systems that deliver care to this vulnerable population. Our work aims to accomplish three policy objectives: (1) increase integration between Medicare and Medicaid through existing or new models, as necessary; (2) increase enrollment in integrated coverage options; and (3) ensure that dual eligible individuals get services that lead to better patient experiences, higher quality of care, and reduced health care costs.

Eligibility: See the Arnold Ventures’ website for complete program guidelines and application instructions.

Link to complete RFP

AstraZeneca External Funding

Organization: AstraZeneca

Award amount: Varies

Deadline: Ongoing

Description: AstraZeneca supports the following funding:

  • Educational Sponsorship/Grants
    •  Educational Sponsorships or Grants that are independent or accredited which focus on education activities and initiatives, such as HCP/scientist and patient education, general support of medical or Scientific. See the Educational Areas of Interest.
  • Sponsorship/Collaborations
    • Sponsorships or Collaborations to advance science and health through genuine medical, science, where AstraZeneca has involvement or receives benefit/recognition,
  • Fellowships
    • Programmes conducted at host institutions and designed to provide training (i.e., training necessary to obtain a degree or license) or advanced education to HCPs or scientists in a particular specialty, Therapeutic area or field of research.
  • Corporate Memberships
    • AZ opt to become a corporate member of a non political medical association or society. AZ will pay a fee to the organization and get access to some of the organizations materials and/or invited to symposiums etc.
  • Community Investment/ Charitable Contributions
    • Community Investment funding includes financial and non-financial (in-kind) support given to registered charity and non-profit organisations for health and health initiatives, science education, fundraisers and disaster relief. It includes donations of medicines in response to public health needs related to national and international disasters and humanitarian crises or as part of free goods Patient Assistance Programmes.

Eligibility: See specific funding areas for eligibility criteria.

Link to complete RFP

Bay Area Lyme Foundation Research Grants

Organization: Bay Area Lyme Foundation

Award amount: Undisclosed

Deadline: Rolling, reviewed three times per year.

Description: At the Bay Area Lyme Foundation, their mission is to put a stop to Lyme disease with a focus on prevention and the development of better diagnostics and treatments.

Lyme disease is one of the most common vector-borne infectious diseases in the world. It is found in 65 countries and throughout the United States, with over 400,000 new cases each year in the US alone. And yet, Lyme research is significantly underfunded relative to other comparable diseases. Bay Area Lyme’s goal is to fill that void and accelerate the pace of new drug and diagnostic development in order to alleviate the suffering.

To that end, Bay Area Lyme accepts proposals on a rolling basis year round and reviews grants, other than the Emerging Leaders Awards (ELA), at three times per year.

Awardees are evaluated on their concepts, ideas, methods, and resourcefulness in bringing new vision into the field of Lyme disease research. Bay Area Lyme’s mission is to fund research and development of novel diagnostics and treatments for Lyme disease.

Eligibility: Bay Area Lyme accepts applications from universities, hospitals, and independent research entities all over the United States. They cannot accept research proposals from outside the U.S.

Grant recipients do not need to have previous experience in Lyme disease research. Every year, they fund researchers who, while respected in their scientific areas of focus, have never previously leveraged their knowledge and abilities for research in Lyme disease.

Link to complete RFP

Bayer Medical Educational Grants

Organization: Bayer

Award amount: Varies

Deadline: Rolling

Description: Bayer US invites educational programming proposals in the following areas: Radiology, Hematology/ Hemophilia, Neurology, Women’s Health, Cardiovascular and Renal, and Oncology.

As general guidelines for submission for grant requests, please note that Bayer US considers many factors including:

  • Promotes excellence in patient care
  • Meets ACCME guidelines related to content, venue, etc.
  • Conducive to an effective and efficient meeting format
  • Ability to educate the broadest healthcare professional and/or consumer target audience at appropriate and reasonable cost.

Eligibility: See the complete opportunity for guidelines, including items outside the scope of the Bayer US Grants.

Link to complete RFP

Bayer Partnerships in Consumer Health

Organization: Bayer

Award amount: Undisclosed

Deadline: Ongoing

Description: Bayer Consumer Health is constantly looking for innovative ideas and solutions to improve its established line of products for the benefit of end consumers.

Innovation is a collaborative process, and we welcome contact from all around the world – entrepreneurs, innovators, startups, researchers and individuals with valuable ideas who are inventing new products, solutions, exploring new fields for the consumer and improving people’s lives.

We are looking into several areas:

  • To improve existing products – new formulation, packaging, online service, medical devices etc.
  • New consumer health solutions – new products, services or apps

Areas of interest:

  • Allergy
  • Cough & cold
  • Dermatology
  • Digestive health
  • Nutritionals
  • Pain & cardio

Eligibility: There are no career-level or citizenship eligibility requirements to partner with Bayer Global.

Link to complete RFP

Bayer Pharma Tech Scouting

Organization: Bayer

Award amount: Undisclosed

Deadline: Ongoing

Description: You have a technology to offer and are looking for a partner to assess, use and progress it? As an innovation leader in life sciences, collaboration is key to us, and we aim to be your partner of choice. Submit your technology or project and we will jointly explore opportunities for collaboration in drug discovery.

Bayer is constantly searching for new technologies pertaining to our indications

  • Cardiovascular (including kidney and lung diseases)
  • Oncology
  • Gynecological therapies
  • Hematology that enable us to identify and develop new drugs:
    • Biologics, Cell Lines, Biomarkers, Biospecimen, Disease Genomics, Formulations

Bayer provides expertise and technologies to help testing the respective hypothesis; this may lead to opportunities for further collaboration with Bayer.

Eligibility: There are no career-level or citizenship eligibility requirements to partner with Bayer Global.

Link to complete RFP

Bayer Pharmaceuticals Investigator-Institution Initiated Research

Organization: Bayer

Award amount: Undisclosed

Deadline: Rolling

Description: Bayer Healthcare Pharmaceuticals Inc., is interested in receiving and reviewing Investigator-Institution Initiated Research grant proposals related to research in the areas of: Dermatology, Radiology, Gynecologic Therapies, Hematology, Multiple Sclerosis, and Oncology . Applications for support are generally reviewed monthly. All documents and contracts must be approved and executed before the project start date, so please plan accordingly.

Eligibility: See the funding opportunity for eligibility requirements.

Link to complete RFP

Bayer Radiology Investigator Initiated Research

Organization: Bayer

Award amount: Undisclosed

Deadline: Rolling

Description: Bayer Healthcare is interested in receiving and reviewing Investigator-Institution Initiated Research grant proposals related to research in our therapeutic areas. Please review the information available through the links at the left for each IIR program. Applications for support are generally reviewed monthly. All documents and contracts must be approved and executed before the project start date so please plan accordingly.

Bayer Radiology Investigator Initiated Research program focuses on research in the following areas:

  • Contrast-enhanced MRI
  • Contrast delivery devices for CT and MRI
  • Informatics for Radiology practice management including radiation dose monitoring, contrast dose and patient protocols

Eligibility:

Link to complete RFP

BD United States External Funding Opportunities

Organization: BD

Award amount: Varies

Deadline: Rolling

Description: BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures and support the management of diabetes.

BD accepts funding requests from qualified external organizations that align with our mission, values, therapeutic areas, and strategic objectives. BD participates in the following types of funding:

Charitable contributions: BD strategically partners with leading nonprofit organizations and foundations to invest in programs and initiatives that address unmet healthcare needs, improve healthcare access and strengthen the capacity of health systems to care for all patients, especially the most vulnerable.

Educational grants: Educational grants are considered for training institutions or conference sponsors to support bona fide education programs dedicated to promoting objective scientific and educational activities and discourse. BD does not support educational grant requests from or benefiting individual healthcare professionals.

Investigator sponsored studies: BD supports independent research to advance scientific and clinical knowledge related to our products, technologies, and therapies. Decisions to support ISS requests never take in to account the volume, nor value of actual or potential business generated by the requestor.

Commercial sponsorship: BD supports commercial sponsorships for events involving healthcare professionals, healthcare organizations, patients, or the public. BD may pay for booths and exhibits at third-party conferences to promote or demonstrate its products, as well as corporate memberships to industry organizations.

Eligibility: BD does not support educational grant requests from or benefiting individual healthcare professionals.

Link to complete RFP

Biogen Medical Education Grants Program

OrganizationBiogen’s Grants Management & Strategic Giving Office

Award amount: Not Disclosed

Deadline: Requests reviewed quarterly. Feb 15, May 15, Aug 15, Nov 1.

Description: Through the program, grants will be awarded to qualified institutions or organizations in support of independent medical educational activities for healthcare professionals and researchers. Medical education may be accredited or non-accredited. Biogen considers requests across a variety of disease areas, including Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, and spinal muscular atrophy.

Eligibility: For complete program guidelines and application instructions, see the Biogen website.

Link to complete RFP

Boehringer Ingelheim Fonds PhD Fellowships (Basic Biomedical Research in Europe or for European Citizens Working Overseas)

Organization: Boehringer Ingelheim Fonds

Award amount: Undisclosed. The scholarship comprises a competitive monthly stipend which is initially granted for 2 years and which can be extended for up to another 12 months.

Deadline: Rolling. Feb 1, Jun 1 and Oct 1.

Description: The Boehringer Ingelheim Fonds (BIF) awards PhD fellowships of 2 to 3.5 years to outstanding junior scientists worldwide who wish to pursue an ambitious PhD project in basic biomedical research in an internationally leading laboratory.

The Boehringer Ingelheim Fonds (BIF) awards PhD fellowships to European citizens working in Europe or overseas, and to non-European citizens pursuing their PhD project in Europe. At the respective deadline (1 February, 1 June, 1 October) the university entrance qualification (secondary school leaving certificate/A-levels/university entrance test that permits to pursue first university studies after finishing school) must not have been achieved more than 8 years ago.

The peer-review selection process evaluates the applicant’s achievements, as well as the scientific quality of the project and host laboratory. The process is highly competitive, with less than 10% of applicants receiving a fellowship.

On top of the monthly stipend, we offer our fellows seminars, travel allowances, individual and personal support, and a worldwide network of fellows and alumni.

Eligibility: The PhD projects must be experimental, in the field of basic biomedical research, and aimed at elucidating basic biological phenomena of human life and acquiring new scientific knowledge.

You should apply when you are about to start, or have just started, your PhD project, no preliminary results are expected. If you have begun your project more than six months prior to the deadline, you are no longer eligible to apply.

Your first university entrance qualification (secondary or high school leaving certificate, A-levels, or entrance/access test for first university studies after finishing school) must not have been completed more than 8 years, i.e. 96 months ago.

Natural scientists should have been awarded their last university degree before embarking on their PhD (BSc, diploma, MSc, or equivalent). If you have not yet finished your MSc studies and/or have not received your MSc degree certificate by the deadline, you can submit it up to four months after the deadline.

Physicians, veterinary surgeons, and pharmacists should have passed their state examinations.

Link to complete RFP

Boston Scientific Investigator Sponsored Research

Organization: Boston Scientific

Award amount: Varies

Deadline: Rolling

Description: The Boston Scientific Investigator Sponsored Research program provides support for researchers to conduct investigator sponsored original research that is of interest to Boston Scientific and the medical community. The program allows researchers, academic and community physicians and researchers to:

  • Participate in expanding clinical and scientific knowledge in their specific areas of expertise.
  • Improve the understanding of Boston Scientific products or applied biomedical research
  • Gather and analyze data for publication

Studies Generally Supported by Boston Scientific

  • Investigator-sponsored human subject and non-human subject studies involving populations benefiting from Boston Scientific products.
  • Studies with expected completion and publication dates within one to two years from initiation are preferred.
  • Research in specific areas of interest to Boston Scientific divisions

Current research interests:

  • Interventional Cardiology/Structural Heart
  • Rhythm & Electrophysiology, incl. Cardiac Rhythm Management
  • Urology and Pelvic Health
  • Peripheral Interventions
  • Endoscopy/Airway
  • Neuromodulation

A sponsor-investigator is a single individual or institution/foundation etc. (where permitted) that is responsible for fulfilling the obligations of both a study sponsor and an investigator.

The sponsor’s role is not related to financial support, which is provided by a funding agency.

Roles and responsibilities in the ISR Program:

  • Funding Agency, Boston Scientific: Provides financial support/product for the study according to a defined Research Contract, which outlines milestones and specific deliverables
  • Sponsor, Physician/Institution: Oversees the conduct of the study, including document management, data management, data analysis, publication, FDA reporting, etc.
  • Investigator, Physician: Conducts the day-to-day research according to a defined protocol and per specified procedures

Eligibility: See the funding opportunities for eligibility criteria.

Link to complete RFP

Bristol Myers Squibb Area of Interest & Competitive Research Grants

OrganizationBristol Myers Squibb

Award amount: Undisclosed

Deadline: Rolling

Description: Bristol Myers Squibb seeks Independent Research applications across all therapeutic areas. Our Areas of Interest outline additional criteria to help guide the scientific community. All concept applications submitted that best align with our interests will be considered and evaluated. Concepts may be submitted outside of the posted AOIs, but the threshold for approval may be relatively high.

Our Competitive Research Grant process defines specific criteria that must be met for your application to be considered. The window for submission will close at a pre­-defined time point.  Concept applications that best align with our posted requirements will be considered, evaluated and compared against all other submissions during the open period prior to final determination of award.

See complete RFP for current therapeutic areas table.

Therapeutic Area and / or Compound
AOIs Posted on BMS.com
Pre-Concept Submission Period
Start Date End date
Immunology – TYK2 (deucravacitinib) 20-Sep-21 18-Oct-21 19-Nov-21
Oncology – Relatlimab 15-Sept-21 4-Oct-21 29-Oct-21

Eligibility: Visit the Bristol Myers Squibb RFP web page for eligibility requirements.

Link to complete RFP

CHARGE Syndrome Foundation Clinical Research Grants

Organization: CHARGE Syndrome Foundation

Award amount: Up to $25,000

Deadline: Ongoing

Description: The CHARGE Syndrome Foundation, Inc. (Foundation) announces the availability of research grants of up to $25,000. Most awards are anticipated to be in the range of $2,000 – $5,000. The purpose of these grants is to promote clinical research on the treatment, intervention, prevention, and support of individuals with medical, health, and behavioral issues, and their families. 

Proposals are for funding for one calendar year. Preference will be given to projects that include investigators who are new to CHARGE research and to projects with clear potential to lead to future funding from other agencies.

Eligibility: Both established and new investigators are encouraged to apply.

Link to complete RFP

Children's Leukemia Research Association Research Grants

Organization: Children’s Leukemia Research Association

Award amount: Up to $30,000

Deadline: Annually on June 30

Description: The Children’s Leukemia Research Association, also known as the National Leukemia Research Association, was founded in 1965 to support research efforts dedicated to finding the cause of and a cure for leukemia. To that end, CLRA is seeking applications from investigators for childhood leukemia research projects.

Grants of up to $30,000 will be awarded to promising projects focused on isolating the causes of and finding a cure for childhood leukemia. Funding from other sources is permissible, but CLRA funding objectives should not duplicate those of other funding sources.

Eligibility: Any doctor at the Ph.D. or M.D. level involved in finding the causes of and a cure for leukemia is eligible to apply.

Link to complete RFP

Crohns & Colitis Foundation of America IBD Plexus: Academic Request for Proposals

Organization: Crohns & Colitis Foundation of America

Award amount: not disclosed

Deadline: Rolling; reviewed 6 times a year

Description:  IBD Plexus was founded by the Foundation to advance science, accelerate progress towards precision medicine, and improve the care of patients living with IBD. This first-of-its kind, national-scale, cloud-based platform integrates clinical, patient-reported, genetic, and other molecular data from diverse research study cohorts, real-world clinical care settings, and patients’ experiences. IBD Plexus provides academic and industry researchers with access to research-ready datasets and biosamples to more rapidly perform activities that promise to speed treatment development, optimize existing therapies through development of biomarkers and diagnostics, and improve health outcomes.

The Crohn’s & Colitis Foundation is excited to release an international request for proposals (RFP) for academic researchers to gain access to IBD patients’ biosamples and / or research-ready datasets housed within IBD Plexus®. The Foundation seeks research proposals that would utilize IBD Plexus biosamples and / or data to facilitate efforts in 4 main areas: 1) identification and / or validation of diagnostics / biomarkers, 2) therapeutic development and optimization 3) disease management 4) disease prevention

Eligibility: The lead principal investigator (PI) must be an investigator (e.g. Professor, Head of Research, Associate Professor, or equivalent) with expertise in a relevant field of research. At the time of application, PI and any co-PIs must be employed by an institution (public non-profit, private non-profit, or government) engaged in health care and/or health care related research. Proposals involving multiple institutions are welcome.

Link to complete RFP

**Cystic Fibrosis Foundation Therapeutics Development Award Program

Organization: Cystic Fibrosis Foundation

Award amount: Up to $5M

Deadline: Rolling LOI

Description: The Cystic Fibrosis Foundation is accepting Letters of Intent for its Therapeutics Development Award Program. 

By supporting early to mid-phase drug development activities with both financial and technical support, the Cystic Fibrosis Foundation’s Therapeutics Development Award (TDA) program is designed to stimulate and de-risk CF drug development of novel therapies for cystic fibrosis. The program provides companies with funding and other resources in support of studies that may include drug discovery, pre-clinical safety, pharmacokinetics/pharmacodynamics (PK/PD), and clinical studies in people with CF through Phase 2 development. Awards will be made for either discovery or preclinical and initial clinical development activities (all therapeutic areas relevant to CF).

Applications will be considered in any therapeutic area that could benefit people with CF but are particularly encouraged in areas related to treating CF infections, CFTR modulation, mucus clearance (mucolytics and airway surface hydration), inflammation, chronic lung allograft dysfunction, CF-related diabetes, CF liver disease, and nutrition. 

The TDA program provides two mechanisms of support:

  • Component I Awards: Funds up to $600,000 over two years will be awarded for early exploratory, discovery, and/or preclinical development studies. 
  • Component II Awards: Considered for more advanced programs that generally have identified a clinical candidate and are moving into investigational new drug (IND)-enabling studies such as PK/PD, GLP toxicology, and Phase 1/2 clinical trials in CF patients. Component II awards are typically supported at a level of up to $3 million to $5 million for two or more years and require substantial matching funds. Only direct costs are covered.

Eligibility: Both U.S.-based and non-U.S. based (i.e., international) companies engaged in research and development are invited to apply.

For complete program guidelines and application instructions, see the Cystic Fibrosis Foundation website.

Link to complete RFP

Eli Lilly and Company Healthcare Professional Education, Patient Advocacy and Consumer Education Grants Program

OrganizationEli Lilly and Company

Award amount: Undisclosed

Deadline: Rolling

Description: As a commitment to improving patient care and providing valuable information to the medical and  broader healthcare community, Lilly will accept the following grant requests:

  • Healthcare professional education (priority will be given to accredited programs)
  • Patient advocacy and Consumer education programs (e.g., disease-state education and awareness, screenings, etc.)

Funding may be requested in the form of support for an educational program, scientific awards, select fellowships, or charitable contributions. Lilly does not provide unrestricted grants or grants to individuals or group practices.

The focus of the Lilly Grant Office (LGO) will be on healthcare-related CME/CE programs as well as  patient education and advocacy in the following therapeutic areas:

  • Autoimmune
  • Endocrine
  • Neurodegeneration
  • Neuroscience – Migraine and Headache Disorders
  • Oncology
  • Chronic pain associated with osteoarthritis and chronic low back pain

Eligibility: Applicants must first register with organizational information, then proceed to supply the required information for the specific opportunity.

Link to complete RFP

Fahs-Beck Fund for Research and Experimentation Grants

Organization: Fahs-Beck Fund for Research and Experimentation

Award amount: Up to $25,000

Deadline: Biannual April 1 and November 1.

Description: 

Faculty/Post -Doctoral Grant Program (Fahs-Beck Fellows)

  • Grants of up to $25,000 are available to help support the research of faculty members or post-doctoral researchers of accredited universities or colleges in the United States and Canada. Areas of interest for funding are: studies to develop, refine, evaluate, or disseminate interventions and preventive/intervention to address social, psychological, behavioral or public health problems affecting children, adults, couples, families, and communities with outcomes that have the potential add to the knowledge base for services and program development. Community engaged research is highly valued.
  • Studies must focus on the United States and/or Canada or comparative studies between the United States and/or Canada and other countries.

Doctoral Dissertation Grant Program (Fahs-Beck Scholars)

  • Grants of up to $7,000 are available to help support dissertation expenses of doctoral students in accredited doctoral programs in the United States and Canada whose studies have the potential for adding significantly to knowledge about the well-being of children, adults, couples, families, communities using interventions or preventive/interventions designed to prevent or alleviate behavioral, social, psychological health problems.
  • The study must focus on populations of the United States and/or Canada or comparative studies between United States and/or Canada populations and other countries.

Eligibility: 

Fahs-Beck Fellows: Faculty members of accredited colleges or universities in the United States or Canada are eligible to apply. The applicant organization must agree to accept administrative responsibility for the project and submit required financial forms and reports to the Fund. The principal investigator (PI) must have an earned doctorate in a relevant discipline. The PI must lead the research and be the principal author of the final report. 

Fahs-Beck Scholars: Applicants must be enrolled in an accredited doctoral program in the United States or Canada. The sponsoring organization must agree to accept administrative responsibility for the project and submit required financial forms and reports to the Fund.

Link to complete RFP

Fibrolamellar Cancer Foundation Research Grants

Organization: Fibrolamellar Cancer Foundation

Award amount: No fixed scope

Deadline: Rolling. Applications reviewed February 1, June 1 and October 1.

Description: The Fibrolamellar Cancer Foundation (FCF) is accepting proposals to support innovative research leading to improved understanding and curative treatments for fibrolamellar carcinoma (FLC). FLC, also known as fibrolamellar hepatocellular carcinoma (FL-HCC), is an aggressive liver cancer that tends to strike teens and young adults.

Eligibility:

    • Applicants must be employed by an institution engaged in health related research. The applicant further must agree to be supervised by the institution at all times while conducting research supported by the FCF.  In cases of a change in institutions while applying for, or utilizing funds from the FCF, applicants must notify FCF, and will be subject to review based upon the change in circumstances.
    • The research must focus on fibrolamellar hepatocellular carcinoma. Studies should be intended to advance knowledge in the areas of FL-CC. Of particular interest are those showing a clear path to clinical trials.
    • Collaboration and open sourcing is a requirement for FCF funding and will be so specified in any grant agreement.

Link to complete RFP

Friedreichs Ataxia Research Alliance (FARA) General Research Grants

Organization: Friedreich’s Ataxia Research Alliance (FARA)

Award amount: Up to $125,000 per year for 1-2 years

Deadline: LOIs due biannually Feb 1 and July 15.

Description: FARA supports research through funding competitive grants across the spectrum from basic research through drug development and clinical research programs in Friedreich’s Ataxia (FA). We promote collaboration among scientists, advocate for public-private partnerships and host open forums for leading scientists to share their insights and ideas to advance therapeutic development for FA.

The General Research Grant is open to qualified investigators proposing projects that fall within FARA Research Priorities:

  • Advancing understanding of neuroscience/ systems
  • Advancing understanding of cardiac disease in FA
  • Advancing understanding of the molecular basis of FA
  • Advancing drug discovery
  • Facilitating the drug development process and translational research
  • Advancing clinical research

Eligibility: See specific funding areas for eligibility criteria.

Link to complete RFP

Foundation Fighting Blindness Ted and Elaine Welp Enhanced Career Development Program Award (Retinal Degenerative Diseases)

Organization: Foundation Fighting Blindness

Award amount: $510,000

Deadline: Rolling

Description: The Enhanced CDA ensures that an adequate pool of highly trained physicians/scientists are available to address current and future needs and opportunities for clinical research and therapy related to inherited orphan retinal degenerative diseases. This award supports and provides protected career development time to individuals with M.D. and M.D./Ph.D. degrees to further their independent research in retinal degenerative diseases. This program supports up to two mid- to senior-level faculty for three (3) years at $170,000 per year. Applicants must possess an M.D. or M.D./Ph.D. degree, hold a full-time tenure-track or equivalent appointment at the sponsoring institution with a commitment of no less than five (5) years, commit at least 80% of their work hours to the program, and have successfully completed an ophthalmology residency or equivalent training.

Eligibility: 

  • Principal Investigator
    • Candidates with different levels of prior research training and experience and at different stages in their career development are eligible to apply.
    • Eligible applicants must:
      • have an M.D. or M.D./Ph.D. degree
      • have successfully completed an ophthalmology residency or equivalent training program
      • hold a full-time tenure track or equivalent appointment at the sponsoring institution with a commitment for five (5) years
      • commit at least 80% of Full Time Equivalent to the program.
    • Up to 20% effort is allowed for activities in other retinal specialties (e.g., vitreoretinal surgery, medical retina, etc.), but is not required.
    • Award recipients may reduce total effort to no less than 50% in the third year. Any reduction in effort will require Foundation approval.
  • Institutions
    • Applications may be submitted on behalf of candidates by domestic and foreign, public and private, academic institutions, as well as hospitals and laboratories affiliated with such institutions.
    • Sponsoring institutions must have a well-established record of research and career development relating to inherited orphan retinal degenerative diseases and provide a high-quality research environment (including staff capable of productive collaboration), and the research facilities, resources and training opportunities necessary to carry out the enhanced research and clinical training program.
    • Sponsoring institution or Department must provide a five (5)-year commitment to the award recipient.

Link to complete RFP

Gateway for Cancer Research Grants

Organization: Gateway for Cancer Research

Award amount: No official funding cap, but Gateway typically funds research studies with a budget estimate in the range of $200,000-$800,000.

Deadline: Rolling

Description: Gateway for Cancer Research funds transformational cancer research that helps patients feel better and live longer, as we seek to put an end to cancer as we know it. Our grants help advance Phase I and Phase II clinical trials for all types of cancer that bring to the bedside new cancer therapies and approaches that make a difference for patients of all ages. Gateway partners with dedicated physicians, clinician-scientists, and renowned research institutions around the world to advance innovative cancer treatments and cures. All of this is guided by a clear vision:  To create a world in which a cancer diagnosis is no longer feared.

We accept submissions on a rolling basis and typically approve funding requests within 3-4 months—an extraordinarily short timeline compared to most research funding streams. As a result, Investigators can capitalize on Gateway funding to quickly enroll patients and move the research forward more rapidly than most funding allows.

We focus on the following areas: Novel Use, New Therapy, Precision, or Integrative Medicine

Eligibility: Any investigator who is ready to conduct a clinical trial in cancer research—one which will have an immediate impact on cancer patients—may apply for funding. Investigator initiated applications from any academic, non-profit institution and medical centers are welcome; investigators don’t need to carry any special qualifications other than proven work as a clinician, researcher or primary investigator.

Link to complete RFP

Genentech Fellowships Support

Organization: Genentech

Award amount: Varies

Deadline: Rolling. Requests must be submitted at least 90 days prior to the project/program start date.

Description: Genentech is committed to supporting programs that help grow and strengthen the diversity of the healthcare and biomedical research workforce, in order to ensure that all patients, including those from communities of color and other underrepresented groups, can receive relevant treatments and high quality care.

Fellowships are for grants to independent professional organizations, independent charitable organizations, or other eligible institutions, where the funds are used to support advanced study by clinical and research professionals at an accredited university or teaching institution. To reflect Genentech’s commitment to building a diverse and inclusive workforce, we prioritize requests that support the career development, persistence and retention of students and professionals who are members of gender, racial and/or ethnic groups that are historically underrepresented in academic medicine and biomedical research.

Genentech/Roche will consider funding requests in the following disease states:

  • Bladder Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Hematologic Malignancy
  • Hemophilia
  • HER2-Positive Metastatic Breast Cancer
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Metastatic Breast Cancer
  • Multiple Sclerosis
  • Myeloma
  • Non-Hodgkins Lymphoma
  • Ovarian Cancer
  • Pan-Tumor
  • Waldenstrom’s Macroglobulinemia
  • Other

Eligibility: The fellowship program must be accredited, or in the case of retina-related fellowships, the program is a 2-year post-residency program. Operating expenses must be directly and exclusively dedicated to the activity for which the requestor is applying

In order to be eligible for this type of funding, the funding must not be used for:

  • The purpose of developing clinical practice guidelines, e.g., statements that include recommendations intended to help practitioners make appropriate health care decisions for specific clinical conditions
  • Religious purpose
  • Promotion of a Genentech or Roche product or to influence formulary decisions
  • Capital campaigns/building funds
  • Indirect costs cannot exceed more than 25% of the charitable grant amount
  • Fellowships that are based outside of the United States

Link to complete RFP

Genentech Scientific Project Support

Organization: Genentech

Award amount: Varies

Deadline: Rolling

Description: Genentech is committed to the pursuit of groundbreaking science to discover and develop breakthrough medicines for people with serious and life-threatening diseases. We envision a world where all individuals can experience their full potential for health and wellbeing, and a future of science and healthcare that is more diverse, equitable, and inclusive.

Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and academic institutions. As part of our company-wide commitment to ensuring a healthier future for all patients, we prioritize projects that build a more fair and just healthcare system in the following areas:

  • Inclusive research: Reducing barriers to participation in clinical trials so healthcare solutions are designed for all patients
  • Equity in care: Ensuring all patients have access to high quality care
  • Future life sciences workforce: Create sustainable pathways into the life sciences for underrepresented groups, particularly low-income students of color

Operating expenses must be directly and exclusively dedicated to the activity for which the requestor is applying.

Genentech/Roche will consider funding requests in the following disease states:

  • Bladder Cancer
  • Breast Cancer
  • Cervical Cancer
  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Genitourinary Cancer
  • Hematologic Malignancy
  • Hemophilia
  • HER2-Positive Metastatic Breast Cancer
  • Leukemia
  • Lung Cancer
  • Lymphoma
  • Melanoma
  • Metastatic Breast Cancer
  • Multiple Sclerosis
  • Myeloma
  • Non-Hodgkins Lymphoma
  • Ovarian Cancer
  • Pan-Tumor
  • Waldenstrom’s Macroglobulinemia
  • Other

Eligibility: Research collaborations, clinical trials, and associated correlative research involving or undertaken in relation to Genentech or Roche products (whether investigational and/or approved for other uses) are excluded from this type of support. For information regarding these types of programs, please refer to our pipeline.

In order to be eligible for this type of funding, the funding must not be used for:

  • The purpose of developing clinical practice guidelines, e.g., statements that include recommendations intended to help practitioners make appropriate health care decisions for specific clinical conditions.
  • Religious purposes
  • Capital campaigns/building funds
  • Research projects that are based outside of the United States

Indirect costs cannot exceed more than 25% of the charitable grant amount.

The scientific project must not have commenced prior to the approval for funding.

Researchers assigned to the research project must be qualified (e.g., not subject to medical license suspension or revocation, not debarred or disqualified by a federal or state agency).

Link to complete RFP

Gerber Foundation Pediatric Health Research Grants

Organization: Gerber Foundation

Award amount: Up to $350,000

Deadline: Biannually May 15 and Nov 15.

Description: The mission of the Gerber Foundation is to enhance the nutrition, care, and development of infants and young children.

To that end, the foundation is accepting concept papers for health and/or nutrition-related research projects with potential to have a significant impact on issues affecting infants and young children from birth to three years of age.

The foundation awards grants for research projects focused on issues faced by care providers that, when implemented, will improve health, nutrition, and/or developmental outcomes for infants and young children. Projects may address etiologic mechanisms of disease; new, improved, or less invasive diagnostic procedures; reduction or elimination of side effects; alleviation of symptoms; new, improved, or less invasive therapies or treatments; dosage or dosing requirements or mechanisms for drugs, nutrient supplementation, or other therapeutic measures (under or overdosing); and preventative measures.

Priority is given to projects offering a substantial promise of meaningful advances in prevention and treatment of diseases, as well as those with broad applicability to the general population on a regional or national level.

Eligibility: Organizations recognized as tax-exempt under Internal Revenue Code 501(c)(3) are eligible to apply for Foundation grants. Public governmental institutions such as universities are included in this definition. Organizations must also be determined not to be private foundations under Internal Revenue Code 509. No grants are made to individuals. With few exceptions, only organizations with principal operations in the United States and its territories are eligible for funding. Within the United States, there is no geographic limitation to the Foundation’s grantmaking.

Link to complete RFP

Gilead Patient Community Support and Medical & Scientific Support

Organization: Gilead

Award amount: Undisclosed

Deadline: Rolling

Description: Gilead welcomes funding requests for innovative, high-impact projects that relate to at least one of five core therapeutic areas:

  • HIV/AIDS
  • Liver diseases
  • Hematology and oncology
  • Inflammatory and respiratory diseases

We consider a number of factors when reviewing grants, but it is most important for applications to demonstrate a strong commitment to — and capacity for — delivering the specific services your funded grant would support. Grant applications are accepted throughout the year.

Patient Community Support: Lack of awareness is often a significant barrier to disease screening and treatment — especially among at-risk populations — leading to acute disparities in care. Gilead supports patients and their communities by funding a variety of awareness-raising projects.

Examples of Patient Community Support projects Gilead has funded include:

  • Events or resources to educate patients about prevention and care options, such as:
  • Presentations
  • Web-based resources
  • Printed materials
  • Testing and screening initiatives

Medical & Scientific Support: Ongoing education is essential to ensuring that healthcare professionals can continue to deliver the best possible care based on the latest advances in medicine. Gilead supports high-impact, continuing medical education programs that expand the knowledge and skills of healthcare professionals.

Gilead has funded a range of Medical and Scientific Support projects, including:

  • Continuing medical education (CME) accredited by ACCME or another relevant organization
  • Non-accredited CME in compliance with FDA guidelines
  • Scientific conferences
  • Lecture series or symposia

Eligibility: See the funding opportunity for eligibility criteria.

Link to complete RFP

Glaucoma Research Foundation Shaffer Grants

OrganizationGlaucoma Research Foundation

Award amount: $50,000 for one year

Deadline: Annually July 15

Description: For more than 40 years, Glaucoma Research Foundation has been the premiere organization in glaucoma research funding. We support new high-impact clinical, epidemiological and laboratory research based on our strategic research goals.

Strategic Research Goals

  • Protect and restore the optic nerve
  • Accurately detect glaucoma and monitor its progress
  • Find the genes responsible for glaucoma
  • Understand the intraocular pressure system and develop better treatments
  • Determine the risk factors for glaucoma damage using systematic outcomes data

Core Values

  • Involve people with glaucoma in the design, implementation and evaluation of programs.
  • Encourage collaboration among experts in many fields of study to achieve GRF goals.
  • Communicate research goals and results to the scientific community and the public.
  • Ensure that new glaucoma treatments maintain or improve individuals’ quality of life.
  • Encourage innovative clinical trial studies and laboratory research.
  • Develop cell and animal models of glaucoma to support research studies.
  • Facilitate and support the development of physician-scientists to advance glaucoma research.

Eligibility: Grant applicants must possess at least a graduate degree. Interdisciplinary teams and collaborations that may lead to new glaucoma treatments are encouraged.

Restrictions

  • Equipment exceeding $12,000; waivers may be granted on a case-by-case basis
  • Salaries for principal investigators and co-investigators
  • Projects with overt commercial applications
  • General lab supplies used for daily purposes such as swabs, gloves, etc.
  • Indirect costs, including overhead

Link to complete RFP

Histiocytosis Association Research Grants

Organization: Histiocytosis Association

Award amount: $50,000

Deadline: Annual. Proposals are typically accepted from Mid-May until July 1 each year.

Description: Proposals for scientific research are accepted for studies into the causes, mechanisms, and improved means of treatment for histiocytic disorders. Proposals are evaluated on the basis of science, feasibility, and relevance. All proposals are expected to address one or more of the histiocytic disorders; below are areas of particular interest; however, all relevant areas of interest are considered.

  • Mechanisms of disease pathogenesis
  • Biology (maturation, migration and immune function) of dendritic cells, macrophages and/or lymphocytes in disease pathogenesis
  • Derangements of cytokine production or function
  • CNS pathology
  • Studies of rare forms — Juvenile xanthogranuloma, Erdheim-Chester disease, Rosai-Dorfman disease
  • Studies of histiocytic disorders in adults
  • Discovery of new disease markers

Eligibility: An applicant must be a full-time faculty member at an academic institution.

Link to complete RFP

Janssen Pharmaceuticals Grant Program

OrganizationJanssen Biotech, Inc., Janssen Therapeutics, Division of Janssen Products, LP, Janssen Scientific Affairs, LLC 

Award amount: Varies 

Deadline: Ongoing

Description:

Janssen Biotech, Inc.

At Janssen Biotech, we harness innovations in large-molecule and small-molecule compounds to create important new therapeutic options. Beyond innovative medicines, we are also committed to programs that ensure healthcare providers, caregivers, patients and advocates have access to the latest treatment information and support services.

Educational grants and fellowships are provided for specific educational purposes that benefit healthcare professionals and patients in the following therapeutic areas:

  • Immunology
    • Gastroenterology: IBD- Crohn’s Disease and Ulcerative Colitis
    • Dermatology: Psoriasis
    • Rheumatology: Psoriatic Arthritis, Ankylosing Spondylitis, Juvenile idiopathic arthritis
  • Oncology
    • Solid Tumors: Prostate, Bladder, and Non-small Cell lung Cancers
    • Hematologic Malignancies
    • B-Cell Malignancies
    • Chimeric antigen receptor T-cell therapy

Janssen Therapeutics, Division of Janssen Products, LP

Janssen Therapeutics strives to be a leader in the field of Infectious Diseases and Vaccines by supporting relevant, innovative, and quality education that enhances the understanding of our areas of interest to fulfill our responsibility to healthcare providers and people who use our products and services.

Educational grants and fellowships are provided for specific educational purposes that benefit patients and healthcare professionals in the following areas:

  • HIV/AIDS
  • Respiratory Syncytial Virus (RSV)
  • Vaccines

Janssen Scientific Affairs, LLC

Janssen Scientific Affairs, LLC is committed to improving patient care in our disease states of interest through support of independent educational grants for activities targeting healthcare providers, fellows, and patients/caregivers.

Educational grants and fellowships are provided for specific educational purposes that benefit patients and healthcare professionals in the following therapeutic areas:

  • Cardiovascular
    • Obesity and the use of NOACs
    • Stroke prevention with NOACs
    • Dual pathway inhibition antithrombotic therapy to reduce major adverse events in patients with CAD and/or PAD
    • Identification and management of high risk medically ill patients of thromboprophylaxis during hospitalization and following discharge.
  • Metabolism
    • Cardiovascular, Heart Failure and Renal Management in Type 2 Diabetes Mellitus with Moderate-to-Severe Renal Impairment
  • Neuroscience
    • Schizophrenia
    • Major Depressive Disorder (including Treatment Resistant Depression)

See the grants program webpage for therapeutic areas currently accepting applications. We are not accepting applications for general support of the following regularly scheduled activities:

  • Professional Society annual meetings, special interest conferences, sponsored regional series, or other regularly scheduled Society- sponsored meetings
  • Single- or half-day regional update conferences Disease state-specific educational activities held in conjunction with these regularly scheduled meetings may be considered.

Eligibility: See the grants program website for specific eligibility requirements.

Link to complete RFP

The Leakey Foundation Research Grants of Human Origins

Organization: The Leakey Foundation

Award amount: Up to $25,000

Deadline: Biannually on January 10 and July 15

Description: The Leakey Foundation exclusively funds research related to human origins. Priority of funding is commonly given to exploratory phases of promising new research projects that meet the stated purpose of the Foundation. The majority of The Leakey Foundation’s Research Grants awarded to doctoral students are in the $3,000-$15,000 range. Larger grants given to senior scientists and post-doctoral researchers may be funded up to $25,000.

The Leakey Foundation exclusively funds research into human origins, including paleoanthropology, genetics, primate behavior and the behavioral ecology of contemporary hunter-gatherers. Other areas of study are generally not considered.

Investigators may only submit one proposal as a principal investigator (PI) per granting cycle. This policy does not apply to co-investigators. For example, you may be the PI on one proposal as well as a co-investigator on another.

Eligibility: Advanced doctoral students (advanced to candidacy – all but dissertation) and established scientists are eligible for Leakey Foundation Research Grants. There are no citizenship restrictions; however, all applications must be written in English.

Link to complete RFP

Les Paul Foundation Grants for Music Education, Recording, Innovation and Medical Research Related to Hearing

Organization: Les Paul Foundation

Award amount: Undisclosed

Deadline: Biannually Jan 15 and Sep 15.

Description: The Les Paul Foundation works to inspire innovative and creative thinking by sharing the legacy of Les Paul through music education, recording, innovation, and medical research related to hearing.

To that end, the foundation invites applications for grants in support of programs and projects that encourage innovation in music production and/or performance and innovative STEM or STEAM programs for students and others in challenging situations. The foundation also will consider proposals for medical research related to curing tinnitus and other hearing impairment issues. Preference will be given to programs that focus on music innovation, engineering, and medical research related to hearing loss.

Eligibility: Applicants must be tax-exempt as defined by section 501(c)(3) of the Internal Revenue Code. 

For complete program guidelines and application instructions, see the Les Paul Foundation website.

Link to complete RFP

Marsha Rivkin Center for Ovarian Cancer Research Research Grants

Organization: Marsha Rivkin Center for Ovarian Cancer Research

Award amount: $30,000-$120,000

Deadline: Annual and biannual depending on award. See description.

Description: Each year, the Marsha Rivkin Center funds promising research for ovarian cancer. These studies and researchers are selected through a highly competitive process. Each application is individually reviewed by a panel of nationally recognized experts for its scientific merit, novelty, and potential to impact the prevention, detection, treatment, and understanding of the disease. There are multiple streams of scientific funding:

  • Pilot Study Program: One-year awards at $75,000 each, Pilot Study Program awards will support investigator-initiated projects in all areas of ovarian cancer research. In addition, projects designed to analyze data from already funded clinical trials will be considered. Deadline: Dec. 1
  • Scientific Scholar Award: Two-year grants at $120,000 each, Scientific Scholar Awards are intended to assist promising laboratory and clinical scientists in pursuing a career as an independent investigator in ovarian cancer research. Deadline: Dec. 1
  • Bridge Funding Award: Bridge Funding allows researchers to produce data needed to substantiate their proposal resubmission to federal funding agencies for a promising new research project. The Rivkin Center provides interim funding of up to $30,000 to researchers who have submitted an R01 or R21 proposal to the National Institutes of Health (NIH) or an original proposal to the Department of Defense (DoD) pertaining to ovarian cancer and who have not received, but were close to, a fundable score. Deadlines: May 1; Oct. 15

Eligibility: Varies depending on award program. See complete funding opportunity for eligibility criteria.

Link to complete RFP

Medtronic External Research Program

Organization: Medtronic

Award amount: Varies

Deadline: Rolling

Description: The Medtronic External Research Program (ERP) supports a global network of investigator-initiated research projects in the spirit of advancing medical and scientific knowledge. Focusing on the discovery, development and cultivation of cutting-edge therapies and diagnostics, the program fosters investigative research with the goal of improving the quality of patient care and clinical outcomes.

Medtronic’s External Research Program (ERP) supports research involving the Company’s products. These studies are intended to add to the base of scientific knowledge expanding the practice of evidence-based medicine.

Studies that may be supported include:

  • Label studies consistent with business strategy and applicable legal, regulatory and internal policy requirements.
  • Studies of strategic importance to Medtronic. A list of such areas of interest is available upon request and is updated regularly.
  • Prospective and retrospective studies.
  • Studies having reasonable sample size and follow-up timelines.
  • Studies having budgets that are of fair market value.
  • Well-designed studies having an appropriate statistical plan.
  • Studies may be clinical or non-clinical (benchtop, algorithm, cadaver or animal studies).

If the request doesn’t have protocol, an individual investigator sponsor, and isn’t focused on a Medtronic product or procedure, please explore the Medtronic Grants and Donations program.

Eligibility: 

Link to complete RFP

Merck Investigator Studies Program (MISP)

Organization: Merck

Award amount: Varies

Deadline: Ongoing

Description: The Merck Investigator Studies Program (MISP)’s mission is to advance science and improve patient care by supporting, through the provision of drug/vaccine and/or total/partial funding, high-quality research that is initiated, designed, implemented and sponsored by external investigators. Results will be generated and properly disseminated in peer-reviewed publications.

MISP is open to all academic and community-based physicians and researchers worldwide who are interested in conducting their own research. This program consists of committees of medical and scientific staff from different therapeutic areas who meet regularly to review our company’s investigator study proposals. Support is provided based on the scientific merit of the proposal as well as whether it is in alignment with the published areas of interest. Information related to areas of interest and requirements for submission can be found by clicking on the appropriate link for your therapeutic area.

Submission of a proposal does not imply or guarantee approval. All proposals will be reviewed based on research merit criteria. Financial and/or product support is contingent upon full execution by both parties of the research agreement.

The current (2/23/21) areas supported are:

  • Cardiovascular
    • Heart Failure
  • Endocrinology
    • Diabetes and Metabolism
  • Infectious Disease
    • Antimicrobial Stewardship
    • Bacterial Infections
    • Clostridium difficile
    • CMV
    • HIV
  • Non-Alcoholic SteatoHepatitis
  • Neuroscience
    • Insomnia
    • Schizophrenia
  • Oncology
  • Patient Engagement, Diversity and Health Literacy
  • Respiratory
    • Cough
  • SARS CoV-2/COVID-19 Treatment
  • Surgery
    • Anesthesia
  • Vaccines
    • Dengue
    • HPV
    • Measles, Mumps, Rubella & Varicella
    • Pediatric Hexavalent
    • Pneumococcus
    • Respiratory Syncytial Virus
    • Rotavirus /  Vaccine Biology
    • Vaccine Confidence
  • Women’s Health
    • Contraception
    • Fertility

Eligibility: See specific areas of interest for eligibility criteria.

Link to complete RFP

National MPS Society Research Grants

Organization: National MPS Society

Award amount: See Description

Deadline: Rolling. LOIs due March 15, July 15 and November 15.

Description: 

Research Tier I Grant

  • Research will address complex or multidisciplinary questions and/or unmet needs in basic, translational, clinical, or diagnostic aspects of the MPS and ML disorders
  • Up to a total of $100,000 US, disbursed over one to two years at the discretion of the PI
  • A competitive renewal under this mechanism is possible, but will only be funded once
  • Total funds of an original grant and its renewal will not exceed $200,000
  • Total funded period of a grant and renewal will not exceed 4 years (excluding NCE)

Research Tier II Grant

  • Research is more defined than Tier I, and may address but is not limited to the following:
    • Discreet studies or deliverables involving drug repurposing, models, etc.
    • Research needs designed to make possible a significant and new research grant
    • Research needs designed to improve a significant research grant resubmission
    • Analysis of previously compiled data or research resources
    • Pre-clinical extension to an alternate syndrome of a previously validated therapy
  • Up to a total of $50,000 US, disbursed over one to two years at the discretion of the PI
  • A competitive renewal under this mechanism is possible but will only be funded once
  • Total funds of an original grant and its renewal will not exceed $100,000
  • Total funded period of a grant and renewal will not exceed 4 years (excluding NCE)

Research/Clinical Scientist Fellow-Initiated Research Grant

  • The Fellow-Initiated application will, in most cases, address a Tier II level question
    • In rare cases the research may approach Tier I level research in scope
  • Awards will be limited to one year at $50,000 (US)
  • The basis of any award decision will rest on rigorous review of the research component
  • A required mentor’s statement must be included which address mentorship in research
  • Eligible for up to one renewal

Eligibility: Any domestic US or foreign, public or private, non-profit or for-profit research organization is eligible to apply for and receive a Society Grant.

Research Tier I and II Grants:

  • Any individual with the skills, knowledge, and resources necessary to carry out the proposed research as a Principal Investigator (PI) is invited to apply.
  • A PI must be institutionally eligible to apply for, be awarded, and administer an extramural research grants

Research/Clinical Scientist Fellow-Initiated Research Grants

  • Eligible applicants include PhD candidates (preliminary exams completed) and medical professional students (to support a one-year hiatus from professional training to pursue research), and post-doctoral fellows (within 3 years of PhD or clinical degree).
    • Medical professional training programs and clinical degrees include the following training programs and degrees: DDS, DO, DVM, MD, VMD and equivalents.
  • Fellow applicants must have a principal mentor who satisfies the institutional requirements of a PI as defined above under the Research Tier I and II Grants heading.

Link to complete RFP

Partnership for Clean Competition Research Grants Program

OrganizationPartnership for Clean Competition

Award amount: No maximum, though the average funding amount is $225,000.

Deadline: Rolling. March 1, July 1 and November 1.

Description: Research and grant-making are the foundation of the PCC and are the focus of everyday business activity. PCC-supported research contributes to a movement in addressing doping’s root causes and ultimately decreasing the use of performance-enhancing drugs by all participants in all sports at all levels of play. With an emphasis on original work that focuses on improving existing analytical methods for detecting particular drugs, developing new analytical methods to test for substances not currently detectable, and discovering cost-effective approaches for testing widely abused substances across all levels of sport, see the PCC website for current research priorities.

Eligibility: See the Partnership for Clean Competition’s website for complete program guidelines and application instructions.

Link to complete RFP

Retirement Research Foundation Research Grants

OrganizationRetirement Research Foundation (RRF) Foundation for Aging

Award amount: Not disclosed

Deadline: Rolling. Next LOI due 6/15/2021.

Description: RRF funds research that seeks to identify interventions, policies and practices to improve the well-being of older adults and/or their caregivers. Preference is given to projects aimed at generating practical knowledge and guidance that can be used by advocates, policy-makers, providers, and the aging network. Of particular interest are:

  • Interventional trials; translational studies; and health services and policy research
  • Projects that build on the investigator’s past studies
  • Proposals that include robust dissemination plans, if appropriate, to assure that findings reach audiences positioned to act on them

Eligibility: Research Grants are provided to nonprofit organizations that are:

  • Proposing applied research projects that have immediate and direct implications on the  adult population, ages 65 and older
  • Proposing a project that will have national relevance across the U.S. or regional relevance within the states of Illinois, Indiana, Iowa, Kentucky, Missouri, Wisconsin, or Florida.

Please review the general grant exclusions before applying for a grant.

Link to complete RFP

Rising Tide Foundation Cancer Research

OrganizationRising Tide Foundation for Clinical Cancer Research

Award amount: varies

Deadline: LOIs ongoing

Description: Using a patient centered approach, Rising Tide Foundation Clinical Cancer Research supports research grants that enable patients to better understand their treatment options and to have a voice in trial design, thereby empowering them to be active agents in enhancing their quality of life.

Primary consideration in granting support is given to truly innovative, unique, patient-centered clinical research that has the potential to positively impact the lives of cancer patients at the earliest opportunity. RTFCCR provides funding for research that directly benefits patients and does not provide funding for basic research.

Focus Areas

  • Improved patient outcomes
    • Therapy optimization
    • Disease and treatment burden
    • Implementation research
    • Patient engagement
  • Science of prevention and detection
    • Improve detection of genetic and modular changes for monitoring of people at increased risk of cancer
    • Selected primary prevention strategy trials
    • Genetic, molecular and imaging technologies to noninvasively identify or monitor the presence or precursors on cancer
    • Better characterize aggressive cancers through the use of biomarkers or other technologies to personalize detection/monitoring

Eligibility: We provide funding for research that can directly benefit patients. As time is not a luxury afforded to cancer patients, we demand that research projects approved for funding are activated within 6 months of funding upon official award notification and that they exert a patient impact within 3 years or less. Funding can be provided to any relevant institution in any country where meaningful grant oversight is possible.

Link to complete RFP

Robert Wood Johnson Foundation Evidence for Action: Innovative Research to Advance Racial Equity

Organization: Evidence for Action

Award amount: There is no cap for the research budget request. We have received a wide range of budget requests and have invited Full Proposals ranging from $35k to $1M and awarded grants ranging from just under $50K to just over $725K.

Deadline: Open. Applicants must first submit an LOI. 

Description: We fund research that is rigorously designed and conducted, to expand the evidence base needed to advance health and racial equity. We prioritize research evaluating the impact of policies, programs, practices, or other system or structure-level changes in such a way as to establish causal relationships between the interventions and important health and racial equity outcomes.

We are looking for researchers, practitioners, community leaders, advocates, policymakers, and/or other stakeholders across the many sectors and domains that impact health and well-being, who are committed to developing and disseminating evidence about what works to dismantle or remedy unjust systems and practices and produce more equitable outcomes for people and communities of color.

The Evidence for Action (E4A): Innovative Research to Advance Racial Equity Call for Proposals (CFP) funds projects that develop and disseminate evidence about what works to advance racial equity and improve health and well-being in the United States. We understand that the terminology and sociopolitical context surrounding racial equity are ever-evolving. We acknowledge that a history of unequal power and privilege influences how knowledge is created and how research is conducted, and we are committed to critically examining and overcoming these biases. The CFP and applicant resources were developed through an iterative and reflective process, and we will continue to review, evaluate, and update our approach, CFP, and applicant materials as our collective understanding evolves. A number of racial equity and social justice scholars, current and former E4A grantees, and members of the E4A National Advisory Committee provided insight, advice, and feedback to inform the development of the CFP and application materials. (See related FAQ for details on the CFP development process.)

Eligibility: Preference will be given to applicant organizations that are either institutes of higher education, public entities, or nonprofit organizations that are tax-exempt under Section 501(c)(3) of the Internal Revenue Code, but other types of nonprofit and for-profit organizations are eligible to apply. Applicant organizations must be based in the United States or its territories; submissions from teams that include both U.S. and international members are eligible, but the lead applicant must be based in the United States.

See the complete RFP for additional eligibility FAQs. 

Link to complete RFP

Sanofi US Educational Grants

Organization: Sanofi

Award amount: Undisclosed

Deadline: Undisclosed

Description: Sanofi US is committed to funding high quality educational activities and materials in the therapeutic areas of interest to the company that have the potential to improve patient care and health outcomes.

The purpose of an educational grant is to support an activity that encourages an educational interchange with respect to available scientific and medical information. Educational activities may or may not be accredited.

Educational grant requests must be submitted at least 12-16 weeks in advance of the request for notification date. Please utilize the notification date to ensure your grant is reviewed within the timeframe necessary for you to be able to disclose funding in a compliant fashion. The production start date is the date activity development begins, which will differ from the launch date.

Review and processing time will take approximately 6-8 weeks. Complete, accurate and detailed information is required to avoid delays. Applications with insufficient information may require additional processing time.

Sanofi US is currently accepting educational grant applications in the following therapeutic area(s):

  • US Cardiovascular, specific to the Area of Interest:
    • The role of AADs in Early Rhythm Control and the Management of Atrial Fibrillation
  • US and Global Multiple Sclerosis, specific to the Area of Interest:
    • Multiple Sclerosis
  • US and Global Neurology, specific to the Area of Interest:
    • Parkinson’s disease with a GBA mutation
  • US Oncology, specific to the following Areas of Interest:
    • Prostate Cancer
    • Tumor Lysis
    • HSCT: stem cell mobilization and collection during autologous HSCT
  • US and Global Rare Blood Disorder, specific to the Areas of Interest:
    • Hemophilia
    • Cold Agglutinin Disease (CAD)
    • Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
  • US Rare Genetic Diseases, specific to the Areas of Interest:
    • Acid sphingomyelinase deficiency (ASMD)
    • Fabry Disease
    • Gaucher Disease
    • Pompe Disease
    • MPS1
    • Lysosomal Storage Disorders
    • Other Genetic Disorders
  • US Transplantation, specific to the Area of Interest:
    • Immunosuppressive Strategies to Reduce Transplant Rejection

Eligibility: Applicants must agree to the attestation to be eligible. Currently programs that involve a US Location or include US participants as a target audience or include US accreditation (e.g. ACCME, ACPE, ANCC) are eligible to receive an Educational Grant:

  • Accredited continuing education providers, health-related academic societies and organizations, medical education communication companies, teaching hospitals, educational institutions and other groups who have the potential to provide high quality education to advance healthcare are eligible to apply for an Educational Grant.
  • In order to avoid any conflict of interest, the company does not support Educational Grants to any of its customers, including HMOs, PPOs, GPOs, etc., or any doctor or group of doctors in private practice.

The only customers or potential customers that may be eligible for an Educational Grant are teaching hospitals and educational institutions whose mission includes public health education. Individuals are not eligible to receive educational grant funding. Applicants who have received past Educational Grant funding but have not provided budget reconciliation for the past activity (if the activity end date was at least 90 days ago) are not eligible for funding.

Link to complete RFP

Simons Foundation Autism Research Initiative (SFARI) Supplement to Enhance Equity and Diversity (SEED

Organization: Simons Foundation

Award amount: The budget is up to $100,000 per year for up to three years.

Deadline: Rolling

Description: The goal of this award is to increase diversity and fight inequity. SFARI Principal Investigators (PIs) are encouraged to recruit candidates for this supplement not only at their home institution, but also at historically Black colleges and universities and other institutions with high minority enrollment.

Eligibility: Principal Investigators from institutions in the United States with a current SFARI grant that has at least 18 months remaining on the project are eligible to apply for this supplement. See the complete RFP for more information.

Complete RFP

Simons Foundation Targeted Grants in MPS

OrganizationSimons Foundation

Award amount: Flexible

Deadline: Rolling

Description: The program is intended to support high-risk theoretical mathematics, physics and computer science projects of exceptional promise and scientific importance on a case-by-case basis.

Eligibility: Applications may be submitted by established U.S. and foreign public and private educational institutions and stand-alone research centers. PIs and co-Investigators must have a Ph.D. and a tenure-track or tenured position at said institutions or centers at the time of application. There are no citizenship or department requirements for PIs. Funding to U.S. national labs or salary support of scientists employed at these labs is not allowed. Scientists employed at national labs may be non-funded participants in a proposal/project and funding may be used to support travel or local expenses related to the participation of the lab-based scientist in activities related to the project.

Complete RFP

Tourette Association of America Support for Research Consortia and Collaborative Research Projects

Organization: Tourette Association of America

Award amount: Undisclosed

Deadline: Rolling

Description: TAA has historically provided critical seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit. These efforts have demonstrated a direct impact on the patient and research community. TAA aims to continue supporting research efforts like these, that crossover different scientific and medical disciplines and that encourage collaboration among researchers and institutions.

Funding may be requested for planning meetings and/or project support.

TAA will accept Letters of Inquiry (LOIs) for this funding mechanism on a rolling basis. Please submit LOIs and any questions to claude.schofield@tourette.org.

Eligibility: See the complete funding opportunity for eligibility criteria.

Link to complete RFP

Vertex Investigator Sponsored Studies

Organization: Vertex

Award amount: Undisclosed

Deadline: Ongoing

Description: The Vertex Investigator Sponsored Study program supports independent, investigator-sponsored research designed to advance scientific knowledge of disease states, patient populations, and medical treatment, in alignment with their clinical and nonclinical areas of interest. Vertex works with leading researchers, doctors, public health experts and other collaborators who share their vision for transforming the lives of people with serious diseases, their families and society.

Funding and/or drug support may be available for the following categories of research:

  • Interventional clinical studies
  • Observational studies that support research into disease states, e.g., epidemiological and outcomes studies
  • Non-clinical studies using Vertex compounds for in vitro assays or in vivo models

CF Areas of Interest:

  • Natural history in cystic fibrosis (CF) and evaluation of novel biomarkers and outcome measures
  • Disease modification with cystic fibrosis transmembrane conductance regulator (CFTR) modulators
  • Impact of treatment with CFTR modulators early in disease course
  • Non-pulmonary effects of CFTR modulators
  • Broadening the knowledge of CFTR modulation in rare CFTR mutations
  • Impact of CFTR modulator use on patient and caregiver burden

Applications are being considered for the following:

  • CF disease state
  • Studies involving approved Vertex drugs

Eligibility: See the funding opportunity for eligibility criteria.

Link to complete RFP

Washington Research Foundation (WRF) Technology Commercialization Grants

Organization: Washington Research Foundation

Award amount: up to $50,000.

Deadline: Rolling

Description: WRF supports translational research in STEM, with a focus on life sciences. Researchers are encouraged to submit a pre-proposal for initial funding of up to $50,000. WRF’s goal is to accelerate the advancement of products and services with public benefit.

Eligibility: see complete RFP for more information

Complete RFP

Wellcome Trust Innovator Awards

OrganizationThe Wellcome Trust

Award amount: Up to £500,000, or up to £750,000 for multidisciplinary collaborations

Deadline: Rolling biannually.

Description: The Innovator Awards support researchers who are transforming great ideas into healthcare innovations that could have a significant impact on human health.

Eligibility: Innovator Awards are open to researchers who are developing healthcare innovations that could have a major and measurable impact on human health. Individuals and teams from not-for-profit and commercial organizations can apply. See ‘key dates’ on this page for information on which application round you can apply to. Organizations can be of any size, but they must be established and/or have working capital. They can be based anywhere in the world (apart from mainland China). You can work in any scientific discipline, including a discipline outside life sciences. You can work on any type of technology. Examples of technologies include:

  • therapeutics (small molecules or biologics)
  • vaccines
  • devices
  • diagnostics
  • digital technologies
  • regenerative medicine.

See the complete RFP for multidisciplinary collaborations and partnerships eligibility.

Link to complete RFP